Difference between revisions of "LncRNAWiki:Featured"

From LncRNAWiki
Jump to: navigation, search
Line 2: Line 2:
 
Jump to section in alphabetical order :  [[LncRNAWiki:A|'''A''']] [[LncRNAWiki:B|'''B''']] [[LncRNAWiki:C|'''C''']] [[LncRNAWiki:D|'''D''']] [[LncRNAWiki:E|'''E''']] [[LncRNAWiki:F|'''F''']] [[LncRNAWiki:G|'''G''']] [[LncRNAWiki:H|'''H''']] [[LncRNAWiki:I|'''I''']] [[LncRNAWiki:J|'''J''']] [[LncRNAWiki:K|'''K''']] [[LncRNAWiki:L|'''L''']] [[LncRNAWiki:M|'''M''']] [[LncRNAWiki:N|'''N''']] [[LncRNAWiki:O|'''O''']] [[LncRNAWiki:P|'''P''']] [[LncRNAWiki:R|'''R''']] [[LncRNAWiki:S|'''S''']] [[LncRNAWiki:T|'''T''']] [[LncRNAWiki:U|'''U''']] [[LncRNAWiki:V|'''V''']] [[LncRNAWiki:W|'''W''']] [[LncRNAWiki:X|'''X''']] [[LncRNAWiki:Y|'''Y''']] [[LncRNAWiki:Z|'''Z''']]
 
Jump to section in alphabetical order :  [[LncRNAWiki:A|'''A''']] [[LncRNAWiki:B|'''B''']] [[LncRNAWiki:C|'''C''']] [[LncRNAWiki:D|'''D''']] [[LncRNAWiki:E|'''E''']] [[LncRNAWiki:F|'''F''']] [[LncRNAWiki:G|'''G''']] [[LncRNAWiki:H|'''H''']] [[LncRNAWiki:I|'''I''']] [[LncRNAWiki:J|'''J''']] [[LncRNAWiki:K|'''K''']] [[LncRNAWiki:L|'''L''']] [[LncRNAWiki:M|'''M''']] [[LncRNAWiki:N|'''N''']] [[LncRNAWiki:O|'''O''']] [[LncRNAWiki:P|'''P''']] [[LncRNAWiki:R|'''R''']] [[LncRNAWiki:S|'''S''']] [[LncRNAWiki:T|'''T''']] [[LncRNAWiki:U|'''U''']] [[LncRNAWiki:V|'''V''']] [[LncRNAWiki:W|'''W''']] [[LncRNAWiki:X|'''X''']] [[LncRNAWiki:Y|'''Y''']] [[LncRNAWiki:Z|'''Z''']]
 
</div>
 
</div>
−
{|class="wikitable sortable" style="width:90%;text-align:center"
+
{|class="wikitable sortable" style="width:80%;text-align:center"
 
|-
 
|-
 
!Name
 
!Name
Line 8: Line 8:
 
!Alias
 
!Alias
 
!Description
 
!Description
 +
!Disease
 
|-
 
|-
 
|''21A''
 
|''21A''
Line 13: Line 14:
 
|ncRNA 21A
 
|ncRNA 21A
 
|N/A
 
|N/A
 +
|_
 
|-
 
|-
 
|''7SK''
 
|''7SK''
 
|[[NONHSAT113149]]
 
|[[NONHSAT113149]]
−
|7-3 RNA, K-RNA, 7SK-RNA, 7SK snRNA, RN7SK, ENSG00000202198
+
|"7-3 RNA, K-RNA, 7SK-RNA, 7SK snRNA, RN7SK, ENSG00000202198"
−
|RNA, 7SK small nuclear
+
|"RNA, 7SK small nuclear"
 +
|AIDS,cardiac hypertrophy,gastric cancer
 
|-
 
|-
 
|''7SL''
 
|''7SL''
 
|[[lnc-LRR1-1:1]]
 
|[[lnc-LRR1-1:1]]
−
|7S RNA, SRP RNA, 4.5S SRP RNA, 4.5S RNA, RN7SL1 RNA, ENSG00000258486
+
|"7S RNA, SRP RNA, 4.5S SRP RNA, 4.5S RNA, RN7SL1 RNA, ENSG00000258486"
−
|RNA, 7SL, cytoplasmic 1
+
|"RNA, 7SL, cytoplasmic 1"
 +
|AIDS,dermatomyositis
 
|-
 
|-
 
|''ABALON''
 
|''ABALON''
Line 28: Line 32:
 
|INXS
 
|INXS
 
|apoptotic BCL2L1-antisense long non-coding RNA
 
|apoptotic BCL2L1-antisense long non-coding RNA
 +
|tumor
 
|-
 
|-
 
|''AIRN''
 
|''AIRN''
 
|[[ENST00000609176.1]]
 
|[[ENST00000609176.1]]
−
|AIR, IGF2RAS
+
|"AIR, IGF2RAS"
 
|Antisense of IGF2R non-protein coding RNA
 
|Antisense of IGF2R non-protein coding RNA
 +
|alcoholic liver disease,chronic nonalcoholic liver disease, hepatocelluar carcinoma
 
|-
 
|-
 
|''APOA1-AS''
 
|''APOA1-AS''
Line 38: Line 44:
 
|APOA1 antisense RNA
 
|APOA1 antisense RNA
 
|N/A
 
|N/A
 +
|_
 
|-
 
|-
 
|''APTR''
 
|''APTR''
Line 43: Line 50:
 
|Alu-mediated CDKN1A/p21
 
|Alu-mediated CDKN1A/p21
 
|N/A
 
|N/A
 +
|liver cirrhosis
 
|-
 
|-
 
|''BANCR''
 
|''BANCR''
Line 48: Line 56:
 
|LINC00586
 
|LINC00586
 
|BRAF-activated non-protein coding RNA
 
|BRAF-activated non-protein coding RNA
 +
|osteosarcoma, hepatocellular carcinoma, gastric cancer
 
|-
 
|-
 
|''BDNF-AS''
 
|''BDNF-AS''
 
|[[ENST00000499008.3]]
 
|[[ENST00000499008.3]]
 
|BDNF antisense RNA
 
|BDNF antisense RNA
−
|BT2A, BT2B,BT2C,BT2D,NCRNA00049,BDNF-AS1, NCRNA00049
+
|"BT2A, BT2B,BT2C,BT2D,NCRNA00049,BDNF-AS1, NCRNA00049"
 +
|Huntington's disease, psychiatric disease, schizophrenia, obesity
 
|-
 
|-
 
|''BLACAT1''
 
|''BLACAT1''
 
|[[BLACAT1]]
 
|[[BLACAT1]]
−
|linc-UBC1,LINC00912, onco-lncRNA-30
+
|"linc-UBC1,LINC00912, onco-lncRNA-30"
 
|bladder cancer associated transcript 1 (non-protein coding)
 
|bladder cancer associated transcript 1 (non-protein coding)
 +
|bladder cancer
 
|-
 
|-
 
|''CAHM''
 
|''CAHM''
Line 63: Line 74:
 
|LINC00468
 
|LINC00468
 
|colon adenocarcinoma hypermethylated (non-protein coding)
 
|colon adenocarcinoma hypermethylated (non-protein coding)
 +
|colorectal neoplasia.
 
|-
 
|-
 
|''PTCSC1''
 
|''PTCSC1''
Line 68: Line 80:
 
|AK023948
 
|AK023948
 
|papillary thyroid carcinoma susceptibility candidate 1 (non-protein coding)
 
|papillary thyroid carcinoma susceptibility candidate 1 (non-protein coding)
 +
|thyroid carcinoma
 
|-
 
|-
 
|''BCYRN1''
 
|''BCYRN1''
 
|[[lnc-EPCAM-1:2]]
 
|[[lnc-EPCAM-1:2]]
−
|BC200,BC200a, NCRNA00004, LINC00004
+
|"BC200,BC200a, NCRNA00004, LINC00004"
−
|BCYRN1, brain cytoplasmic RNA 1
+
|"BCYRN1, brain cytoplasmic RNA 1"
 +
|"Alzheimer's disease,breast cancer,cervical cancer, lung cancer,oesophagus cancer, ovarian cancer, parotid cancer,tongue cancer"
 
|-
 
|-
 
|''BPESC1''
 
|''BPESC1''
 
|[[ENST00000418282.1]]
 
|[[ENST00000418282.1]]
 
|NCRNA00187
 
|NCRNA00187
−
|blepharophimosis, epicanthus inversus and ptosis, candidate 1 (non-protein coding)
+
|"blepharophimosis, epicanthus inversus and ptosis, candidate 1 (non-protein coding)"
 +
|blepharophimosis syndrome
 
|-
 
|-
 
|''CYP4A22-AS1''
 
|''CYP4A22-AS1''
 
|[[ENST00000444042.2]]
 
|[[ENST00000444042.2]]
−
|Noncoding RNA activating3: ncRNA-a3, ENST00000444042.2, ENSG00000225506
+
|"Noncoding RNA activating3: ncRNA-a3, ENST00000444042.2, ENSG00000225506"
 
|CYP4A22 antisense RNA 1
 
|CYP4A22 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''CASC8''
 
|''CASC8''
 
|[[CASC8]]
 
|[[CASC8]]
−
|LINC00860,CARLo-1
+
|"LINC00860,CARLo-1"
 
|cancer susceptibility candidate 8 (non-protein coding)
 
|cancer susceptibility candidate 8 (non-protein coding)
 +
|"Colorectal Cancer,Lung Cancer"
 
|-
 
|-
 
|''CCAT1''
 
|''CCAT1''
 
|[[NONHSAT129017]]
 
|[[NONHSAT129017]]
−
|CARLo-5, onco-lncRNA-40
+
|"CARLo-5, onco-lncRNA-40"
 
|colon cancer associated transcript 1 (non-protein coding)
 
|colon cancer associated transcript 1 (non-protein coding)
 +
|"colorectal cancer,gastric cancer"
 
|-
 
|-
 
|''CCAT2''
 
|''CCAT2''
 
|[[CCAT2]]
 
|[[CCAT2]]
−
|NCCP1, LINC00873
+
|"NCCP1, LINC00873"
 
|colon cancer associated transcript 2 (non-protein coding)
 
|colon cancer associated transcript 2 (non-protein coding)
 +
|non-small cell lung cancer
 
|-
 
|-
 
|''CISTR''
 
|''CISTR''
 
|[[NONHSAT028496]]
 
|[[NONHSAT028496]]
−
|CISTR-ACT, CISTRACT, re52431
+
|"CISTR-ACT, CISTRACT, re52431"
 
|chondrogenesis-associated transcript
 
|chondrogenesis-associated transcript
 +
|_
 
|-
 
|-
 
|''CRNDE''
 
|''CRNDE''
 
|[[Lnc-IRX3-4:2]]
 
|[[Lnc-IRX3-4:2]]
−
|LOC643911, LINC00180, CRNDEP
+
|"LOC643911, LINC00180, CRNDEP"
 
|colorectal neoplasia differentially expressed (non-protein coding)
 
|colorectal neoplasia differentially expressed (non-protein coding)
 +
|colorectal cancer
 
|-
 
|-
 
|''CYYR1-AS1''
 
|''CYYR1-AS1''
Line 113: Line 134:
 
|cysteine and tyrosine rich 1 antisense RNA 1
 
|cysteine and tyrosine rich 1 antisense RNA 1
 
|N/A
 
|N/A
 +
|_
 
|-
 
|-
 
|''DALIR''
 
|''DALIR''
Line 118: Line 140:
 
|DALI
 
|DALI
 
|DNMT1-associated long intergenic non-coding RNA
 
|DNMT1-associated long intergenic non-coding RNA
 +
|_
 
|-
 
|-
 
|''DANCR''
 
|''DANCR''
 
|[[NONHSAT096369]]
 
|[[NONHSAT096369]]
 
|differentiation antagonizing non-protein coding RNA
 
|differentiation antagonizing non-protein coding RNA
−
|ANCR, AGU2, lncRNA-ANCR
+
|"ANCR, AGU2, lncRNA-ANCR"
 +
|bone diseases
 
|-
 
|-
 
|''DBET''
 
|''DBET''
 
|[[NONHSAT099821]]
 
|[[NONHSAT099821]]
−
|DBE-T, DUX4L30
+
|"DBE-T, DUX4L30"
 
|D4Z4 binding element transcript (non-protein coding)
 
|D4Z4 binding element transcript (non-protein coding)
 +
|"Pancreatic ductal adenocarcinoma, Facioscapulohumeral muscular dystrophy"
 
|-
 
|-
 
|''DHFR upstream transcripts''
 
|''DHFR upstream transcripts''
 
|[[NONHSAT102417]]
 
|[[NONHSAT102417]]
−
| DHFR minor transcript 5'-UTR, ENSG00000228716
+
|"DHFR minor transcript 5'-UTR, ENSG00000228716"
−
| N/A
+
|N/A
 +
|_
 
|-
 
|-
 
|''DHRS4-AS1''
 
|''DHRS4-AS1''
 
|[[NONHSAT035954]]
 
|[[NONHSAT035954]]
 
|DHRS4 antisense RNA 1
 
|DHRS4 antisense RNA 1
−
|PRO1488,AS1DHRS4
+
|"PRO1488,AS1DHRS4"
 +
|_
 
|-
 
|-
 
|''DLEU1''
 
|''DLEU1''
 
|[[NONHSAT033797]]
 
|[[NONHSAT033797]]
 
|deleted in lymphocytic leukemia 1 (non-protein coding)
 
|deleted in lymphocytic leukemia 1 (non-protein coding)
−
|LEU1, XTP6, NCRNA00021, LINC00021, BCMS1
+
|"LEU1, XTP6, NCRNA00021, LINC00021, BCMS1"
 +
|chronic lymphocytic leukemia
 
|-
 
|-
 
|''DLEU2''
 
|''DLEU2''
 
|[[NONHSAT033821]]
 
|[[NONHSAT033821]]
 
|deleted in lymphocytic leukemia 2 (non-protein coding)
 
|deleted in lymphocytic leukemia 2 (non-protein coding)
−
|LEU2, TRIM13OS, NCRNA00022, LINC00022, MIR15AHG
+
|"LEU2, TRIM13OS, NCRNA00022, LINC00022, MIR15AHG"
 +
|"chronic lymphocytic leukemia, lymphocytic leukemia, myeloma"
 
|-
 
|-
 
|''DISC2''
 
|''DISC2''
 
|[[NONHSAT010191]]
 
|[[NONHSAT010191]]
−
|DISC1-AS1, DISC1OS, NCRNA00015
+
|"DISC1-AS1, DISC1OS, NCRNA00015"
 
|disrupted in schizophrenia 2 (non-protein coding)
 
|disrupted in schizophrenia 2 (non-protein coding)
 +
|"affective disorders, Autism spectrum disorder, bipolar disorder, depression, schizophrenia"
 
|-
 
|-
 
|''EGOT''
 
|''EGOT''
 
|[[NONHSAT087635]]
 
|[[NONHSAT087635]]
−
|EGO, "eosinophil granule ontogeny", NCRNA00190, "non-protein coding RNA 190", ENSG00000235947
+
|"EGO, ""eosinophil granule ontogeny"", NCRNA00190, ""non-protein coding RNA 190"", ENSG00000235947"
 
|Eosinophil granule ontogeny (EGO) RNA
 
|Eosinophil granule ontogeny (EGO) RNA
 +
|"breast cancer,"
 
|-
 
|-
 
|''EMX2OS''
 
|''EMX2OS''
 
|[[lnc-PDZD8-3:1]]
 
|[[lnc-PDZD8-3:1]]
−
|EMX2-AS1, NCRNA00045, "non-protein coding RNA 45",ENSG00000229847
+
|"EMX2-AS1, NCRNA00045, ""non-protein coding RNA 45"",ENSG00000229847"
 
|Emx2 opposite strand transcript.
 
|Emx2 opposite strand transcript.
 +
|_
 
|-
 
|-
 
|''ERICD''
 
|''ERICD''
 
|[[Lnc-CHRAC1-2:1]]
 
|[[Lnc-CHRAC1-2:1]]
−
|TCONS_00014875, ERIC
+
|"TCONS_00014875, ERIC"
 
|E2F1-regulated inhibitor of cell death (non-protein coding)
 
|E2F1-regulated inhibitor of cell death (non-protein coding)
 +
|_
 
|-
 
|-
 
|''ESRG''
 
|''ESRG''
Line 173: Line 206:
 
|HESRG
 
|HESRG
 
|embryonic stem cell related (non-protein coding)
 
|embryonic stem cell related (non-protein coding)
 +
|"embryonal carcinoma, intracranial aneurism"
 
|-
 
|-
 
|''Evf2''
 
|''Evf2''
 
|[[lnc-DLX5-3:1]]
 
|[[lnc-DLX5-3:1]]
−
|Evf-2, Dlx6as1, Dlx6os1, ENSG00000231764
+
|"Evf-2, Dlx6as1, Dlx6os1, ENSG00000231764"
−
|
+
|_
 +
|_
 
|-
 
|-
 
|''FENDRR''
 
|''FENDRR''
 
|[[FENDRR]]
 
|[[FENDRR]]
 
|FOXF1 adjacent non-coding developmental regulatory RNA
 
|FOXF1 adjacent non-coding developmental regulatory RNA
−
|lincFOXF1, onco-lncRNA-21
+
|"lincFOXF1, onco-lncRNA-21"
 +
|Heart Failure
 
|-
 
|-
 
|''FIRRE''
 
|''FIRRE''
Line 188: Line 224:
 
|firre intergenic repeating RNA element
 
|firre intergenic repeating RNA element
 
|LINC01200
 
|LINC01200
 +
|_
 
|-
 
|-
 
|''FOXCUT''
 
|''FOXCUT''
−
|[[Lnc-FOXC1-1:1]],[[NONHSAT106529]]
+
|[["Lnc-FOXC1-1:1,NONHSAT106529"]]
 
|TCONS_00011636
 
|TCONS_00011636
 
|FOXC1 upstream transcript (non-protein coding)
 
|FOXC1 upstream transcript (non-protein coding)
 +
|"esophageal squamous cell carcinoma, basal-like breast cancer"
 
|-
 
|-
 
|''FTX''
 
|''FTX''
 
|[[ENST00000602812.1]]
 
|[[ENST00000602812.1]]
−
|LINC00182,FLJ33139
+
|"LINC00182,FLJ33139"
−
|FTX transcript, XIST regulator (non-protein coding)
+
|"FTX transcript, XIST regulator (non-protein coding)"
 +
|"hepatocellular carcinoma, colorectal cancer"
 
|-
 
|-
 
|''GHET1''
 
|''GHET1''
Line 203: Line 242:
 
|lncRNA-GHET1
 
|lncRNA-GHET1
 
|gastric carcinoma proliferation enhancing transcript 1
 
|gastric carcinoma proliferation enhancing transcript 1
 +
|gastric cancer
 
|-
 
|-
 
|''GHRLOS''
 
|''GHRLOS''
 
|[[NONHSAT087920]]
 
|[[NONHSAT087920]]
−
|NCRNA00068,GHRL-AS1
+
|"NCRNA00068,GHRL-AS1"
 
|ghrelin opposite strand/antisense RNA
 
|ghrelin opposite strand/antisense RNA
 +
|"obesity, diabetes and cancer"
 
|-
 
|-
 
|''GPR1-AS''
 
|''GPR1-AS''
Line 213: Line 254:
 
|GPR1AS
 
|GPR1AS
 
|GPR1 antisense RNA
 
|GPR1 antisense RNA
 +
|_
 
|-
 
|-
 
|''HAGLR''
 
|''HAGLR''
−
|[[ENST00000416928.2]],[[NONHSAT075638]]
+
|[["ENST00000416928.2,NONHSAT075638"]]
 
|Mdgt
 
|Mdgt
 
|HOXD antisense growth-associated long non-coding RNA
 
|HOXD antisense growth-associated long non-coding RNA
 +
|neuroblastoma
 
|-
 
|-
 
|''HEIH''
 
|''HEIH''
 
|[[HEIH]]
 
|[[HEIH]]
−
|LINC-HEIH, lncRNA-HEIH, LINC00848, HCCAT2
+
|"LINC-HEIH, lncRNA-HEIH, LINC00848, HCCAT2"
 
|hepatocellular carcinoma up-regulated EZH2-associated long non-coding RNA
 
|hepatocellular carcinoma up-regulated EZH2-associated long non-coding RNA
 +
|hepatocelluar carcinoma
 
|-
 
|-
 
|''JADRR''
 
|''JADRR''
Line 228: Line 272:
 
|lncRNA-JADE
 
|lncRNA-JADE
 
|JADE1 adjacent regulatory RNA
 
|JADE1 adjacent regulatory RNA
 +
|breast cancer
 
|-
 
|-
 
|''KANTR''
 
|''KANTR''
Line 233: Line 278:
 
|KDM5C adjacent non-coding transcript
 
|KDM5C adjacent non-coding transcript
 
|Spasm
 
|Spasm
 +
|_
 
|-
 
|-
 
|''LINC-PINT''
 
|''LINC-PINT''
 
|[[NONHSAT123382]]
 
|[[NONHSAT123382]]
−
|FLJ43663, PINT, LincRNA-Pint
+
|"FLJ43663, PINT, LincRNA-Pint"
−
|long intergenic non-protein coding RNA, p53 induced transcript
+
|"long intergenic non-protein coding RNA, p53 induced transcript"
 +
|pancreatic cancer
 
|-
 
|-
 
|''LINC00163''
 
|''LINC00163''
 
|[[LINC00163]]
 
|[[LINC00163]]
−
|NLC1-A, NLC1A
+
|"NLC1-A, NLC1A"
 
|long intergenic non-protein coding RNA 163
 
|long intergenic non-protein coding RNA 163
 +
|_
 
|-
 
|-
 
|''LINC00312''
 
|''LINC00312''
 
|[[NONHSAT087716]]
 
|[[NONHSAT087716]]
−
|NAG7, NAG-7, ERR10, LMCD1DN, ERR-10
+
|"NAG7, NAG-7, ERR10, LMCD1DN, ERR-10"
 
|long intergenic non-protein coding RNA 312
 
|long intergenic non-protein coding RNA 312
 +
|nasopharyngeal carcinoma
 
|-
 
|-
 
|''LINC00850''
 
|''LINC00850''
Line 253: Line 302:
 
|KUCG1
 
|KUCG1
 
|long intergenic non-protein coding RNA 850
 
|long intergenic non-protein coding RNA 850
 +
|_
 
|-
 
|-
 
|''LINC01191''
 
|''LINC01191''
 
|[[ENST00000412690.1]]
 
|[[ENST00000412690.1]]
−
|VIN, lnc-ACTR3
+
|"VIN, lnc-ACTR3"
 
|long intergenic non-protein coding RNA 1191
 
|long intergenic non-protein coding RNA 1191
 +
|_
 
|-
 
|-
 
|''LSINCT5''
 
|''LSINCT5''
Line 263: Line 314:
 
|N/A
 
|N/A
 
|long stress-induced non-coding transcript 5
 
|long stress-induced non-coding transcript 5
 +
|"gastric cancer,breast and ovarian cancer"
 
|-
 
|-
 
|''LUCAT1''
 
|''LUCAT1''
Line 268: Line 320:
 
|SCAL1
 
|SCAL1
 
|lung cancer associated transcript 1 (non-protein coding)
 
|lung cancer associated transcript 1 (non-protein coding)
 +
|non-small cell lung cancer
 
|-
 
|-
 
|''MIR22HG''
 
|''MIR22HG''
 
|[[ENST00000574306.1]]
 
|[[ENST00000574306.1]]
−
|MGC14376, DKFZp686O06159, LOC554202
+
|"MGC14376, DKFZp686O06159, LOC554202"
 
|MIR22 host gene
 
|MIR22 host gene
 +
|_
 
|-
 
|-
 
|''MIR31HG''
 
|''MIR31HG''
Line 278: Line 332:
 
|LOC554202
 
|LOC554202
 
|MIR31 host gene
 
|MIR31 host gene
 +
|"gastric cancer, pancreatic ductal adenocarcinoma"
 
|-
 
|-
 
|''MIR99AHG''
 
|''MIR99AHG''
Line 283: Line 338:
 
|MONC
 
|MONC
 
|mir-99a-let-7c cluster host gene
 
|mir-99a-let-7c cluster host gene
 +
|myeloid leukemia
 
|-
 
|-
 
|''MIR100HG''
 
|''MIR100HG''
 
|[[ENST00000531381.1]]
 
|[[ENST00000531381.1]]
−
|AGD1, lncRNA-N2
+
|"AGD1, lncRNA-N2"
 
|mir-100-let-7a-2 cluster host gene
 
|mir-100-let-7a-2 cluster host gene
 +
|myeloid leukemia
 
|-
 
|-
 
|''MIR155HG''
 
|''MIR155HG''
 
|[[NONHSAT081499]]
 
|[[NONHSAT081499]]
−
|BIC, NCRNA00172
+
|"BIC, NCRNA00172"
 
|MIR155 host gene
 
|MIR155 host gene
 +
|chronic lymphocytic leukemia
 
|-
 
|-
 
|''MIR222HG''
 
|''MIR222HG''
Line 298: Line 356:
 
|Lnc-Ang362
 
|Lnc-Ang362
 
|MIR222 host gene
 
|MIR222 host gene
 +
|Ang II-associated cardiovascular disease
 
|-
 
|-
 
|''MIR503HG''
 
|''MIR503HG''
 
|[[ENST00000414769.1]]
 
|[[ENST00000414769.1]]
−
|MGC16121, H19X
+
|"MGC16121, H19X"
 
|MIR503 host gene
 
|MIR503 host gene
 +
|choriocarcinoma
 
|-
 
|-
 
|''MYCNUT''
 
|''MYCNUT''
Line 308: Line 368:
 
|lncUSMycN
 
|lncUSMycN
 
|MYCN upstream transcript (non-protein coding)
 
|MYCN upstream transcript (non-protein coding)
 +
|neuroblastoma
 
|-
 
|-
 
|''NAMA''
 
|''NAMA''
 
|[[ENST00000604258.1]]
 
|[[ENST00000604258.1]]
 
|N/A
 
|N/A
−
|non-protein coding RNA, associated with MAP kinase pathway and growth arrest
+
|"non-protein coding RNA, associated with MAP kinase pathway and growth arrest"
 +
|papillary thyroid carcinoma
 
|-
 
|-
 
|''NRIR''
 
|''NRIR''
Line 318: Line 380:
 
|lncRNA-CMPK2
 
|lncRNA-CMPK2
 
|negative regulator of interferon response (non-protein coding)
 
|negative regulator of interferon response (non-protein coding)
 +
|_
 
|-
 
|-
 
|''OIP5-AS1''
 
|''OIP5-AS1''
 
|[[ENST00000500949.2]]
 
|[[ENST00000500949.2]]
−
|cyrano,LOC729082, linc-NUSAP1-1, OIP5-AS1
+
|"cyrano,LOC729082, linc-NUSAP1-1, OIP5-AS1"
 
|OIP5 antisense RNA 1
 
|OIP5 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''OVAAL''
 
|''OVAAL''
 
|[[ENST00000442621.1]]
 
|[[ENST00000442621.1]]
−
|LINC01131,OVAL
+
|"LINC01131,OVAL"
 
|ovarian adenocarcinoma amplified long non-coding RNA
 
|ovarian adenocarcinoma amplified long non-coding RNA
 +
|ovarian cancer
 
|-
 
|-
 
|''PACERR''
 
|''PACERR''
 
|[[ENST00000608917.1]]
 
|[[ENST00000608917.1]]
−
|PACER, PTGS2-AS1
+
|"PACER, PTGS2-AS1"
 
|PTGS2 antisense NFKB1 complex-mediated expression regulator RNA
 
|PTGS2 antisense NFKB1 complex-mediated expression regulator RNA
 +
|"1-PACER, as a new potential target for COX-2-modulation in inflammation and cancer."
 
|-
 
|-
 
|''PART1''
 
|''PART1''
 
|[[ENST00000506884.1]]
 
|[[ENST00000506884.1]]
−
|DKFZP586D0823, NCRNA00206
+
|"DKFZP586D0823, NCRNA00206"
 
|prostate androgen-regulated transcript 1 (non-protein coding)
 
|prostate androgen-regulated transcript 1 (non-protein coding)
 +
|prostate carcinogenesis
 
|-
 
|-
 
|''PAUPAR''
 
|''PAUPAR''
Line 343: Line 410:
 
|N/A
 
|N/A
 
|PAX6 upstream antisense RNA
 
|PAX6 upstream antisense RNA
 +
|_
 
|-
 
|-
 
|''PCA3''
 
|''PCA3''
 
|[[ENST00000412654.1]]
 
|[[ENST00000412654.1]]
−
|DD3, NCRNA00019, PCAT3
+
|"DD3, NCRNA00019, PCAT3"
 
|prostate cancer associated 3 (non-protein coding)
 
|prostate cancer associated 3 (non-protein coding)
 +
|Prostate Cancer
 
|-
 
|-
 
|''PCAT1''
 
|''PCAT1''
 
|[[ENST00000561978.1]]
 
|[[ENST00000561978.1]]
−
|PCAT-1, PCA1
+
|"PCAT-1, PCA1"
 
|prostate cancer associated transcript 1 (non-protein coding)
 
|prostate cancer associated transcript 1 (non-protein coding)
 +
|Prostate Cancer
 
|-
 
|-
 
|''PCAT4''
 
|''PCAT4''
 
|[[ENST00000504263.1]]
 
|[[ENST00000504263.1]]
−
|GDEP, PCAN1, PCA4
+
|"GDEP, PCAN1, PCA4"
 
|prostate cancer associated transcript 4 (non-protein coding)
 
|prostate cancer associated transcript 4 (non-protein coding)
 +
|Prostate Cancer
 
|-
 
|-
 
|''PCAT7''
 
|''PCAT7''
Line 363: Line 434:
 
|PCAN-R2
 
|PCAN-R2
 
|prostate cancer associated transcript 7 (non-protein coding)
 
|prostate cancer associated transcript 7 (non-protein coding)
 +
|Prostate Cancer
 
|-
 
|-
 
|''PRNCR1''
 
|''PRNCR1''
Line 368: Line 440:
 
|N/A
 
|N/A
 
|prostate cancer associated non-coding RNA 1
 
|prostate cancer associated non-coding RNA 1
 +
|Prostate Cancer
 
|-
 
|-
 
|''PTCSC2''
 
|''PTCSC2''
Line 373: Line 446:
 
|N/A
 
|N/A
 
|papillary thyroid carcinoma susceptibility candidate 2 (non-protein coding)
 
|papillary thyroid carcinoma susceptibility candidate 2 (non-protein coding)
 +
|papillary thyroid carcinoma
 
|-
 
|-
 
|''PTCSC3''
 
|''PTCSC3''
Line 378: Line 452:
 
|N/A
 
|N/A
 
|papillary thyroid carcinoma susceptibility candidate 3 (non-protein coding)
 
|papillary thyroid carcinoma susceptibility candidate 3 (non-protein coding)
 +
|psoriasis
 
|-
 
|-
 
|''PVT1''
 
|''PVT1''
 
|[[ENST00000513868.2]]
 
|[[ENST00000513868.2]]
−
|NCRNA00079, LINC00079, onco-lncRNA-100
+
|"NCRNA00079, LINC00079, onco-lncRNA-100"
 
|Pvt1 oncogene (non-protein coding)
 
|Pvt1 oncogene (non-protein coding)
 +
|"breast cancer, Burkitt's lymphomas, diabetic nephropathy, Hodgkin's lymphoma, lymphoma, murine plasmacytomas, ovarian cancer, pancreas cancer, prostate cancer,renal cancer"
 
|-
 
|-
 
|''PWRN1''
 
|''PWRN1''
Line 388: Line 464:
 
|NCRNA00198
 
|NCRNA00198
 
|Prader-Willi region non-protein coding RNA 1
 
|Prader-Willi region non-protein coding RNA 1
 +
|Prader-Willi syndrome
 
|-
 
|-
 
|''PWRN2''
 
|''PWRN2''
Line 393: Line 470:
 
|NCRNA00199
 
|NCRNA00199
 
|Prader-Willi region non-protein coding RNA 2
 
|Prader-Willi region non-protein coding RNA 2
 +
|Prader-Willi syndrome
 
|-
 
|-
 
|''RASSF1-AS1''
 
|''RASSF1-AS1''
Line 398: Line 476:
 
|RASSF1 antisense RNA 1
 
|RASSF1 antisense RNA 1
 
|ANRASSF1
 
|ANRASSF1
 +
|breast cancer
 
|-
 
|-
 
|''SCAANT1''
 
|''SCAANT1''
Line 403: Line 482:
 
|SCA7/ATXN7 antisense RNA 1
 
|SCA7/ATXN7 antisense RNA 1
 
|ATXN7-AS1
 
|ATXN7-AS1
 +
|Spinocerebellar ataxia type 7
 
|-
 
|-
 
|''SCHLAP1''
 
|''SCHLAP1''
 
|[[NONHSAT075852]]
 
|[[NONHSAT075852]]
 
|SWI/SNF complex antagonist associated with prostate cancer 1 (non-protein coding)
 
|SWI/SNF complex antagonist associated with prostate cancer 1 (non-protein coding)
−
|SChLAP1,PCAT11
+
|"SChLAP1,PCAT11"
 +
|prostate cancer
 
|-
 
|-
 
|''SENCR''
 
|''SENCR''
Line 413: Line 494:
 
|smooth muscle and endothelial cell enriched migration/differentiation-associated long non-coding RNA
 
|smooth muscle and endothelial cell enriched migration/differentiation-associated long non-coding RNA
 
|N/A
 
|N/A
 +
|_
 
|-
 
|-
 
|''TARID''
 
|''TARID''
Line 418: Line 500:
 
|N/A
 
|N/A
 
|TCF21 antisense RNA inducing promoter demethylation
 
|TCF21 antisense RNA inducing promoter demethylation
 +
|_
 
|-
 
|-
 
|''WFDC21P''
 
|''WFDC21P''
 
|[[Lnc-HEATR6-1:4]]
 
|[[Lnc-HEATR6-1:4]]
−
|WAP four-disulfide core domain 21, pseudogene
+
|"WAP four-disulfide core domain 21, pseudogene"
−
|LOC645638, lnc-DC, LNCDC
+
|"LOC645638, lnc-DC, LNCDC"
 +
|_
 
|-
 
|-
 
|''GAS5''
 
|''GAS5''
 
|[[NONHSAT007663]]
 
|[[NONHSAT007663]]
−
|SNHG2, ENSG00000234741  
+
|"SNHG2, ENSG00000234741"
−
|
+
|_
 +
|"autoimmune disease, B-cell neoplasms, breast cancer, kidney cancer, lymphoma, prostate cancer, melanoma, systemic lupus erythaematosus"
 
|-
 
|-
 
|''MIAT''
 
|''MIAT''
 
|[[lnc-CRYBA4-2:1]]
 
|[[lnc-CRYBA4-2:1]]
−
|FLJ25967, gomafu, LINC00066, lncRNA-MIAT, "long intergenic non-protein coding RNA 66", NCRNA00066, "non-protein coding RNA 66", Rncr2
+
|"FLJ25967, gomafu, LINC00066, lncRNA-MIAT, ""long intergenic non-protein coding RNA 66"", NCRNA00066, ""non-protein coding RNA 66"", Rncr2"
 
|myocardial infarction associated transcript (non-protein coding)
 
|myocardial infarction associated transcript (non-protein coding)
 +
|myocardial infarction
 
|-
 
|-
 
|''H19''
 
|''H19''
 
|[[NONHSAT017465]]
 
|[[NONHSAT017465]]
−
|Q96MK8,ENSG00000130600
+
|"Q96MK8,ENSG00000130600"
−
|H19, imprinted maternally expressed transcript (non-protein coding)
+
|"H19, imprinted maternally expressed transcript (non-protein coding)"
 +
|"bladder cancer, breast cancer, cervical cancer, choricarcinoma, colon cancer, Congenital hyperinsulinism, Esophageal squamous cell cancer, gastric cancer, germ cell tumor, gestational choriocarcinoma, glioblastoma, glioma, growth restriction, hematopoiesis, infertility, kidney cancer, liver cancer, lung cancer, Marek's disease, Medulloblastoma, melanoma, Meningioma, Mullerian aplasia, myeloproliferative polycythaemia vera, neural tube defects, neuroblastoma, obesity, ovarian cancer, pheochromocytoma, pituitary adenoma, Prader-Willi syndrome, pre-eclampsia, prostate cancer, Silver-Russell syndrome, Wiedemann-Beckwith syndrome, Wilms' tumor"
 
|-
 
|-
 
|''HAR1A''
 
|''HAR1A''
 
|[[lnc-BIRC7-2:1]]
 
|[[lnc-BIRC7-2:1]]
−
|HAR1F, ENSG00000238820
+
|"HAR1F, ENSG00000238820"
 
|highly accelerated region 1A
 
|highly accelerated region 1A
 +
|"Alzheimer's disease,Huntington's disease, schizophrenia"
 
|-
 
|-
 
|''HAR1B''
 
|''HAR1B''
 
|[[ENST00000447910.2]]
 
|[[ENST00000447910.2]]
−
|HAR1R, ENSG00000231133
+
|"HAR1R, ENSG00000231133"
 
|highly accelerated region 1B
 
|highly accelerated region 1B
 +
|"Huntington's disease, schizophrenia"
 
|-
 
|-
 
|''HOTAIR''
 
|''HOTAIR''
 
|[[NONHSAT028508]]
 
|[[NONHSAT028508]]
−
|Gm16258, Hox antisense intergenic RNA, ENSG00000228630  
+
|"Gm16258, Hox antisense intergenic RNA, ENSG00000228630"
 
|Hox antisense intergenic RNA
 
|Hox antisense intergenic RNA
 +
|B-cell neoplasms,breast cancer,cervical cancer,colon cancer,colorectal cancer,endometrial cancer,gastric cancer,hepatocelluar carcinoma,laryngeal squamous cell carcinoma,liver cancer,lung adenocarcinoma,nasopharyngeal carcinoma,non-small cell lung cancer,oesophageal squamous cell carcinoma,oral squamous cell carcinoma,pancreas cancer,rheumatoid arthritis,small cell lung cancer
 
|-
 
|-
 
|''HOTAIRM1''
 
|''HOTAIRM1''
 
|[[lnc-EVX1-12:1]]
 
|[[lnc-EVX1-12:1]]
−
|HIT06113, HIT92376, linc1548, ENSG00000233429
+
|"HIT06113, HIT92376, linc1548, ENSG00000233429"
−
|HOXA transcript antisense RNA, myeloid-specific 1
+
|"HOXA transcript antisense RNA, myeloid-specific 1"
 +
|_
 
|-
 
|-
 
|''HOTTIP''
 
|''HOTTIP''
 
|[[NONHSAT119717]]
 
|[[NONHSAT119717]]
−
|HOXA13as, HIT18844, NCRNA00213, ENSG00000243766
+
|"HOXA13as, HIT18844, NCRNA00213, ENSG00000243766"
 
|HOXA transcript at the distal tip
 
|HOXA transcript at the distal tip
 +
|hepatocelluar carcinoma
 
|-
 
|-
 
|''HOXA11-AS''
 
|''HOXA11-AS''
 
|[[NONHSAT119704]]
 
|[[NONHSAT119704]]
−
|"HOXA cluster antisense RNA 5 (non-protein coding)", HOXA-AS5, "HOXA11 antisense RNA 1 (non-protein coding)", HOXA11-AS1, HOXA11S, NCRNA00076, "non-protein coding RNA 76", ENSG00000240990
+
|"HOXA cluster antisense RNA 5 (non-protein coding), HOXA-AS5, ""HOXA11 antisense RNA 1 (non-protein coding)"", HOXA11-AS1, HOXA11S, NCRNA00076, ""non-protein coding RNA 76"", ENSG00000240990"
 
|HOXA11 antisense RNA
 
|HOXA11 antisense RNA
 +
|"glioma, ovarian cancer"
 
|-
 
|-
 
|''HOXA-AS2''
 
|''HOXA-AS2''
 
|[[NONHSAT119676]]
 
|[[NONHSAT119676]]
−
|HOXA3as, ENSG00000253552
+
|"HOXA3as, ENSG00000253552"
 
|HOXA cluster antisense RNA 2
 
|HOXA cluster antisense RNA 2
 +
|gastric cancer
 
|-
 
|-
 
|''HOXA-AS3''
 
|''HOXA-AS3''
 
|[[lnc-EVX1-9:1]]
 
|[[lnc-EVX1-9:1]]
−
|HOXA6as  
+
|HOXA6as
 
|HOXA cluster antisense RNA 3
 
|HOXA cluster antisense RNA 3
 +
|_
 
|-
 
|-
 
|''HULC''
 
|''HULC''
Line 483: Line 578:
 
|ENSG00000251164
 
|ENSG00000251164
 
|hepatocellular carcinoma up-regulated long non-coding RNA
 
|hepatocellular carcinoma up-regulated long non-coding RNA
 +
|"hepatocelluar carcinoma, liver cancer"
 
|-
 
|-
 
|''IPW''
 
|''IPW''
Line 488: Line 584:
 
|NCRNA00002
 
|NCRNA00002
 
|imprinted in Prader-Willi syndrome
 
|imprinted in Prader-Willi syndrome
 +
|Prader-Willi syndrome
 
|-
 
|-
 
|''JPX''
 
|''JPX''
 
|[[lnc-ZCCHC13-1:1]]
 
|[[lnc-ZCCHC13-1:1]]
−
|DCBALD06, ENOX, "expressed neighbor of XIST", "just proximal to XIST", LINC00183
+
|"DCBALD06, ENOX, ""expressed neighbor of XIST"", ""just proximal to XIST"", LINC00183"
−
|JPX transcript, XIST activator (non-protein coding)
+
|"JPX transcript, XIST activator (non-protein coding)"
 +
|X chromosome inactivatio
 
|-
 
|-
 
|''KCNQ1OT1''
 
|''KCNQ1OT1''
 
|[[NONHSAT017524]]
 
|[[NONHSAT017524]]
−
|"KCNQ1 antisense RNA 2 (non-protein coding)", "KCNQ1 overlapping transcript 1 (non-protein coding)", KCNQ1-AS2, KvDMR1, KvLQT1-AS, LIT1, NCRNA00012, "non-protein coding RNA 12"
+
|"KCNQ1 antisense RNA 2 (non-protein coding), ""KCNQ1 overlapping transcript 1 (non-protein coding)"", KCNQ1-AS2, KvDMR1, KvLQT1-AS, LIT1, NCRNA00012, ""non-protein coding RNA 12"""
 
|KCNQ1 opposite strand/antisense transcript 1 (non-protein coding)
 
|KCNQ1 opposite strand/antisense transcript 1 (non-protein coding)
 +
|Beckwith-Wiedemann syndrome,colorectal cancer,hepatocelluar carcinoma,kidney cancer
 
|-
 
|-
 
|''KRASP1''
 
|''KRASP1''
 
|[[NONHSAT113225]]
 
|[[NONHSAT113225]]
−
|ENSG00000220635  
+
|ENSG00000220635
 
|KRAS Pseudogene 1
 
|KRAS Pseudogene 1
 +
|_
 
|-
 
|-
 
|''FALEC''
 
|''FALEC''
 
|[[ENST00000416894.1]]
 
|[[ENST00000416894.1]]
−
|LINC00568, "long intergenic non-protein coding RNA 568", ENSG00000228126.1
+
|"LINC00568, ""long intergenic non-protein coding RNA 568"", ENSG00000228126.1"
 
|focally amplified long non-coding RNA in epithelial cancer
 
|focally amplified long non-coding RNA in epithelial cancer
 +
|ovarian cancer
 
|-
 
|-
 
|''lincRNA-ROR''
 
|''lincRNA-ROR''
 
|[[NONHSAT059436]]
 
|[[NONHSAT059436]]
−
|ROR, lincRNA-ST8SIA3, ENSG00000258609
+
|"ROR, lincRNA-ST8SIA3, ENSG00000258609"
−
|long intergenic non-protein coding RNA, regulator of reprogramming
+
|"long intergenic non-protein coding RNA, regulator of reprogramming"
 +
|_
 
|-
 
|-
 
|''LOC100887755''
 
|''LOC100887755''
 
|[[lnc-SNAI1-1:1]]
 
|[[lnc-SNAI1-1:1]]
−
|Noncoding RNA activating7: ncRNA-a7, ENST00000431460.1,ENSG00000231265,TRERNA1
+
|"Noncoding RNA activating7: ncRNA-a7, ENST00000431460.1,ENSG00000231265,TRERNA1"
 
|translation regulatory long non-coding RNA 1
 
|translation regulatory long non-coding RNA 1
 +
|_
 
|-
 
|-
 
|''TUSC7''
 
|''TUSC7''
 
|[[NONHSAT091315]]
 
|[[NONHSAT091315]]
−
|LINC00902, LOC285194, ENSG00000243197
+
|"LINC00902, LOC285194, ENSG00000243197"
 
|tumor suppressor candidate 7 (non-protein coding)
 
|tumor suppressor candidate 7 (non-protein coding)
 +
|colorectal cancer
 
|-
 
|-
 
|''RBM5-AS1''
 
|''RBM5-AS1''
 
|[[NONHSAT089783]]
 
|[[NONHSAT089783]]
−
|"LUCA-15-specific transcript", LUST, ENSG00000003756  
+
|"LUCA-15-specific transcript, LUST, ENSG00000003756"
 
|RBM5 antisense RNA 1
 
|RBM5 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''MALAT1''
 
|''MALAT1''
 
|[[ENST00000534336.1]]
 
|[[ENST00000534336.1]]
−
|HCN, "hepcarcin", LINC00047, "long intergenic non-protein coding RNA 47", MALAT-1, mascRNA, "metastasis associated in lung adenocarcinoma transcript 1", NCRNA00047, NEAT2, "non-protein coding RNA 47", "nuclear enriched abundant transcript 2", "nuclear paraspeckle assembly transcript 2 (non-protein coding)", PRO1073, ENSG00000251562  
+
|"HCN, ""hepcarcin"", LINC00047, ""long intergenic non-protein coding RNA 47"", MALAT-1, mascRNA, ""metastasis associated in lung adenocarcinoma transcript 1"", NCRNA00047, NEAT2, ""non-protein coding RNA 47"", ""nuclear enriched abundant transcript 2"", ""nuclear paraspeckle assembly transcript 2 (non-protein coding)"", PRO1073, ENSG00000251562"
 
|metastasis associated lung adenocarcinoma transcript 1 (non-protein coding)
 
|metastasis associated lung adenocarcinoma transcript 1 (non-protein coding)
 +
|B-cell neoplasms,bladder cancer,breast cancer, cervial cancer, colon cancer, decreased myogenesis,Diabetes, endometrial cancer, gallbladder cancer, hepatocelluar carcinoma, kidney cancer, laryngeal squamous cell carcinoma, liver cancer, lung cancer, nasopharyngeal carcinoma, neuroblastoma, non-small cell lung cancer, osteosarcoma, pancreas cancer, prostate cancer, small cell lung cancer, uterus cancer
 
|-
 
|-
 
|''mascRNA''
 
|''mascRNA''
Line 538: Line 644:
 
|Malat1
 
|Malat1
 
|mascRNA (MALAT1-associated small cytoplasmic RNA)
 
|mascRNA (MALAT1-associated small cytoplasmic RNA)
 +
|_
 
|-
 
|-
 
|''MEG3''
 
|''MEG3''
 
|[[NONHSAT039745]]
 
|[[NONHSAT039745]]
−
|Gtl2, ENSG00000214548
+
|"Gtl2, ENSG00000214548"
 
|maternally expressed 3 (non-protein coding)
 
|maternally expressed 3 (non-protein coding)
 +
|bladder cancer, breast cancer, chronic myeloid leukemia, colon cancer, gastric cancer, glioma, hepatocelluar carcinoma, heroin abuse, Huntington's disease, kidney cancer, lung cancer, Meningioma, myelodysplastic syndrome, nonfunctioning pituitary adenomas, Pituitary adenoma, prostate cancer, type 1 diabetes
 
|-
 
|-
 
|''ncR-PAR''
 
|''ncR-PAR''
 
|[[NONHSAT102247]]
 
|[[NONHSAT102247]]
−
|NCRUPAR, ENSG00000225407
+
|"NCRUPAR, ENSG00000225407"
−
|non-protein coding RNA, upstream of F2R/PAR1
+
|"non-protein coding RNA, upstream of F2R/PAR1"
 +
|_
 
|-
 
|-
 
|''NDM29''
 
|''NDM29''
 
|[[lnc-C11orf16-1:1]]
 
|[[lnc-C11orf16-1:1]]
 
|29A
 
|29A
−
|neuroblastoma differentiation marker 29 ([http://www.ncbi.nlm.nih.gov/pubmed/20581224 Castelnuovo (2010)], [http://www.ncbi.nlm.nih.gov/pubmed/17274687 Pagano (2007)]).
+
|"neuroblastoma differentiation marker 29 (Castelnuovo (2010), Pagano (2007))."
 +
|neuroblastoma
 
|-
 
|-
 
|''GNAS-AS1''
 
|''GNAS-AS1''
 
|[[lnc-CTSZ-5:1]]
 
|[[lnc-CTSZ-5:1]]
−
|"GNAS antisense", GNAS1AS, NCRNA00075, NESP-AS, NESPAS, "non-protein coding RNA 75", SANG, ENSG00000235590  
+
|"GNAS antisense, GNAS1AS, NCRNA00075, NESP-AS, NESPAS, ""non-protein coding RNA 75"", SANG, ENSG00000235590"
 
|neuroendocrine secretory protein (Nesp) antisense.
 
|neuroendocrine secretory protein (Nesp) antisense.
 +
|pseudohypoparathyroidism type Ib
 
|-
 
|-
 
|''NRON''
 
|''NRON''
 
|[[NONHSAT134764]]
 
|[[NONHSAT134764]]
−
|ENSG00000253079  
+
|ENSG00000253079
−
|non-protein coding RNA, repressor of NFAT
+
|"non-protein coding RNA, repressor of NFAT"
 +
|AIDS
 
|-
 
|-
 
|''NTT''
 
|''NTT''
Line 568: Line 680:
 
|
 
|
 
|noncoding transcript in T cells.
 
|noncoding transcript in T cells.
 +
|_
 
|-
 
|-
 
|''OTX2-AS1''
 
|''OTX2-AS1''
 
|[[lnc-C14orf101-5:1]]
 
|[[lnc-C14orf101-5:1]]
−
|OTX2OS1, ENSG00000248550
+
|"OTX2OS1, ENSG00000248550"
 
|OTX2 antisense RNA 1 (head to head)
 
|OTX2 antisense RNA 1 (head to head)
 +
|_
 
|-
 
|-
 
|''PANDAR''
 
|''PANDAR''
 
|[[lnc-CDKN1A-1:1]]
 
|[[lnc-CDKN1A-1:1]]
−
|P21 associated ncRNA DNA damage activated, PANDA antisense RNA, ENSG00000213500, PANDAR
+
|"P21 associated ncRNA DNA damage activated, PANDA antisense RNA, ENSG00000213500, PANDAR"
 
|promoter of CDKN1A antisense DNA damage activated RNA
 
|promoter of CDKN1A antisense DNA damage activated RNA
 +
|cancer
 
|-
 
|-
 
|''PCGEM1''
 
|''PCGEM1''
 
|[[NONHSAT076153]]
 
|[[NONHSAT076153]]
−
|ENSG00000227418; PCAT9; LINC00071; NCRNA00071 lncRNA  
+
|ENSG00000227418; PCAT9; LINC00071; NCRNA00071 lncRNA
 
|Prostate-specific transcript 1
 
|Prostate-specific transcript 1
 +
|prostate cancer
 
|-
 
|-
 
|''LINC00853''
 
|''LINC00853''
 
|[[ENST00000429328.2]]
 
|[[ENST00000429328.2]]
−
|"PDZK1IP1 antisense RNA 1 (non-protein coding)", "PDZK1IP1 antisense RNA 1 (tail to tail)", PDZK1IP1-AS1 ,ENSG00000224805
+
|"PDZK1IP1 antisense RNA 1 (non-protein coding), ""PDZK1IP1 antisense RNA 1 (tail to tail)"", PDZK1IP1-AS1 ,ENSG00000224805"
 
|long intergenic non-protein coding RNA 853
 
|long intergenic non-protein coding RNA 853
 +
|_
 
|-
 
|-
 
|''PRINS''
 
|''PRINS''
Line 593: Line 710:
 
|ENSG00000238115
 
|ENSG00000238115
 
|Psoriasis susceptibility-related RNA Gene Induced by Stress
 
|Psoriasis susceptibility-related RNA Gene Induced by Stress
 +
|psoriasis
 
|-
 
|-
 
|''PTENP1''
 
|''PTENP1''
 
|[[NONHSAT130775]]
 
|[[NONHSAT130775]]
−
|PTENpg1, PTEN2, ENSG00000237984
+
|"PTENpg1, PTEN2, ENSG00000237984"
 
|PTEN Pseudogene 1
 
|PTEN Pseudogene 1
 +
|prostate cancer
 
|-
 
|-
 
|''MEG8''
 
|''MEG8''
 
|[[ENST00000553584.1]]
 
|[[ENST00000553584.1]]
−
|Bsr, "Imprinted RNA near Meg3/Gtl2", Irm, LINC00024, "long intergenic non-protein coding RNA 24", NCRNA00024, "non-protein coding RNA 24", Rian, "RNA Imprinted and Accumulated in Nucleus", ENSG00000258399  
+
|"Bsr, ""Imprinted RNA near Meg3/Gtl2"", Irm, LINC00024, ""long intergenic non-protein coding RNA 24"", NCRNA00024, ""non-protein coding RNA 24"", Rian, ""RNA Imprinted and Accumulated in Nucleus"", ENSG00000258399"
 
|Rian: RNA Imprinted and Accumulated in Nucleus;Irm: Imprinted RNA near Meg3/Gtl2;MEG8: Maternally expressed gene 8
 
|Rian: RNA Imprinted and Accumulated in Nucleus;Irm: Imprinted RNA near Meg3/Gtl2;MEG8: Maternally expressed gene 8
 +
|Prader-Willi/Angelman syndrome
 
|-
 
|-
 
|''LINC00599''
 
|''LINC00599''
 
|[[lnc-TNKS-1:1]]
 
|[[lnc-TNKS-1:1]]
−
|"retinal non-coding RNA 3", Rncr3, ENSG00000253230
+
|"retinal non-coding RNA 3, Rncr3, ENSG00000253230"
−
|Retinal noncoding RNA 3, long intergenic non-protein coding RNA 599
+
|"Retinal noncoding RNA 3, long intergenic non-protein coding RNA 599"
 +
|_
 
|-
 
|-
 
|''FAS-AS''
 
|''FAS-AS''
 
|[[NONHSAT015489]]
 
|[[NONHSAT015489]]
−
|SAF, ENSG00000026103
+
|"SAF, ENSG00000026103"
 
|FAS antisense RNA 1
 
|FAS antisense RNA 1
 +
|B-cell lymphoma
 
|-
 
|-
 
|''ATXN8OS''
 
|''ATXN8OS''
 
|[[NONHSAT034251]]
 
|[[NONHSAT034251]]
−
|NCRNA00003, "non-protein coding RNA 3", ATXN8OS, KLHL1AS, SCA8, ENSG00000230223
+
|"NCRNA00003, ""non-protein coding RNA 3"", ATXN8OS, KLHL1AS, SCA8, ENSG00000230223"
 
|Spinocerebellar ataxia 8 (SCA8) RNA;KLHL1AS: kelch-like 1 (Drosophila) antisense;ATXN8OS: ataxin 8 opposite strand
 
|Spinocerebellar ataxia 8 (SCA8) RNA;KLHL1AS: kelch-like 1 (Drosophila) antisense;ATXN8OS: ataxin 8 opposite strand
 +
|human spinocerebellar ataxia type 8,Spinocerebellar ataxia type 8
 
|-
 
|-
 
|''SNHG1''
 
|''SNHG1''
 
|[[NONHSAT021826]]
 
|[[NONHSAT021826]]
−
|UHG, ENSG00000255717
+
|"UHG, ENSG00000255717"
 
|SNHG1:Small nucleolar RNA host gene 1;UHG: U22 host gene.
 
|SNHG1:Small nucleolar RNA host gene 1;UHG: U22 host gene.
 +
|gastric cancer
 
|-
 
|-
 
|''SNHG3''
 
|''SNHG3''
 
|[[lnc-OR10H5-1:1]]
 
|[[lnc-OR10H5-1:1]]
−
|U17HG, linc1343, ENSG00000242125
+
|"U17HG, linc1343, ENSG00000242125"
 
|Small nucleolar RNA host gene 3
 
|Small nucleolar RNA host gene 3
 +
|Alzheimer's disease
 
|-
 
|-
 
|''SNHG4''
 
|''SNHG4''
 
|[[NONHSAT104072]]
 
|[[NONHSAT104072]]
−
|U19H, ENSG00000200959
+
|"U19H, ENSG00000200959"
 
|Small nucleolar RNA host gene 4
 
|Small nucleolar RNA host gene 4
 +
|myelodysplastic syndrome
 
|-
 
|-
 
|''SNHG5''
 
|''SNHG5''
 
|[[NONHSAT054526]]
 
|[[NONHSAT054526]]
−
|U50HG, ENSG00000203875
+
|"U50HG, ENSG00000203875"
 
|Small nucleolar RNA host gene 5
 
|Small nucleolar RNA host gene 5
 +
|lymphoma
 
|-
 
|-
 
|''SNHG6''
 
|''SNHG6''
 
|[[lnc-TCF24-2:3]]
 
|[[lnc-TCF24-2:3]]
−
|U87HG, ENSG00000245910
+
|"U87HG, ENSG00000245910"
 
|Small nucleolar RNA host gene 6
 
|Small nucleolar RNA host gene 6
 +
|_
 
|-
 
|-
 
|''SPRY4-IT1''
 
|''SPRY4-IT1''
 
|[[lnc-NDFIP1-3:1]]
 
|[[lnc-NDFIP1-3:1]]
−
|AK024556, ENSG00000274721
+
|"AK024556, ENSG00000274721"
 
|SPRY4 intronic transcript 1 (non-protein coding)
 
|SPRY4 intronic transcript 1 (non-protein coding)
 +
|melanoma
 
|-
 
|-
 
|''SRA''
 
|''SRA''
 
|[[lnc-SRA1-1:1]]
 
|[[lnc-SRA1-1:1]]
−
|SRA1, ENSG00000213523
+
|"SRA1, ENSG00000213523"
 
|Steroid receptor RNA Activator
 
|Steroid receptor RNA Activator
 +
|_
 
|-
 
|-
 
|''TEA-ncRNAs''
 
|''TEA-ncRNAs''
Line 658: Line 788:
 
|ENSG00000251002
 
|ENSG00000251002
 
|T early alpha
 
|T early alpha
 +
|_
 
|-
 
|-
 
|''IFNG-AS1''
 
|''IFNG-AS1''
 
|[[ENST00000538665.1]]
 
|[[ENST00000538665.1]]
−
|LincR-Ifng-3'AS, NEST, "Theiler's murine encephalomyelitis virus persistence candidate gene 1", Tmevpg1, ENSG00000255733
+
|"LincR-Ifng-3'AS, NEST, ""Theiler's murine encephalomyelitis virus persistence candidate gene 1"", Tmevpg1, ENSG00000255733"
 
|IFNG antisense RNA 1
 
|IFNG antisense RNA 1
 +
|multiple sclerosis
 
|-
 
|-
 
|''TncRNA''
 
|''TncRNA''
Line 668: Line 800:
 
|TSU
 
|TSU
 
|TncRNA: trophoblast noncoding RNA; TSU: trophoblast STAT utron (untranslated region of an mRNA).
 
|TncRNA: trophoblast noncoding RNA; TSU: trophoblast STAT utron (untranslated region of an mRNA).
 +
|_
 
|-
 
|-
 
|''TUG1''
 
|''TUG1''
Line 673: Line 806:
 
|ENSG00000253352
 
|ENSG00000253352
 
|taurine up-regulated gene 1
 
|taurine up-regulated gene 1
 +
|B-cell neoplasms, bladder cancer, Huntington's disease, non-small cell lung cancer
 
|-
 
|-
 
|''UCA1''
 
|''UCA1''
 
|[[lnc-OR10H5-1:1]]
 
|[[lnc-OR10H5-1:1]]
−
|UCA1a, CUDR, UCAT1, LINC00178, NCRNA00178, GCAP2, GUCA1B, GUCA2, RP48, ENSG00000214049
+
|"UCA1a, CUDR, UCAT1, LINC00178, NCRNA00178, GCAP2, GUCA1B, GUCA2, RP48, ENSG00000214049"
 
|urothelial cancer associated 1 (non-protein coding)
 
|urothelial cancer associated 1 (non-protein coding)
 +
|bladder cancer, oral squamous cell carcinoma, pancreaticobiliary maljunction, squamous carcinoma,  tongue squamous cell carcinomas
 
|-
 
|-
 
|''KCNIP4-IT1''
 
|''KCNIP4-IT1''
 
|[[NONHSAT095745]]
 
|[[NONHSAT095745]]
−
|"non coding transcript UM9(5)", UM9-5
+
|"non coding transcript UM9(5), UM9-5"
 
|KCNIP4 intronic transcript 1 (non-protein coding)
 
|KCNIP4 intronic transcript 1 (non-protein coding)
 +
|_
 
|-
 
|-
 
|''WT1-AS''
 
|''WT1-AS''
 
|[[lnc-EIF3M-1:1]]
 
|[[lnc-EIF3M-1:1]]
−
|WIT1, ENSG00000183242
+
|"WIT1, ENSG00000183242"
 
|WT1 (Wilms' tumor 1) antisense transcript
 
|WT1 (Wilms' tumor 1) antisense transcript
 +
|"gastric cancer, hepatocellular carcinoma"
 
|-
 
|-
 
|''XIST''
 
|''XIST''
Line 693: Line 830:
 
|ENSG00000229807
 
|ENSG00000229807
 
|X inactive-specific transcript
 
|X inactive-specific transcript
 +
|bladder cancer, breast cancer, Klinefelter's syndrome, testicular cancer,
 
|-
 
|-
 
|''ZEB2-AS1''
 
|''ZEB2-AS1''
 
|[[NONHSAT074775]]
 
|[[NONHSAT074775]]
−
|Zeb2NAT, ENSG00000238057
+
|"Zeb2NAT, ENSG00000238057"
 
|Zeb2 natural antisense transcript
 
|Zeb2 natural antisense transcript
 +
|bladder cancer
 
|-
 
|-
 
|''ZFAS1''
 
|''ZFAS1''
 
|[[NONHSAT080206]]
 
|[[NONHSAT080206]]
−
|Znfx1 antisense, 1500012F01Rik, NCRNA00275, ENSG00000177410
+
|"Znfx1 antisense, 1500012F01Rik, NCRNA00275, ENSG00000177410"
 
|ZNFX1 antisense RNA 1
 
|ZNFX1 antisense RNA 1
 +
|breast cancer
 
|-
 
|-
 
|''Zfhx2as''
 
|''Zfhx2as''
 
|[[ENST00000554403.1]]
 
|[[ENST00000554403.1]]
−
|Zfh-5AS, ENSG00000157306
+
|"Zfh-5AS, ENSG00000157306"
−
|zinc finger homeobox 2, antisense
+
|"zinc finger homeobox 2, antisense"
 +
|_
 
|-
 
|-
 
|''TMEM161B-AS1''
 
|''TMEM161B-AS1''
−
|[[lnc-RASA1-3:23]],[[lnc-RASA1-3:25]]
+
|[["lnc-RASA1-3:23,lnc-RASA1-3:25"]]
−
|AK082072,linc-POLR3G-8, ENSG00000247828
+
|"AK082072,linc-POLR3G-8, ENSG00000247828"
 
|TMEM161B antisense RNA 1
 
|TMEM161B antisense RNA 1
 +
|_
 
|-
 
|-
−
|''Alpha 250''/ ''Alpha 280''
+
|''Alpha 250/ Alpha 280''
−
|[[NONHSAT104559]],[[lnc-NDST1-1:2]]
+
|[["NONHSAT104559,lnc-NDST1-1:2"]]
 
|N/A
 
|N/A
 
|N/A
 
|N/A
 +
|_
 
|-
 
|-
 
|''CDKN2B-AS1''
 
|''CDKN2B-AS1''
−
|[[NONHSAT130421]],[[lnc-C9orf53-2:1]]
+
|[["NONHSAT130421,lnc-C9orf53-2:1"]]
−
|ANRIL, p15AS, ENSG00000240498
+
|"ANRIL, p15AS, ENSG00000240498"
 
|CDKN2B antisense RNA 1
 
|CDKN2B antisense RNA 1
 +
|abdominal aortic aneurysm,acute lymphoblastic leukemia,basal cell carcinoma,breast cancer,cardiovascular disease,coronary artery disease,coronary heart disease,Diabetes,endometriosis,Esophageal squamous cell cancer,gastric cancer,glioma,hereditary cutaneous malignant melanoma,intracranial aneurism,ischemic stroke,melanoma,myocardial infarction,nasopharyngeal carcinoma,neural system tumors syndrome,Neurofibromatosis type 1,periodontitis,prostate cancer,
 
|-
 
|-
 
|''BACE1-AS''
 
|''BACE1-AS''
−
|[[NONHSAT024403]],[[lnc-RNF214-1:2]]
+
|[["NONHSAT024403,lnc-RNF214-1:2"]]
−
|BACE1AS,NCRNA00177; FJ573250
+
|"BACE1AS,NCRNA00177; FJ573250"
 
|BACE1 antisense RNA
 
|BACE1 antisense RNA
 +
|Alzheimer's disease,
 
|-
 
|-
 
|''Beta-globin transcripts''
 
|''Beta-globin transcripts''
−
|[[NONHSAT017676]],[[NONHSAT017675]],[[NONHSAT017674]]
+
|[["NONHSAT017676,NONHSAT017675,NONHSAT017674"]]
 
|N/A
 
|N/A
 
|N/A
 
|N/A
 +
|_
 
|-
 
|-
 
|''LINC00581''
 
|''LINC00581''
−
|[[lnc-PRL-6:2]],[[lnc-PRL-6:1]]
+
|[["lnc-PRL-6:2,lnc-PRL-6:1"]]
−
|BX118339,Hs.112750, linc-MBOAT1-4: TCONS_00012107, linc-MBOAT1-4: TCONS_00012678
+
|"BX118339,Hs.112750, linc-MBOAT1-4: TCONS_00012107, linc-MBOAT1-4: TCONS_00012678"
 
|long intergenic non-protein coding RNA 581
 
|long intergenic non-protein coding RNA 581
 +
|West Syndrome
 
|-
 
|-
 
|''CAR Intergenic 10''
 
|''CAR Intergenic 10''
−
|[[NONHSAT016928]],[[lnc-FANK1-3:1]]
+
|[["NONHSAT016928,lnc-FANK1-3:1"]]
−
|Intergenic10, CR611911, AK055628
+
|"Intergenic10, CR611911, AK055628"
 
|Chromatin Associated RNA 10
 
|Chromatin Associated RNA 10
 +
|_
 
|-
 
|-
 
|''DIO3OS''
 
|''DIO3OS''
−
|[[NONHSAT040032]],[[NONHSAT040039]]
+
|[["NONHSAT040032,NONHSAT040039"]]
−
|DIO3-AS1, NCRNA00041, "non-protein coding RNA 41", ENSG00000258498
+
|"DIO3-AS1, NCRNA00041, ""non-protein coding RNA 41"", ENSG00000258498"
 
|DIO3 opposite strand/antisense RNA (head to head)
 
|DIO3 opposite strand/antisense RNA (head to head)
 +
|_
 
|-
 
|-
 
|''PCAT6''
 
|''PCAT6''
−
|[[ENST00000425295.1]],[[ENST00000553157.1]],[[ENST00000417262.1]]
+
|[["ENST00000425295.1,ENST00000553157.1,ENST00000417262.1"]]
−
|Noncoding RNA activating2: ncRNA-a2, KDM5B antisense RNA 1 (KDM5B-AS1),, ENSG00000228288
+
|"Noncoding RNA activating2: ncRNA-a2, KDM5B antisense RNA 1 (KDM5B-AS1),, ENSG00000228288"
 
|N/A
 
|N/A
 +
|prostate cancer
 
|-
 
|-
 
|''LINC00570''
 
|''LINC00570''
−
|[[ENST00000437795.1]],[[ENST00000432665.1]],[[ENST00000453100.1]],[[ENST00000417473.2]]
+
|[["ENST00000437795.1,ENST00000432665.1,ENST00000453100.1,ENST00000417473.2"]]
−
|KDM5BAS1, ncRNA-a2, onco-lncRNA-96, PCAN-R1, "prostate cancer-associated noncoding RNA 1",ENSG00000224177,
+
|"KDM5BAS1, ncRNA-a2, onco-lncRNA-96, PCAN-R1, ""prostate cancer-associated noncoding RNA 1"",ENSG00000224177,"
 
|prostate cancer associated transcript 6 (non-protein coding)
 
|prostate cancer associated transcript 6 (non-protein coding)
 +
|_
 
|-
 
|-
 
|''NEAT1''
 
|''NEAT1''
−
|[[ENST00000501122.2]],[[NONHSAT022111]]
+
|[["ENST00000501122.2,NONHSAT022111"]]
−
|MEN epsilon/beta, VINC, TncRNA, linc1317, ENSG00000245532
+
|"MEN epsilon/beta, VINC, TncRNA, linc1317, ENSG00000245532"
 
|Nuclear enriched abundant transcript 1.
 
|Nuclear enriched abundant transcript 1.
 +
|infertility
 
|-
 
|-
 
|''ST7OT''
 
|''ST7OT''
−
|[[NONHSAT122926]],[[NONHSAT122918]],[[NONHSAT122914]],[[NONHSAT122932]]
+
|[["NONHSAT122926,NONHSAT122918,NONHSAT122914,NONHSAT122932"]]
−
|ST7OT1, ST7OT2, ST7OT3, ST7OT4, ST7AS1, ST7AS2, ST7AS3, ST7AS4, ENSG00000214188
+
|"ST7OT1, ST7OT2, ST7OT3, ST7OT4, ST7AS1, ST7AS2, ST7AS3, ST7AS4, ENSG00000214188"
 
|N/A
 
|N/A
 +
|_
 
|-
 
|-
 
|''snaR''
 
|''snaR''
−
|[[lnc-BSPH1-1:1]],[[lnc-BSPH1-2:1]]
+
|[["lnc-BSPH1-1:1,lnc-BSPH1-2:1"]]
 
|small NF90-associated RNAs
 
|small NF90-associated RNAs
 
|small NF90-associated RNAs
 
|small NF90-associated RNAs
 +
|_
 
|-
 
|-
 
|''Y RNAs''
 
|''Y RNAs''
Line 778: Line 932:
 
|N/A
 
|N/A
 
|N/A
 
|N/A
 +
|_
 
|-
 
|-
 
|''PR antisense transcripts''
 
|''PR antisense transcripts''
Line 783: Line 938:
 
|N/A
 
|N/A
 
|N/A
 
|N/A
 +
|_
 
|-
 
|-
 
|''FAM3D-AS1''
 
|''FAM3D-AS1''
Line 788: Line 944:
 
|lnc-KCTD6-3
 
|lnc-KCTD6-3
 
|FAM3D antisense RNA 1
 
|FAM3D antisense RNA 1
 +
|head and neck squamous cell carcinoma
 
|-
 
|-
 
|''SHANK2-AS3''
 
|''SHANK2-AS3''
Line 793: Line 950:
 
|N/A
 
|N/A
 
|SHANK2 antisense RNA 3
 
|SHANK2 antisense RNA 3
 +
|_
 
|-
 
|-
 
|''AATBC''
 
|''AATBC''
Line 798: Line 956:
 
|N/A
 
|N/A
 
|apoptosis associated transcript in bladder cancer
 
|apoptosis associated transcript in bladder cancer
 +
|bladder cancer
 
|-
 
|-
 
|''ABHD11-AS1''
 
|''ABHD11-AS1''
Line 803: Line 962:
 
|NCRNA00035
 
|NCRNA00035
 
|ABHD11 antisense RNA 1 (tail to tail)
 
|ABHD11 antisense RNA 1 (tail to tail)
 +
|gastric cancer
 
|-
 
|-
 
|''ABHD15-AS1''
 
|''ABHD15-AS1''
 
|[[ABHD15-AS1]]
 
|[[ABHD15-AS1]]
−
|linc-TP53I13, lnc-TP53I13
+
|"linc-TP53I13, lnc-TP53I13"
 
|ABHD15 antisense RNA 1
 
|ABHD15 antisense RNA 1
 +
|cardiometabolic diseases
 
|-
 
|-
 
|''ACTA2-AS1''
 
|''ACTA2-AS1''
 
|[[ACTA2-AS1]]
 
|[[ACTA2-AS1]]
−
|uc001kfo.1, ZXF1
+
|"uc001kfo.1, ZXF1"
 
|ACTA2 antisense RNA 1
 
|ACTA2 antisense RNA 1
 +
|lung adenocarcinoma
 
|-
 
|-
 
|''ADAMTS9-AS2''
 
|''ADAMTS9-AS2''
Line 818: Line 980:
 
|N/A
 
|N/A
 
|ADAMTS9 antisense RNA 2
 
|ADAMTS9 antisense RNA 2
 +
|glioma
 
|-
 
|-
 
|''ADORA2A-AS1''
 
|''ADORA2A-AS1''
Line 823: Line 986:
 
|FLJ34651
 
|FLJ34651
 
|ADORA2A antisense RNA 1
 
|ADORA2A antisense RNA 1
 +
|_
 
|-
 
|-
 
|''AFAP1-AS1''
 
|''AFAP1-AS1''
Line 828: Line 992:
 
|MGC10981
 
|MGC10981
 
|AFAP1 antisense RNA 1
 
|AFAP1 antisense RNA 1
 +
|Barrett's esophagus and esophageal adenocarcinoma
 
|-
 
|-
 
|''AGAP2-AS1''
 
|''AGAP2-AS1''
 
|[[AGAP2-AS1]]
 
|[[AGAP2-AS1]]
−
|LOC100130776, PUNISHER
+
|"LOC100130776, PUNISHER"
 
|AGAP2 antisense RNA 1
 
|AGAP2 antisense RNA 1
 +
|_
 
|-
 
|-
−
|''Alpha 250''/''Alpha 280''
+
|''Alpha 250/Alpha 280''
−
|[[NONHSAT104559]],[[lnc-NDST1-1:2]]
+
|[["NONHSAT104559,lnc-NDST1-1:2"]]
 
|N/A
 
|N/A
 
|N/A
 
|N/A
 +
|_
 
|-
 
|-
 
|''ANP32A-IT1''
 
|''ANP32A-IT1''
 
|[[ANP32A-IT1]]
 
|[[ANP32A-IT1]]
−
|FLJ11722, HsT18971
+
|"FLJ11722, HsT18971"
 
|ANP32A intronic transcript 1
 
|ANP32A intronic transcript 1
 +
|_
 
|-
 
|-
 
|''ARRDC1-AS1''
 
|''ARRDC1-AS1''
Line 848: Line 1,016:
 
|N/A
 
|N/A
 
|ARRDC1 antisense RNA 1
 
|ARRDC1 antisense RNA 1
 +
|breast cancer
 
|-
 
|-
 
|''ASAP1-IT1''
 
|''ASAP1-IT1''
 
|[[ASAP1-IT1]]
 
|[[ASAP1-IT1]]
−
|HSPC054, NCRNA00050, ASAP1IT, ASAP1-IT
+
|"HSPC054, NCRNA00050, ASAP1IT, ASAP1-IT"
 
|ASAP1 intronic transcript 1
 
|ASAP1 intronic transcript 1
 +
|_
 
|-
 
|-
 
|''ASMTL-AS1''
 
|''ASMTL-AS1''
Line 858: Line 1,028:
 
|FLJ13330
 
|FLJ13330
 
|ASMTL antisense RNA 1
 
|ASMTL antisense RNA 1
 +
|_
 
|-
 
|-
 
|''ATP1A1-AS1''
 
|''ATP1A1-AS1''
Line 863: Line 1,034:
 
|MGC16179
 
|MGC16179
 
|ATP1A1 antisense RNA 1
 
|ATP1A1 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''B3GALT5-AS1''
 
|''B3GALT5-AS1''
Line 868: Line 1,040:
 
|N/A
 
|N/A
 
|B3GALT5 antisense RNA 1
 
|B3GALT5 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''B4GALT1-AS1''
 
|''B4GALT1-AS1''
Line 873: Line 1,046:
 
|N/A
 
|N/A
 
|B4GALT1 antisense RNA 1
 
|B4GALT1 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''BAALC-AS2''
 
|''BAALC-AS2''
Line 878: Line 1,052:
 
|MGC39526
 
|MGC39526
 
|BAALC antisense RNA 2
 
|BAALC antisense RNA 2
 +
|_
 
|-
 
|-
 
|''BCAR4''
 
|''BCAR4''
Line 883: Line 1,058:
 
|N/A
 
|N/A
 
|breast cancer anti-estrogen resistance 4 (non-protein coding)
 
|breast cancer anti-estrogen resistance 4 (non-protein coding)
 +
|breast cancer
 
|-
 
|-
 
|''BFSP2-AS1''
 
|''BFSP2-AS1''
Line 888: Line 1,064:
 
|MGC2848
 
|MGC2848
 
|BFSP2 antisense RNA 1
 
|BFSP2 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''BGLT3''
 
|''BGLT3''
 
|[[BGLT3]]
 
|[[BGLT3]]
−
|LINC01083, BGL3, lncRNA-BGL3
+
|"LINC01083, BGL3, lncRNA-BGL3"
 
|beta globin locus transcript 3 (non-protein coding)
 
|beta globin locus transcript 3 (non-protein coding)
 +
|Bcr-Abl-positive leukemia
 
|-
 
|-
 
|''BIN3-IT1''
 
|''BIN3-IT1''
Line 898: Line 1,076:
 
|FLJ14107
 
|FLJ14107
 
|BIN3 intronic transcript 1
 
|BIN3 intronic transcript 1
 +
|_
 
|-
 
|-
 
|''BIRC6-AS1''
 
|''BIRC6-AS1''
Line 903: Line 1,082:
 
|N/A
 
|N/A
 
|BIRC6 antisense RNA 1
 
|BIRC6 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''BIRC6-AS2''
 
|''BIRC6-AS2''
Line 908: Line 1,088:
 
|megamind
 
|megamind
 
|BIRC6 antisense RNA 2
 
|BIRC6 antisense RNA 2
 +
|_
 
|-
 
|-
 
|''BISPR''
 
|''BISPR''
Line 913: Line 1,094:
 
|N/A
 
|N/A
 
|BST2 interferon stimulated positive regulator (non-protein coding)
 
|BST2 interferon stimulated positive regulator (non-protein coding)
 +
|_
 
|-
 
|-
 
|''BOK-AS1''
 
|''BOK-AS1''
 
|[[BOK-AS1]]
 
|[[BOK-AS1]]
−
|NCRNA00151, NAToB
+
|"NCRNA00151, NAToB"
 
|BOK antisense RNA 1
 
|BOK antisense RNA 1
 +
|testicular cancer
 
|-
 
|-
 
|''BRWD1-AS2''
 
|''BRWD1-AS2''
Line 923: Line 1,106:
 
|N/A
 
|N/A
 
|BRWD1 antisense RNA 2
 
|BRWD1 antisense RNA 2
 +
|_
 
|-
 
|-
 
|''C1QTNF9B-AS1''
 
|''C1QTNF9B-AS1''
Line 928: Line 1,112:
 
|PCOTH
 
|PCOTH
 
|C1QTNF9B antisense RNA 1
 
|C1QTNF9B antisense RNA 1
 +
|prostate cancer
 
|-
 
|-
 
|''C21orf91-OT1''
 
|''C21orf91-OT1''
Line 933: Line 1,118:
 
|D21S2089E
 
|D21S2089E
 
|C21orf91 overlapping transcript 1
 
|C21orf91 overlapping transcript 1
 +
|_
 
|-
 
|-
 
|''C5orf66-AS1''
 
|''C5orf66-AS1''
 
|[[C5orf66-AS1]]
 
|[[C5orf66-AS1]]
−
|CTC-276P9.1, Epist
+
|"CTC-276P9.1, Epist"
 
|C5orf66 antisense RNA 1
 
|C5orf66 antisense RNA 1
 +
|esophageal squamous cell carcinoma
 
|-
 
|-
 
|''C5orf66-AS2''
 
|''C5orf66-AS2''
Line 943: Line 1,130:
 
|N/A
 
|N/A
 
|C5orf66 antisense RNA 2
 
|C5orf66 antisense RNA 2
 +
|_
 
|-
 
|-
 
|''C8orf34-AS1''
 
|''C8orf34-AS1''
Line 948: Line 1,136:
 
|N/A
 
|N/A
 
|C8orf34 antisense RNA 1
 
|C8orf34 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''CACNA1G-AS1''
 
|''CACNA1G-AS1''
Line 953: Line 1,142:
 
|N/A
 
|N/A
 
|CACNA1G antisense RNA 1
 
|CACNA1G antisense RNA 1
 +
| keloid
 
|-
 
|-
 
|''CAPN10-AS1''
 
|''CAPN10-AS1''
Line 958: Line 1,148:
 
|locus959
 
|locus959
 
|CAPN10 antisense RNA 1 (head to head)
 
|CAPN10 antisense RNA 1 (head to head)
 +
|_
 
|-
 
|-
 
|''CARD8-AS1''
 
|''CARD8-AS1''
Line 963: Line 1,154:
 
|LOC100505812
 
|LOC100505812
 
|CARD8 antisense RNA 1
 
|CARD8 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''CARMN''
 
|''CARMN''
Line 968: Line 1,160:
 
|CARMEN
 
|CARMEN
 
|cardiac mesoderm enhancer-associated non-coding RNA
 
|cardiac mesoderm enhancer-associated non-coding RNA
 +
|_
 
|-
 
|-
 
|''CASC11''
 
|''CASC11''
 
|[[CASC11]]
 
|[[CASC11]]
−
|TCONSN/A00014535, LINC00990, CARLo-7
+
|"TCONSN/A00014535, LINC00990, CARLo-7"
 
|cancer susceptibility candidate 11 (non-protein coding)
 
|cancer susceptibility candidate 11 (non-protein coding)
 +
|colorectal cancer
 
|-
 
|-
 
|''CASC15''
 
|''CASC15''
Line 978: Line 1,172:
 
|N/A
 
|N/A
 
|cancer susceptibility candidate 15 (non-protein coding)
 
|cancer susceptibility candidate 15 (non-protein coding)
 +
|metastatic melanoma
 
|-
 
|-
 
|''CASC19''
 
|''CASC19''
Line 983: Line 1,178:
 
|CARLo-6
 
|CARLo-6
 
|cancer susceptibility candidate 19 (non-protein coding)
 
|cancer susceptibility candidate 19 (non-protein coding)
 +
|prostate cancer
 
|-
 
|-
 
|''CASC2''
 
|''CASC2''
Line 988: Line 1,184:
 
|N/A
 
|N/A
 
|cancer susceptibility candidate 2 (non-protein coding)
 
|cancer susceptibility candidate 2 (non-protein coding)
 +
|colorectal cancer
 
|-
 
|-
 
|''CASC21''
 
|''CASC21''
Line 993: Line 1,190:
 
|CARLo-2
 
|CARLo-2
 
|cancer susceptibility candidate 21 (non-protein coding)
 
|cancer susceptibility candidate 21 (non-protein coding)
 +
|_
 
|-
 
|-
 
|''CASC22''
 
|''CASC22''
 
|[[CASC22]]
 
|[[CASC22]]
−
|TCONSN/A00024290, LincRNA-ENST00000515084
+
|"TCONSN/A00024290, LincRNA-ENST00000515084"
 
|cancer susceptibility candidate 22 (non-protein coding)
 
|cancer susceptibility candidate 22 (non-protein coding)
 +
|breast cancer
 
|-
 
|-
 
|''CASC9''
 
|''CASC9''
 
|[[CASC9]]
 
|[[CASC9]]
−
|LINC00981, ESCCAL-1
+
|"LINC00981, ESCCAL-1"
 
|cancer susceptibility candidate 9 (non-protein coding)
 
|cancer susceptibility candidate 9 (non-protein coding)
 +
|3-predicted esophageal squamous cell carcinoma
 
|-
 
|-
 
|''CBR3-AS1''
 
|''CBR3-AS1''
Line 1,008: Line 1,208:
 
|PlncRNA-1
 
|PlncRNA-1
 
|CBR3 antisense RNA 1
 
|CBR3 antisense RNA 1
 +
|esophageal squamous carcinoma cell
 
|-
 
|-
 
|''CCDC18-AS1''
 
|''CCDC18-AS1''
Line 1,013: Line 1,214:
 
|ENST00000440778.1
 
|ENST00000440778.1
 
|CCDC18 antisense RNA 1
 
|CCDC18 antisense RNA 1
 +
|Adolescent Idiopathic Scoliosis
 
|-
 
|-
 
|''CCDC26''
 
|''CCDC26''
 
|[[CCDC26]]
 
|[[CCDC26]]
−
|MGC27434, RAM
+
|"MGC27434, RAM"
 
|CCDC26 long non-coding RNA
 
|CCDC26 long non-coding RNA
 +
|glioma
 
|-
 
|-
 
|''CCEPR''
 
|''CCEPR''
Line 1,023: Line 1,226:
 
|CCHE1
 
|CCHE1
 
|cervical carcinoma expressed PCNA regulatory lncRNA
 
|cervical carcinoma expressed PCNA regulatory lncRNA
 +
|cervical cancer
 
|-
 
|-
 
|''CDKN1A-AS1''
 
|''CDKN1A-AS1''
Line 1,028: Line 1,232:
 
|p21NAT
 
|p21NAT
 
|CDKN1A antisense RNA 1
 
|CDKN1A antisense RNA 1
 +
|_
 
|-
 
|-
 
|''CDR1-AS''
 
|''CDR1-AS''
 
|[[CDR1-AS]]
 
|[[CDR1-AS]]
−
|CDR1NAT, ciRS-7, CDR1as
+
|"CDR1NAT, ciRS-7, CDR1as"
 
|CDR1 antisense RNA
 
|CDR1 antisense RNA
 +
|_
 
|-
 
|-
 
|''CDRT7''
 
|''CDRT7''
 
|[[CDRT7]]
 
|[[CDRT7]]
−
|NCRNA00025, LINC00025
+
|"NCRNA00025, LINC00025"
 
|CMT1A duplicated region transcript 7 (non-protein coding)
 
|CMT1A duplicated region transcript 7 (non-protein coding)
 +
|_
 
|-
 
|-
 
|''CDRT8''
 
|''CDRT8''
Line 1,043: Line 1,250:
 
|N/A
 
|N/A
 
|CMT1A duplicated region transcript 8
 
|CMT1A duplicated region transcript 8
 +
|_
 
|-
 
|-
 
|''CECR3''
 
|''CECR3''
 
|[[CECR3]]
 
|[[CECR3]]
 
|N/A
 
|N/A
−
|cat eye syndrome chromosome region, candidate 3 (non-protein coding)
+
|"cat eye syndrome chromosome region, candidate 3 (non-protein coding)"
 +
|cat eye syndrome
 
|-
 
|-
 
|''CECR5-AS1''
 
|''CECR5-AS1''
Line 1,053: Line 1,262:
 
|NCRNA00017
 
|NCRNA00017
 
|CECR5 antisense RNA 1
 
|CECR5 antisense RNA 1
 +
|cat eye syndrome
 
|-
 
|-
 
|''CECR7''
 
|''CECR7''
 
|[[CECR7]]
 
|[[CECR7]]
 
|SAHL1
 
|SAHL1
−
|cat eye syndrome chromosome region, candidate 7 (non-protein coding)
+
|"cat eye syndrome chromosome region, candidate 7 (non-protein coding)"
 +
|cat eye syndrome
 
|-
 
|-
 
|''CECR9''
 
|''CECR9''
 
|[[CECR9]]
 
|[[CECR9]]
 
|N/A
 
|N/A
−
|cat eye syndrome chromosome region, candidate 9 (non-protein coding)
+
|"cat eye syndrome chromosome region, candidate 9 (non-protein coding)"
 +
|cat eye syndrome
 
|-
 
|-
 
|''CEP83-AS1''
 
|''CEP83-AS1''
Line 1,068: Line 1,280:
 
|N/A
 
|N/A
 
|CEP83 antisense RNA 1 (head to head)
 
|CEP83 antisense RNA 1 (head to head)
 +
|_
 
|-
 
|-
 
|''CIRBP-AS1''
 
|''CIRBP-AS1''
Line 1,073: Line 1,286:
 
|MGC39338
 
|MGC39338
 
|CIRBP antisense RNA 1
 
|CIRBP antisense RNA 1
 +
|_
 
|-
 
|-
 
|''CLRN1-AS1''
 
|''CLRN1-AS1''
Line 1,078: Line 1,292:
 
|UCRP
 
|UCRP
 
|CLRN1 antisense RNA 1
 
|CLRN1 antisense RNA 1
 +
|Usher syndrome type 3
 
|-
 
|-
 
|''COPG2IT1''
 
|''COPG2IT1''
 
|[[COPG2IT1]]
 
|[[COPG2IT1]]
−
|CIT1, NCRNA00170, COPG2AS
+
|"CIT1, NCRNA00170, COPG2AS"
 
|COPG2 imprinted transcript 1 (non-protein coding)
 
|COPG2 imprinted transcript 1 (non-protein coding)
 +
|_
 
|-
 
|-
 
|''CPS1-IT1''
 
|''CPS1-IT1''
 
|[[CPS1-IT1]]
 
|[[CPS1-IT1]]
−
|PRO0132, CPS1-IT
+
|"PRO0132, CPS1-IT"
 
|CPS1 intronic transcript 1
 
|CPS1 intronic transcript 1
 +
|_
 
|-
 
|-
 
|''CSNK1G2-AS1''
 
|''CSNK1G2-AS1''
Line 1,093: Line 1,310:
 
|MGC39696
 
|MGC39696
 
|CSNK1G2 antisense RNA 1
 
|CSNK1G2 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''CSTF3-AS1''
 
|''CSTF3-AS1''
Line 1,098: Line 1,316:
 
|N/A
 
|N/A
 
|CSTF3 antisense RNA 1 (head to head)
 
|CSTF3 antisense RNA 1 (head to head)
 +
|_
 
|-
 
|-
 
|''CTBP1-AS''
 
|''CTBP1-AS''
Line 1,103: Line 1,322:
 
|PCAT10
 
|PCAT10
 
|CTBP1 antisense RNA
 
|CTBP1 antisense RNA
 +
| prostate cancer
 
|-
 
|-
 
|''CTBP1-AS2''
 
|''CTBP1-AS2''
Line 1,108: Line 1,328:
 
|MGC21675
 
|MGC21675
 
|CTBP1 antisense RNA 2 (head to head)
 
|CTBP1 antisense RNA 2 (head to head)
 +
|_
 
|-
 
|-
 
|''CYP1B1-AS1''
 
|''CYP1B1-AS1''
Line 1,113: Line 1,334:
 
|MGC34824
 
|MGC34824
 
|CYP1B1 antisense RNA 1
 
|CYP1B1 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''CYP51A1-AS1''
 
|''CYP51A1-AS1''
 
|[[CYP51A1-AS1]]
 
|[[CYP51A1-AS1]]
−
|ENST00000453068, LRRD1-AS1
+
|"ENST00000453068, LRRD1-AS1"
 
|CYP51A1 antisense RNA 1
 
|CYP51A1 antisense RNA 1
 +
|renal cell carcinoma
 
|-
 
|-
 
|''DACOR1''
 
|''DACOR1''
Line 1,123: Line 1,346:
 
|TCONSN/A00023265
 
|TCONSN/A00023265
 
|DNMT1-associated colon cancer repressed lncRNA 1
 
|DNMT1-associated colon cancer repressed lncRNA 1
 +
|colon cancer
 
|-
 
|-
 
|''DANT1''
 
|''DANT1''
 
|[[DANT1]]
 
|[[DANT1]]
 
|N/A
 
|N/A
−
|DXZ4 associated non-coding transcript 1, proximal
+
|"DXZ4 associated non-coding transcript 1, proximal"
 +
|_
 
|-
 
|-
 
|''DANT2''
 
|''DANT2''
 
|[[DANT2]]
 
|[[DANT2]]
 
|N/A
 
|N/A
−
|DXZ4 associated non-coding transcript 2, distal
+
|"DXZ4 associated non-coding transcript 2, distal"
 +
|_
 
|-
 
|-
 
|''DAOA-AS1''
 
|''DAOA-AS1''
Line 1,138: Line 1,364:
 
|G30
 
|G30
 
|DAOA antisense RNA 1
 
|DAOA antisense RNA 1
 +
|"bipolar illness,schizophrenia"
 
|-
 
|-
 
|''DAPK1-IT1''
 
|''DAPK1-IT1''
Line 1,143: Line 1,370:
 
|N/A
 
|N/A
 
|DAPK1 intronic transcript 1
 
|DAPK1 intronic transcript 1
 +
| pancreatic cancer
 
|-
 
|-
 
|''DBH-AS1''
 
|''DBH-AS1''
Line 1,148: Line 1,376:
 
|BPR
 
|BPR
 
|DBH antisense RNA 1
 
|DBH antisense RNA 1
 +
|hepatocellular carcinoma
 
|-
 
|-
 
|''DGCR10''
 
|''DGCR10''
Line 1,153: Line 1,382:
 
|DGS-B
 
|DGS-B
 
|DiGeorge syndrome critical region gene 10 (non-protein coding)
 
|DiGeorge syndrome critical region gene 10 (non-protein coding)
 +
|DiGeorge syndrome
 
|-
 
|-
 
|''DGCR11''
 
|''DGCR11''
Line 1,158: Line 1,388:
 
|DGS-D
 
|DGS-D
 
|DiGeorge syndrome critical region gene 11 (non-protein coding)
 
|DiGeorge syndrome critical region gene 11 (non-protein coding)
 +
|1-DiGeorge and velo-cardio-facial syndrome
 
|-
 
|-
 
|''DGCR12''
 
|''DGCR12''
Line 1,163: Line 1,394:
 
|DGS-E
 
|DGS-E
 
|DiGeorge syndrome critical region gene 12 (non-protein coding)
 
|DiGeorge syndrome critical region gene 12 (non-protein coding)
 +
|DiGeorge and velo-cardio-facial syndrome
 
|-
 
|-
 
|''DGCR5''
 
|''DGCR5''
 
|[[DGCR5]]
 
|[[DGCR5]]
−
|NCRNA00037, LINC00037
+
|"NCRNA00037, LINC00037"
 
|DiGeorge syndrome critical region gene 5 (non-protein coding)
 
|DiGeorge syndrome critical region gene 5 (non-protein coding)
 +
|DiGeorge syndrome
 
|-
 
|-
 
|''DGCR9''
 
|''DGCR9''
 
|[[DGCR9]]
 
|[[DGCR9]]
−
|DGS-A, POM121L5P
+
|"DGS-A, POM121L5P"
 
|DiGeorge syndrome critical region gene 9 (non-protein coding)
 
|DiGeorge syndrome critical region gene 9 (non-protein coding)
 +
|DiGeorge syndrome
 
|-
 
|-
 
|''DIAPH2-AS1''
 
|''DIAPH2-AS1''
Line 1,178: Line 1,412:
 
|N/A
 
|N/A
 
|DIAPH2 antisense RNA 1
 
|DIAPH2 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''DISC1FP1''
 
|''DISC1FP1''
Line 1,183: Line 1,418:
 
|N/A
 
|N/A
 
|DISC1 fusion partner 1 (non-protein coding)
 
|DISC1 fusion partner 1 (non-protein coding)
 +
|_
 
|-
 
|-
 
|''DLG2-AS1''
 
|''DLG2-AS1''
 
|[[DLG2-AS1]]
 
|[[DLG2-AS1]]
−
|PSZA11q14, SZ-1
+
|"PSZA11q14, SZ-1"
 
|DLG2 antisense RNA 1
 
|DLG2 antisense RNA 1
 +
|schizophrenia
 
|-
 
|-
 
|''DLGAP1-AS3''
 
|''DLGAP1-AS3''
Line 1,193: Line 1,430:
 
|N/A
 
|N/A
 
|DLGAP1 antisense RNA 3
 
|DLGAP1 antisense RNA 3
 +
|_
 
|-
 
|-
 
|''DLX6-AS1''
 
|''DLX6-AS1''
 
|[[DLX6-AS1]]
 
|[[DLX6-AS1]]
−
|FLJ34048, Evf-2
+
|"FLJ34048, Evf-2"
 
|DLX6 antisense RNA 1
 
|DLX6 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''DNM3OS''
 
|''DNM3OS''
 
|[[DNM3OS]]
 
|[[DNM3OS]]
−
|MIR199A2HG, DNM3-AS1
+
|"MIR199A2HG, DNM3-AS1"
 
|DNM3 opposite strand/antisense RNA
 
|DNM3 opposite strand/antisense RNA
 +
|Sézary syndrome
 
|-
 
|-
 
|''DRAIC''
 
|''DRAIC''
 
|[[DRAIC]]
 
|[[DRAIC]]
 
|N/A
 
|N/A
−
|downregulated RNA in cancer, inhibitor of cell invasion and migration
+
|"downregulated RNA in cancer, inhibitor of cell invasion and migration"
 +
|"prostate cancer, bladder cancer, low-grade gliomas, lung adenocarcinoma, stomach adenocarcinoma, renal clear cell carcinoma, hepatocellular carcinoma, skin melanoma"
 
|-
 
|-
 
|''DSCR10''
 
|''DSCR10''
Line 1,213: Line 1,454:
 
|N/A
 
|N/A
 
|Down syndrome critical region 10 (non-protein coding)
 
|Down syndrome critical region 10 (non-protein coding)
 +
|_
 
|-
 
|-
 
|''DSCR9''
 
|''DSCR9''
Line 1,218: Line 1,460:
 
|NCRNA00038
 
|NCRNA00038
 
|Down syndrome critical region 9 (non-protein coding)
 
|Down syndrome critical region 9 (non-protein coding)
 +
|_
 
|-
 
|-
 
|''DUBR''
 
|''DUBR''
Line 1,223: Line 1,466:
 
|N/A
 
|N/A
 
|DPPA2 upstream binding RNA
 
|DPPA2 upstream binding RNA
 +
|_
 
|-
 
|-
 
|''EGFR-AS1''
 
|''EGFR-AS1''
Line 1,228: Line 1,472:
 
|N/A
 
|N/A
 
|EGFR antisense RNA 1
 
|EGFR antisense RNA 1
 +
|_
 
|-
 
|-
 
|''ELFN1-AS1''
 
|''ELFN1-AS1''
Line 1,233: Line 1,478:
 
|N/A
 
|N/A
 
|ELFN1 antisense RNA 1
 
|ELFN1 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''ENTPD3-AS1''
 
|''ENTPD3-AS1''
Line 1,238: Line 1,484:
 
|FLJ36665
 
|FLJ36665
 
|ENTPD3 antisense RNA 1
 
|ENTPD3 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''EPB41L4A-AS1''
 
|''EPB41L4A-AS1''
Line 1,243: Line 1,490:
 
|TIGA1
 
|TIGA1
 
|EPB41L4A antisense RNA 1
 
|EPB41L4A antisense RNA 1
 +
|cancer
 
|-
 
|-
 
|''EPB41L4A-AS2''
 
|''EPB41L4A-AS2''
Line 1,248: Line 1,496:
 
|FLJ11235
 
|FLJ11235
 
|EPB41L4A antisense RNA 2 (head to head)
 
|EPB41L4A antisense RNA 2 (head to head)
 +
|_
 
|-
 
|-
 
|''ERC2-IT1''
 
|''ERC2-IT1''
Line 1,253: Line 1,502:
 
|Po42
 
|Po42
 
|ERC2 intronic transcript 1
 
|ERC2 intronic transcript 1
 +
|_
 
|-
 
|-
 
|''ERICH1-AS1''
 
|''ERICH1-AS1''
Line 1,258: Line 1,508:
 
|N/A
 
|N/A
 
|ERICH1 antisense RNA 1
 
|ERICH1 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''EWSAT1''
 
|''EWSAT1''
Line 1,263: Line 1,514:
 
|FLJ33768
 
|FLJ33768
 
|Ewing sarcoma associated transcript 1
 
|Ewing sarcoma associated transcript 1
 +
|Ewing sarcoma
 
|-
 
|-
 
|''EXOC3-AS1''
 
|''EXOC3-AS1''
Line 1,268: Line 1,520:
 
|N/A
 
|N/A
 
|EXOC3 antisense RNA 1
 
|EXOC3 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''EXTL3-AS1''
 
|''EXTL3-AS1''
Line 1,273: Line 1,526:
 
|N/A
 
|N/A
 
|EXTL3 antisense RNA 1
 
|EXTL3 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''F11-AS1''
 
|''F11-AS1''
Line 1,278: Line 1,532:
 
|N/A
 
|N/A
 
|F11 antisense RNA 1
 
|F11 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''FAM138A''
 
|''FAM138A''
Line 1,283: Line 1,538:
 
|F379
 
|F379
 
|family with sequence similarity 138 member A
 
|family with sequence similarity 138 member A
 +
|_
 
|-
 
|-
 
|''FAM138B''
 
|''FAM138B''
Line 1,288: Line 1,544:
 
|F379
 
|F379
 
|family with sequence similarity 138 member B
 
|family with sequence similarity 138 member B
 +
|_
 
|-
 
|-
 
|''FAM138C''
 
|''FAM138C''
Line 1,293: Line 1,550:
 
|F379
 
|F379
 
|family with sequence similarity 138 member C
 
|family with sequence similarity 138 member C
 +
|_
 
|-
 
|-
 
|''FAM138D''
 
|''FAM138D''
Line 1,298: Line 1,556:
 
|F379
 
|F379
 
|family with sequence similarity 138 member D
 
|family with sequence similarity 138 member D
 +
|_
 
|-
 
|-
 
|''FAM138E''
 
|''FAM138E''
Line 1,303: Line 1,562:
 
|F379
 
|F379
 
|family with sequence similarity 138 member E
 
|family with sequence similarity 138 member E
 +
|_
 
|-
 
|-
 
|''FAM138F''
 
|''FAM138F''
Line 1,308: Line 1,568:
 
|F379
 
|F379
 
|family with sequence similarity 138 member F
 
|family with sequence similarity 138 member F
 +
|_
 
|-
 
|-
 
|''FAM13A-AS1''
 
|''FAM13A-AS1''
Line 1,313: Line 1,574:
 
|NCRNA00039
 
|NCRNA00039
 
|FAM13A antisense RNA 1
 
|FAM13A antisense RNA 1
 +
|_
 
|-
 
|-
 
|''FAM201A''
 
|''FAM201A''
Line 1,318: Line 1,580:
 
|N/A
 
|N/A
 
|family with sequence similarity 201 member A
 
|family with sequence similarity 201 member A
 +
|_
 
|-
 
|-
 
|''FAM215A''
 
|''FAM215A''
 
|[[FAM215A]]
 
|[[FAM215A]]
−
|APR-2, LINC00530
+
|"APR-2, LINC00530"
 
|family with sequence similarity 215 member A (non-protein coding)
 
|family with sequence similarity 215 member A (non-protein coding)
 +
|_
 
|-
 
|-
 
|''FAM222A-AS1''
 
|''FAM222A-AS1''
Line 1,328: Line 1,592:
 
|N/A
 
|N/A
 
|FAM222A antisense RNA 1
 
|FAM222A antisense RNA 1
 +
|_
 
|-
 
|-
 
|''FAM226A''
 
|''FAM226A''
Line 1,333: Line 1,598:
 
|MGC34827
 
|MGC34827
 
|family with sequence similarity 226 member A (non-protein coding)
 
|family with sequence similarity 226 member A (non-protein coding)
 +
|_
 
|-
 
|-
 
|''FAM226B''
 
|''FAM226B''
Line 1,338: Line 1,604:
 
|N/A
 
|N/A
 
|family with sequence similarity 226 member B (non-protein coding)
 
|family with sequence similarity 226 member B (non-protein coding)
 +
|_
 
|-
 
|-
 
|''FAM27E3''
 
|''FAM27E3''
Line 1,343: Line 1,610:
 
|MGC42630
 
|MGC42630
 
|family with sequence similarity 27 member E3
 
|family with sequence similarity 27 member E3
 +
|_
 
|-
 
|-
 
|''FAM41AY1''
 
|''FAM41AY1''
 
|[[FAM41AY1]]
 
|[[FAM41AY1]]
 
|N/A
 
|N/A
−
|family with sequence similarity 41 member A, Y-linked 1
+
|"family with sequence similarity 41 member A, Y-linked 1"
 +
|_
 
|-
 
|-
 
|''FAM41C''
 
|''FAM41C''
Line 1,353: Line 1,622:
 
|N/A
 
|N/A
 
|family with sequence similarity 41 member C
 
|family with sequence similarity 41 member C
 +
|_
 
|-
 
|-
 
|''FAM66C''
 
|''FAM66C''
Line 1,358: Line 1,628:
 
|N/A
 
|N/A
 
|family with sequence similarity 66 member C
 
|family with sequence similarity 66 member C
 +
|_
 
|-
 
|-
 
|''FAM74A3''
 
|''FAM74A3''
Line 1,363: Line 1,634:
 
|OTTHUMG00000067149
 
|OTTHUMG00000067149
 
|family with sequence similarity 74 member A3
 
|family with sequence similarity 74 member A3
 +
|_
 
|-
 
|-
 
|''FAM83H-AS1''
 
|''FAM83H-AS1''
Line 1,368: Line 1,640:
 
|onco-lncRNA-3
 
|onco-lncRNA-3
 
|FAM83H antisense RNA 1 (head to head)
 
|FAM83H antisense RNA 1 (head to head)
 +
|_
 
|-
 
|-
 
|''FAM87A''
 
|''FAM87A''
Line 1,373: Line 1,646:
 
|N/A
 
|N/A
 
|family with sequence similarity 87 member A
 
|family with sequence similarity 87 member A
 +
|_
 
|-
 
|-
 
|''FAS-AS1''
 
|''FAS-AS1''
Line 1,378: Line 1,652:
 
|SAF
 
|SAF
 
|FAS antisense RNA 1
 
|FAS antisense RNA 1
 +
|_
 
|-
 
|-
 
|''FGF10-AS1''
 
|''FGF10-AS1''
Line 1,383: Line 1,658:
 
|RP11-473L15.2
 
|RP11-473L15.2
 
|FGF10 antisense RNA 1
 
|FGF10 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''FLG-AS1''
 
|''FLG-AS1''
Line 1,388: Line 1,664:
 
|N/A
 
|N/A
 
|FLG antisense RNA 1
 
|FLG antisense RNA 1
 +
|_
 
|-
 
|-
 
|''FLVCR1-AS1''
 
|''FLVCR1-AS1''
Line 1,393: Line 1,670:
 
|LQK1
 
|LQK1
 
|FLVCR1 antisense RNA 1 (head to head)
 
|FLVCR1 antisense RNA 1 (head to head)
 +
|_
 
|-
 
|-
 
|''FMR1-AS1''
 
|''FMR1-AS1''
 
|[[FMR1-AS1]]
 
|[[FMR1-AS1]]
−
|ASFMR1, FMR4
+
|"ASFMR1, FMR4"
 
|FMR1 antisense RNA 1
 
|FMR1 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''FOXC2-AS1''
 
|''FOXC2-AS1''
Line 1,403: Line 1,682:
 
|ODRUL
 
|ODRUL
 
|FOXC2 antisense RNA 1
 
|FOXC2 antisense RNA 1
 +
|osteosarcoma
 
|-
 
|-
 
|''FOXG1-AS1''
 
|''FOXG1-AS1''
Line 1,408: Line 1,688:
 
|FOXG1-AS
 
|FOXG1-AS
 
|FOXG1 antisense RNA 1 (head to head)
 
|FOXG1 antisense RNA 1 (head to head)
 +
|autism spectrum disorders
 
|-
 
|-
 
|''FRGCA''
 
|''FRGCA''
 
|[[FRGCA]]
 
|[[FRGCA]]
 
|LncRNA-AP001631.9
 
|LncRNA-AP001631.9
−
|FOXM1-regulated, gastric cancer associated
+
|"FOXM1-regulated, gastric cancer associated"
 +
|gastric cancer
 
|-
 
|-
 
|''GABPB1-AS1''
 
|''GABPB1-AS1''
Line 1,418: Line 1,700:
 
|N/A
 
|N/A
 
|GABPB1 antisense RNA 1
 
|GABPB1 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''GACAT1''
 
|''GACAT1''
 
|[[ENST00000441383.1]]
 
|[[ENST00000441383.1]]
−
|LINC00876, AC096655.1-002
+
|"LINC00876, AC096655.1-002"
 
|gastric cancer associated transcript 1 (non-protein coding)
 
|gastric cancer associated transcript 1 (non-protein coding)
 +
|gastric cancer
 
|-
 
|-
 
|''GACAT2''
 
|''GACAT2''
Line 1,428: Line 1,712:
 
|HMlincRNA717
 
|HMlincRNA717
 
|gastric cancer associated transcript 2 (non-protein coding)
 
|gastric cancer associated transcript 2 (non-protein coding)
 +
|gastric cancer
 
|-
 
|-
 
|''GACAT3''
 
|''GACAT3''
Line 1,433: Line 1,718:
 
|lncRNA-AC130710
 
|lncRNA-AC130710
 
|gastric cancer associated transcript 3 (non-protein coding)
 
|gastric cancer associated transcript 3 (non-protein coding)
 +
|gastric cancer
 
|-
 
|-
 
|''GAPLINC''
 
|''GAPLINC''
 
|[[GAPLINC]]
 
|[[GAPLINC]]
 
|TCONSN/A00026238
 
|TCONSN/A00026238
−
|gastric adenocarcinoma associated, positive CD44 regulator, long intergenic non-coding RNA
+
|"gastric adenocarcinoma associated, positive CD44 regulator, long intergenic non-coding RNA"
 +
|gastric cancer
 
|-
 
|-
 
|''GAS1RR''
 
|''GAS1RR''
Line 1,443: Line 1,730:
 
|LncRNA-Hh
 
|LncRNA-Hh
 
|GAS1 adjacent regulatory RNA
 
|GAS1 adjacent regulatory RNA
 +
|_
 
|-
 
|-
 
|''GAS6-AS1''
 
|''GAS6-AS1''
Line 1,448: Line 1,736:
 
|N/A
 
|N/A
 
|GAS6 antisense RNA 1
 
|GAS6 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''GAS8-AS1''
 
|''GAS8-AS1''
Line 1,453: Line 1,742:
 
|N/A
 
|N/A
 
|GAS8 antisense RNA 1
 
|GAS8 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''GATA3-AS1''
 
|''GATA3-AS1''
Line 1,458: Line 1,748:
 
|N/A
 
|N/A
 
|GATA3 antisense RNA 1
 
|GATA3 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''GATA6-AS1''
 
|''GATA6-AS1''
Line 1,463: Line 1,754:
 
|locus5689
 
|locus5689
 
|GATA6 antisense RNA 1 (head to head)
 
|GATA6 antisense RNA 1 (head to head)
 +
|_
 
|-
 
|-
 
|''GDNF-AS1''
 
|''GDNF-AS1''
Line 1,468: Line 1,760:
 
|GDNFOS
 
|GDNFOS
 
|GDNF antisense RNA 1 (head to head)
 
|GDNF antisense RNA 1 (head to head)
 +
|_
 
|-
 
|-
 
|''GLIDR''
 
|''GLIDR''
 
|[[GLIDR]]
 
|[[GLIDR]]
−
|MGC21881, TCONSN/A00015562
+
|"MGC21881, TCONSN/A00015562"
 
|glioblastoma down-regulated RNA
 
|glioblastoma down-regulated RNA
 +
| glioblastoma
 
|-
 
|-
 
|''GLIS3-AS1''
 
|''GLIS3-AS1''
Line 1,478: Line 1,772:
 
|MGC16153
 
|MGC16153
 
|GLIS3 antisense RNA 1
 
|GLIS3 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''GNG12-AS1''
 
|''GNG12-AS1''
Line 1,483: Line 1,778:
 
|N/A
 
|N/A
 
|GNG12 antisense RNA 1
 
|GNG12 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''GTSCR1''
 
|''GTSCR1''
 
|[[GTSCR1]]
 
|[[GTSCR1]]
 
|N/A
 
|N/A
−
|Gilles de la Tourette syndrome chromosome region, candidate 1 (non-protein coding)
+
|"Gilles de la Tourette syndrome chromosome region, candidate 1 (non-protein coding)"
 +
|_
 
|-
 
|-
 
|''H1FX-AS1''
 
|''H1FX-AS1''
Line 1,493: Line 1,790:
 
|FLJ34151
 
|FLJ34151
 
|H1FX antisense RNA 1
 
|H1FX antisense RNA 1
 +
|_
 
|-
 
|-
 
|''HAND2-AS1''
 
|''HAND2-AS1''
 
|[[HAND2-AS1]]
 
|[[HAND2-AS1]]
−
|DEIN, NBLA00301, FLJ11539
+
|"DEIN, NBLA00301, FLJ11539"
 
|HAND2 antisense RNA 1 (head to head)
 
|HAND2 antisense RNA 1 (head to head)
 +
|neuroblastoma
 
|-
 
|-
 
|''HAS2-AS1''
 
|''HAS2-AS1''
 
|[[HAS2-AS1]]
 
|[[HAS2-AS1]]
−
|HASNT, NCRNA00077
+
|"HASNT, NCRNA00077"
 
|HAS2 antisense RNA 1
 
|HAS2 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''HCCAT5''
 
|''HCCAT5''
 
|[[HCCAT5]]
 
|[[HCCAT5]]
−
|HTA, FJ222407
+
|"HTA, FJ222407"
 
|hepatocellular carcinoma associated transcript 5 (non-protein coding)
 
|hepatocellular carcinoma associated transcript 5 (non-protein coding)
 +
| hepatocellular carcinoma
 
|-
 
|-
 
|''HCG27''
 
|''HCG27''
 
|[[HCG27]]
 
|[[HCG27]]
−
|bPG299F13.9, bCX101P6.9, bQB115I13.2, FLJ40123
+
|"bPG299F13.9, bCX101P6.9, bQB115I13.2, FLJ40123"
 
|HLA complex group 27 (non-protein coding)
 
|HLA complex group 27 (non-protein coding)
 +
|_
 
|-
 
|-
 
|''HCG4''
 
|''HCG4''
 
|[[HCG4]]
 
|[[HCG4]]
−
|HCGIV-10, HCGIV.9
+
|"HCGIV-10, HCGIV.9"
 
|HLA complex group 4 (non-protein coding)
 
|HLA complex group 4 (non-protein coding)
 +
|_
 
|-
 
|-
 
|''HCG4B''
 
|''HCG4B''
 
|[[HCG4B]]
 
|[[HCG4B]]
−
|HCGIV-6, HCGIV.5, HCGIV-06, bCX67J3.3, Em:AB023056.16, bPG309N1.1, bQB90C11.3
+
|"HCGIV-6, HCGIV.5, HCGIV-06, bCX67J3.3, Em:AB023056.16, bPG309N1.1, bQB90C11.3"
 
|HLA complex group 4B (non-protein coding)
 
|HLA complex group 4B (non-protein coding)
 +
|_
 
|-
 
|-
 
|''HCG9''
 
|''HCG9''
 
|[[HCG9]]
 
|[[HCG9]]
−
|PERB11, HCGIX, HCGIX4, HCGIX-4
+
|"PERB11, HCGIX, HCGIX4, HCGIX-4"
 
|HLA complex group 9 (non-protein coding)
 
|HLA complex group 9 (non-protein coding)
 +
|_
 
|-
 
|-
 
|''HCP5''
 
|''HCP5''
 
|[[HCP5]]
 
|[[HCP5]]
−
|D6S2650E, P5-1
+
|"D6S2650E, P5-1"
 
|HLA complex P5 (non-protein coding)
 
|HLA complex P5 (non-protein coding)
 +
|_
 
|-
 
|-
 
|''HELLPAR''
 
|''HELLPAR''
Line 1,538: Line 1,844:
 
|LINC-HELLP
 
|LINC-HELLP
 
|HELLP associated long non-coding RNA
 
|HELLP associated long non-coding RNA
 +
|extravillous trophoblast
 
|-
 
|-
 
|''HEXA-AS1''
 
|''HEXA-AS1''
Line 1,543: Line 1,850:
 
|FLJ13315
 
|FLJ13315
 
|HEXA antisense RNA 1
 
|HEXA antisense RNA 1
 +
|_
 
|-
 
|-
 
|''HIF1A-AS1''
 
|''HIF1A-AS1''
Line 1,548: Line 1,856:
 
|5'aHIF-1A
 
|5'aHIF-1A
 
|HIF1A antisense RNA 1
 
|HIF1A antisense RNA 1
 +
|kidney cancer
 
|-
 
|-
 
|''HIF1A-AS2''
 
|''HIF1A-AS2''
 
|[[HIF1A-AS2]]
 
|[[HIF1A-AS2]]
−
|3'aHIF-1A, aHIF
+
|"3'aHIF-1A, aHIF"
 
|HIF1A antisense RNA 2
 
|HIF1A antisense RNA 2
 +
| kidney cancer
 
|-
 
|-
 
|''HNF1A-AS1''
 
|''HNF1A-AS1''
Line 1,558: Line 1,868:
 
|FLJ38690
 
|FLJ38690
 
|HNF1A antisense RNA 1
 
|HNF1A antisense RNA 1
 +
|"adenocarcinoma, oesophageal adenocarcinoma"
 
|-
 
|-
 
|''HNF4A-AS1''
 
|''HNF4A-AS1''
Line 1,563: Line 1,874:
 
|uc002xlx
 
|uc002xlx
 
|HNF4A antisense RNA 1
 
|HNF4A antisense RNA 1
 +
|_
 
|-
 
|-
 
|''HORMAD2-AS1''
 
|''HORMAD2-AS1''
 
|[[HORMAD2-AS1]]
 
|[[HORMAD2-AS1]]
−
|MTMR3-AS1, NONHSAG033653
+
|"MTMR3-AS1, NONHSAG033653"
 
|HORMAD2 antisense RNA 1
 
|HORMAD2 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''HPVC1''
 
|''HPVC1''
 
|[[HPVC1]]
 
|[[HPVC1]]
−
|PE5L, HPV18E5L
+
|"PE5L, HPV18E5L"
 
|human papillomavirus (type 18) E5 central sequence-like 1
 
|human papillomavirus (type 18) E5 central sequence-like 1
 +
|_
 
|-
 
|-
 
|''HTT-AS''
 
|''HTT-AS''
Line 1,578: Line 1,892:
 
|HTTAS
 
|HTTAS
 
|HTT antisense RNA (head to head)
 
|HTT antisense RNA (head to head)
 +
|Huntington's disease
 
|-
 
|-
 
|''HYMAI''
 
|''HYMAI''
Line 1,583: Line 1,898:
 
|NCRNA00020
 
|NCRNA00020
 
|hydatidiform mole associated and imprinted (non-protein coding)
 
|hydatidiform mole associated and imprinted (non-protein coding)
 +
|_
 
|-
 
|-
 
|''IDI2-AS1''
 
|''IDI2-AS1''
 
|[[IDI2-AS1]]
 
|[[IDI2-AS1]]
−
|HT009, Em:AC022536.4
+
|"HT009, Em:AC022536.4"
 
|IDI2 antisense RNA 1
 
|IDI2 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''IGF2-AS''
 
|''IGF2-AS''
 
|[[IGF2-AS]]
 
|[[IGF2-AS]]
−
|PEG8, IGF2-AS1
+
|"PEG8, IGF2-AS1"
 
|IGF2 antisense RNA
 
|IGF2 antisense RNA
 +
|"hepatocelluar carcinoma,prostate cancer, type 1 diabetes, Wilms' tumor"
 
|-
 
|-
 
|''ILF3-AS1''
 
|''ILF3-AS1''
Line 1,598: Line 1,916:
 
|N/A
 
|N/A
 
|ILF3 antisense RNA 1 (head to head)
 
|ILF3 antisense RNA 1 (head to head)
 +
|_
 
|-
 
|-
 
|''INE1''
 
|''INE1''
Line 1,603: Line 1,922:
 
|NCRNA00010
 
|NCRNA00010
 
|inactivation escape 1 (non-protein coding)
 
|inactivation escape 1 (non-protein coding)
 +
|_
 
|-
 
|-
 
|''INE2''
 
|''INE2''
Line 1,608: Line 1,928:
 
|NCRNA00011
 
|NCRNA00011
 
|inactivation escape 2 (non-protein coding)
 
|inactivation escape 2 (non-protein coding)
 +
|_
 
|-
 
|-
 
|''IRAIN''
 
|''IRAIN''
Line 1,613: Line 1,934:
 
|IGF1R-AS
 
|IGF1R-AS
 
|IGF1R antisense imprinted non-protein coding RNA
 
|IGF1R antisense imprinted non-protein coding RNA
 +
|_
 
|-
 
|-
 
|''JMJD1C-AS1''
 
|''JMJD1C-AS1''
Line 1,618: Line 1,940:
 
|N/A
 
|N/A
 
|JMJD1C antisense RNA 1
 
|JMJD1C antisense RNA 1
 +
|_
 
|-
 
|-
 
|''KCNK15-AS1''
 
|''KCNK15-AS1''
Line 1,623: Line 1,946:
 
|RP11-445H22.4
 
|RP11-445H22.4
 
|KCNK15 antisense RNA 1 (head to head)
 
|KCNK15 antisense RNA 1 (head to head)
 +
|_
 
|-
 
|-
 
|''KCNMB2-AS1''
 
|''KCNMB2-AS1''
Line 1,628: Line 1,952:
 
|RP11-385J1.2
 
|RP11-385J1.2
 
|KCNMB2 antisense RNA 1
 
|KCNMB2 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''KCNQ1DN''
 
|''KCNQ1DN''
 
|[[KCNQ1DN]]
 
|[[KCNQ1DN]]
−
|BWRT, HSA404617
+
|"BWRT, HSA404617"
 
|KCNQ1 downstream neighbor (non-protein coding)
 
|KCNQ1 downstream neighbor (non-protein coding)
 +
|Wilms' tumor
 
|-
 
|-
 
|''KIAA1614-AS1''
 
|''KIAA1614-AS1''
Line 1,638: Line 1,964:
 
|RP11-46A10.4
 
|RP11-46A10.4
 
|KIAA1614 antisense RNA 1
 
|KIAA1614 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''KIF25-AS1''
 
|''KIF25-AS1''
Line 1,643: Line 1,970:
 
|HGC6.1.1
 
|HGC6.1.1
 
|KIF25 antisense RNA 1
 
|KIF25 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''LAMP5-AS1''
 
|''LAMP5-AS1''
Line 1,648: Line 1,976:
 
|N/A
 
|N/A
 
|LAMP5 antisense RNA 1
 
|LAMP5 antisense RNA 1
 +
|leukemogenesis
 
|-
 
|-
 
|''LBX2-AS1''
 
|''LBX2-AS1''
Line 1,653: Line 1,982:
 
|N/A
 
|N/A
 
|LBX2 antisense RNA 1
 
|LBX2 antisense RNA 1
 +
|renal cell carcinoma
 
|-
 
|-
 
|''LCAL1''
 
|''LCAL1''
Line 1,658: Line 1,988:
 
|onco-lncRNA-27
 
|onco-lncRNA-27
 
|lung cancer associated lncRNA 1
 
|lung cancer associated lncRNA 1
 +
| lung cancer
 
|-
 
|-
 
|''LHX5-AS1''
 
|''LHX5-AS1''
Line 1,663: Line 1,994:
 
|locus4010
 
|locus4010
 
|LHX5 antisense RNA 1 (head to head)
 
|LHX5 antisense RNA 1 (head to head)
 +
|_
 
|-
 
|-
 
|''LIFR-AS1''
 
|''LIFR-AS1''
Line 1,668: Line 2,000:
 
|N/A
 
|N/A
 
|LIFR antisense RNA 1
 
|LIFR antisense RNA 1
 +
|1-preterm birth
 
|-
 
|-
 
|''LINC00029''
 
|''LINC00029''
Line 1,673: Line 2,006:
 
|bA305P22.4
 
|bA305P22.4
 
|long intergenic non-protein coding RNA 29
 
|long intergenic non-protein coding RNA 29
 +
|_
 
|-
 
|-
 
|''LINC00052''
 
|''LINC00052''
Line 1,678: Line 2,012:
 
|FLJ31461
 
|FLJ31461
 
|long intergenic non-protein coding RNA 52
 
|long intergenic non-protein coding RNA 52
 +
|_
 
|-
 
|-
 
|''LINC00094''
 
|''LINC00094''
 
|[[LINC00094]]
 
|[[LINC00094]]
−
|FLJ35348, bA374P20.3
+
|"FLJ35348, bA374P20.3"
 
|long intergenic non-protein coding RNA 94
 
|long intergenic non-protein coding RNA 94
 +
|_
 
|-
 
|-
 
|''LINC00114''
 
|''LINC00114''
Line 1,688: Line 2,024:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 114
 
|long intergenic non-protein coding RNA 114
 +
|_
 
|-
 
|-
 
|''LINC00115''
 
|''LINC00115''
Line 1,693: Line 2,030:
 
|FLJ22639
 
|FLJ22639
 
|long intergenic non-protein coding RNA 115
 
|long intergenic non-protein coding RNA 115
 +
|cancer
 
|-
 
|-
 
|''LINC00152''
 
|''LINC00152''
Line 1,698: Line 2,036:
 
|MGC4677
 
|MGC4677
 
|long intergenic non-protein coding RNA 152
 
|long intergenic non-protein coding RNA 152
 +
|clear cell renal cell carcinoma
 
|-
 
|-
 
|''LINC00160''
 
|''LINC00160''
Line 1,703: Line 2,042:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 160
 
|long intergenic non-protein coding RNA 160
 +
|Breast Cancer
 
|-
 
|-
 
|''LINC00161''
 
|''LINC00161''
Line 1,708: Line 2,048:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 161
 
|long intergenic non-protein coding RNA 161
 +
|predicted
 
|-
 
|-
 
|''LINC00165''
 
|''LINC00165''
Line 1,713: Line 2,054:
 
|NLC1-B
 
|NLC1-B
 
|long intergenic non-protein coding RNA 165
 
|long intergenic non-protein coding RNA 165
 +
| narcolepsy
 
|-
 
|-
 
|''LINC00189''
 
|''LINC00189''
Line 1,718: Line 2,060:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 189
 
|long intergenic non-protein coding RNA 189
 +
|Breast Cancer
 
|-
 
|-
 
|''LINC00205''
 
|''LINC00205''
Line 1,723: Line 2,066:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 205
 
|long intergenic non-protein coding RNA 205
 +
|_
 
|-
 
|-
 
|''LINC00235''
 
|''LINC00235''
Line 1,728: Line 2,072:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 235
 
|long intergenic non-protein coding RNA 235
 +
|_
 
|-
 
|-
 
|''LINC00237''
 
|''LINC00237''
Line 1,733: Line 2,078:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 237
 
|long intergenic non-protein coding RNA 237
 +
|"macrosomia, obesity, macrocephaly, and ocular abnormalities"
 
|-
 
|-
 
|''LINC00244''
 
|''LINC00244''
Line 1,738: Line 2,084:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 244
 
|long intergenic non-protein coding RNA 244
 +
|_
 
|-
 
|-
 
|''LINC00261''
 
|''LINC00261''
 
|[[LINC00261]]
 
|[[LINC00261]]
−
|bA216C10.1, HCCDR1, TCONSN/A00027846, ALIEN, DEANR1, onco-lncRNA-17
+
|"bA216C10.1, HCCDR1, TCONSN/A00027846, ALIEN, DEANR1, onco-lncRNA-17"
 
|long intergenic non-protein coding RNA 261
 
|long intergenic non-protein coding RNA 261
 +
|gastric cancer
 
|-
 
|-
 
|''LINC00265''
 
|''LINC00265''
Line 1,748: Line 2,096:
 
|NCRNA00265-1
 
|NCRNA00265-1
 
|long intergenic non-protein coding RNA 265
 
|long intergenic non-protein coding RNA 265
 +
|_
 
|-
 
|-
 
|''LINC00272''
 
|''LINC00272''
Line 1,753: Line 2,102:
 
|RP1-223H12.3
 
|RP1-223H12.3
 
|long intergenic non-protein coding RNA 272
 
|long intergenic non-protein coding RNA 272
 +
| prostate cancer region
 
|-
 
|-
 
|''LINC00293''
 
|''LINC00293''
Line 1,758: Line 2,108:
 
|BEYLA
 
|BEYLA
 
|long intergenic non-protein coding RNA 293
 
|long intergenic non-protein coding RNA 293
 +
|_
 
|-
 
|-
 
|''LINC00294''
 
|''LINC00294''
Line 1,763: Line 2,114:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 294
 
|long intergenic non-protein coding RNA 294
 +
|_
 
|-
 
|-
 
|''LINC00299''
 
|''LINC00299''
Line 1,768: Line 2,120:
 
|FLJ45673
 
|FLJ45673
 
|long intergenic non-protein coding RNA 299
 
|long intergenic non-protein coding RNA 299
 +
|Intellectual and developmental disability
 
|-
 
|-
 
|''LINC00301''
 
|''LINC00301''
Line 1,773: Line 2,126:
 
|MGC39681
 
|MGC39681
 
|long intergenic non-protein coding RNA 301
 
|long intergenic non-protein coding RNA 301
 +
|_
 
|-
 
|-
 
|''LINC00302''
 
|''LINC00302''
Line 1,778: Line 2,132:
 
|XP33
 
|XP33
 
|long intergenic non-protein coding RNA 302
 
|long intergenic non-protein coding RNA 302
 +
|_
 
|-
 
|-
 
|''LINC00305''
 
|''LINC00305''
 
|[[LINC00305]]
 
|[[LINC00305]]
−
|MGC39571, HsT1235
+
|"MGC39571, HsT1235"
 
|long intergenic non-protein coding RNA 305
 
|long intergenic non-protein coding RNA 305
 +
|_
 
|-
 
|-
 
|''LINC00307''
 
|''LINC00307''
Line 1,788: Line 2,144:
 
|D21S2091E
 
|D21S2091E
 
|long intergenic non-protein coding RNA 307
 
|long intergenic non-protein coding RNA 307
 +
|_
 
|-
 
|-
 
|''LINC00308''
 
|''LINC00308''
Line 1,793: Line 2,150:
 
|PRED16
 
|PRED16
 
|long intergenic non-protein coding RNA 308
 
|long intergenic non-protein coding RNA 308
 +
|_
 
|-
 
|-
 
|''LINC00310''
 
|''LINC00310''
Line 1,798: Line 2,156:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 310
 
|long intergenic non-protein coding RNA 310
 +
|_
 
|-
 
|-
 
|''LINC00311''
 
|''LINC00311''
Line 1,803: Line 2,162:
 
|MGC22001
 
|MGC22001
 
|long intergenic non-protein coding RNA 311
 
|long intergenic non-protein coding RNA 311
 +
|_
 
|-
 
|-
 
|''LINC00313''
 
|''LINC00313''
Line 1,808: Line 2,168:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 313
 
|long intergenic non-protein coding RNA 313
 +
|lung cancer
 
|-
 
|-
 
|''LINC00314''
 
|''LINC00314''
Line 1,813: Line 2,174:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 314
 
|long intergenic non-protein coding RNA 314
 +
|_
 
|-
 
|-
 
|''LINC00315''
 
|''LINC00315''
Line 1,818: Line 2,180:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 315
 
|long intergenic non-protein coding RNA 315
 +
|_
 
|-
 
|-
 
|''LINC00320''
 
|''LINC00320''
 
|[[LINC00320]]
 
|[[LINC00320]]
−
|PRED14, FLJ37539
+
|"PRED14, FLJ37539"
 
|long intergenic non-protein coding RNA 320
 
|long intergenic non-protein coding RNA 320
 +
|_
 
|-
 
|-
 
|''LINC00322''
 
|''LINC00322''
Line 1,828: Line 2,192:
 
|FLJ16545
 
|FLJ16545
 
|long intergenic non-protein coding RNA 322
 
|long intergenic non-protein coding RNA 322
 +
|_
 
|-
 
|-
 
|''LINC00323''
 
|''LINC00323''
 
|[[LINC00323]]
 
|[[LINC00323]]
−
|PRED42, FLJ37173
+
|"PRED42, FLJ37173"
 
|long intergenic non-protein coding RNA 323
 
|long intergenic non-protein coding RNA 323
 +
|_
 
|-
 
|-
 
|''LINC00324''
 
|''LINC00324''
 
|[[LINC00324]]
 
|[[LINC00324]]
−
|FLJ34790, MGC104931
+
|"FLJ34790, MGC104931"
 
|long intergenic non-protein coding RNA 324
 
|long intergenic non-protein coding RNA 324
 +
|_
 
|-
 
|-
 
|''LINC00334''
 
|''LINC00334''
Line 1,843: Line 2,210:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 334
 
|long intergenic non-protein coding RNA 334
 +
|_
 
|-
 
|-
 
|''LINC00337''
 
|''LINC00337''
Line 1,848: Line 2,216:
 
|MGC40168
 
|MGC40168
 
|long intergenic non-protein coding RNA 337
 
|long intergenic non-protein coding RNA 337
 +
|_
 
|-
 
|-
 
|''LINC00339''
 
|''LINC00339''
Line 1,853: Line 2,222:
 
|HSPC157
 
|HSPC157
 
|long intergenic non-protein coding RNA 339
 
|long intergenic non-protein coding RNA 339
 +
|_
 
|-
 
|-
 
|''LINC00342''
 
|''LINC00342''
Line 1,858: Line 2,228:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 342
 
|long intergenic non-protein coding RNA 342
 +
|Non-small cell lung cancer
 
|-
 
|-
 
|''LINC00346''
 
|''LINC00346''
Line 1,863: Line 2,234:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 346
 
|long intergenic non-protein coding RNA 346
 +
|_
 
|-
 
|-
 
|''LINC00347''
 
|''LINC00347''
Line 1,868: Line 2,240:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 347
 
|long intergenic non-protein coding RNA 347
 +
|_
 
|-
 
|-
 
|''LINC00426''
 
|''LINC00426''
Line 1,873: Line 2,246:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 426
 
|long intergenic non-protein coding RNA 426
 +
|_
 
|-
 
|-
 
|''LINC00441''
 
|''LINC00441''
Line 1,878: Line 2,252:
 
|ncRNA-RB1
 
|ncRNA-RB1
 
|long intergenic non-protein coding RNA 441
 
|long intergenic non-protein coding RNA 441
 +
|_
 
|-
 
|-
 
|''LINC00461''
 
|''LINC00461''
 
|[[LINC00461]]
 
|[[LINC00461]]
−
|EyeLinc1, Visc-1a, Visc-1b, Visc-2, LOC645323
+
|"EyeLinc1, Visc-1a, Visc-1b, Visc-2, LOC645323"
 
|long intergenic non-protein coding RNA 461
 
|long intergenic non-protein coding RNA 461
 +
|_
 
|-
 
|-
 
|''LINC00466''
 
|''LINC00466''
Line 1,888: Line 2,264:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 466
 
|long intergenic non-protein coding RNA 466
 +
|_
 
|-
 
|-
 
|''LINC00467''
 
|''LINC00467''
Line 1,893: Line 2,270:
 
|MGC14801
 
|MGC14801
 
|long intergenic non-protein coding RNA 467
 
|long intergenic non-protein coding RNA 467
 +
|_
 
|-
 
|-
 
|''LINC00470''
 
|''LINC00470''
Line 1,898: Line 2,276:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 470
 
|long intergenic non-protein coding RNA 470
 +
|_
 
|-
 
|-
 
|''LINC00471''
 
|''LINC00471''
Line 1,903: Line 2,282:
 
|MGC43122
 
|MGC43122
 
|long intergenic non-protein coding RNA 471
 
|long intergenic non-protein coding RNA 471
 +
|_
 
|-
 
|-
 
|''LINC00472''
 
|''LINC00472''
 
|[[LINC00472]]
 
|[[LINC00472]]
−
|dJ288M22.3, FLJ13189
+
|"dJ288M22.3, FLJ13189"
 
|long intergenic non-protein coding RNA 472
 
|long intergenic non-protein coding RNA 472
 +
|breast cancer
 
|-
 
|-
 
|''LINC00473''
 
|''LINC00473''
Line 1,913: Line 2,294:
 
|bA142J11.1
 
|bA142J11.1
 
|long intergenic non-protein coding RNA 473
 
|long intergenic non-protein coding RNA 473
 +
|lung cancer
 
|-
 
|-
 
|''LINC00477''
 
|''LINC00477''
 
|[[LINC00477]]
 
|[[LINC00477]]
−
|FLJ32894, FAM191B
+
|"FLJ32894, FAM191B"
 
|long intergenic non-protein coding RNA 477
 
|long intergenic non-protein coding RNA 477
 +
|_
 
|-
 
|-
 
|''LINC00491''
 
|''LINC00491''
Line 1,923: Line 2,306:
 
|BC008363
 
|BC008363
 
|long intergenic non-protein coding RNA 491
 
|long intergenic non-protein coding RNA 491
 +
|pancreatic ductal adenocarcinoma
 
|-
 
|-
 
|''LINC00493''
 
|''LINC00493''
Line 1,928: Line 2,312:
 
|LOC388789
 
|LOC388789
 
|long intergenic non-protein coding RNA 493
 
|long intergenic non-protein coding RNA 493
 +
|_
 
|-
 
|-
 
|''LINC00494''
 
|''LINC00494''
Line 1,933: Line 2,318:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 494
 
|long intergenic non-protein coding RNA 494
 +
|_
 
|-
 
|-
 
|''LINC00507''
 
|''LINC00507''
Line 1,938: Line 2,324:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 507
 
|long intergenic non-protein coding RNA 507
 +
|_
 
|-
 
|-
 
|''LINC00511''
 
|''LINC00511''
Line 1,943: Line 2,330:
 
|onco-lncRNA-12
 
|onco-lncRNA-12
 
|long intergenic non-protein coding RNA 511
 
|long intergenic non-protein coding RNA 511
 +
|_
 
|-
 
|-
 
|''LINC00518''
 
|''LINC00518''
Line 1,948: Line 2,336:
 
|MGC40222
 
|MGC40222
 
|long intergenic non-protein coding RNA 518
 
|long intergenic non-protein coding RNA 518
 +
|_
 
|-
 
|-
 
|''LINC00526''
 
|''LINC00526''
 
|[[LINC00526]]
 
|[[LINC00526]]
−
|MGC17515, HsT959
+
|"MGC17515, HsT959"
 
|long intergenic non-protein coding RNA 526
 
|long intergenic non-protein coding RNA 526
 +
|_
 
|-
 
|-
 
|''LINC00528''
 
|''LINC00528''
Line 1,958: Line 2,348:
 
|FLJ40542
 
|FLJ40542
 
|long intergenic non-protein coding RNA 528
 
|long intergenic non-protein coding RNA 528
 +
|_
 
|-
 
|-
 
|''LINC00529''
 
|''LINC00529''
Line 1,963: Line 2,354:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 529
 
|long intergenic non-protein coding RNA 529
 +
| keratolytic winter erythema
 
|-
 
|-
 
|''LINC00536''
 
|''LINC00536''
Line 1,968: Line 2,360:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 536
 
|long intergenic non-protein coding RNA 536
 +
|_
 
|-
 
|-
 
|''LINC00538''
 
|''LINC00538''
 
|[[LINC00538]]
 
|[[LINC00538]]
−
|Yiya, PROX1UT
+
|"Yiya, PROX1UT"
 
|long intergenic non-protein coding RNA 538
 
|long intergenic non-protein coding RNA 538
 +
|cancers
 
|-
 
|-
 
|''LINC00575''
 
|''LINC00575''
Line 1,978: Line 2,372:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 575
 
|long intergenic non-protein coding RNA 575
 +
|_
 
|-
 
|-
 
|''LINC00588''
 
|''LINC00588''
Line 1,983: Line 2,378:
 
|DKFZP434F122
 
|DKFZP434F122
 
|long intergenic non-protein coding RNA 588
 
|long intergenic non-protein coding RNA 588
 +
|_
 
|-
 
|-
 
|''LINC00593''
 
|''LINC00593''
Line 1,988: Line 2,384:
 
|MGC42951
 
|MGC42951
 
|long intergenic non-protein coding RNA 593
 
|long intergenic non-protein coding RNA 593
 +
|_
 
|-
 
|-
 
|''LINC00598''
 
|''LINC00598''
Line 1,993: Line 2,390:
 
|TTL
 
|TTL
 
|long intergenic non-protein coding RNA 598
 
|long intergenic non-protein coding RNA 598
 +
|_
 
|-
 
|-
 
|''LINC00608''
 
|''LINC00608''
Line 1,998: Line 2,396:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 608
 
|long intergenic non-protein coding RNA 608
 +
|_
 
|-
 
|-
 
|''LINC00612''
 
|''LINC00612''
 
|[[LINC00612]]
 
|[[LINC00612]]
−
|MGC40170, FLJ41814
+
|"MGC40170, FLJ41814"
 
|long intergenic non-protein coding RNA 612
 
|long intergenic non-protein coding RNA 612
 +
|_
 
|-
 
|-
 
|''LINC00620''
 
|''LINC00620''
Line 2,008: Line 2,408:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 620
 
|long intergenic non-protein coding RNA 620
 +
|_
 
|-
 
|-
 
|''LINC00623''
 
|''LINC00623''
Line 2,013: Line 2,414:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 623
 
|long intergenic non-protein coding RNA 623
 +
|_
 
|-
 
|-
 
|''LINC00628''
 
|''LINC00628''
Line 2,018: Line 2,420:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 628
 
|long intergenic non-protein coding RNA 628
 +
|_
 
|-
 
|-
 
|''LINC00632''
 
|''LINC00632''
Line 2,023: Line 2,426:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 632
 
|long intergenic non-protein coding RNA 632
 +
|_
 
|-
 
|-
 
|''LINC00634''
 
|''LINC00634''
Line 2,028: Line 2,432:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 634
 
|long intergenic non-protein coding RNA 634
 +
|_
 
|-
 
|-
 
|''LINC00635''
 
|''LINC00635''
Line 2,033: Line 2,438:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 635
 
|long intergenic non-protein coding RNA 635
 +
|_
 
|-
 
|-
 
|''LINC00636''
 
|''LINC00636''
Line 2,038: Line 2,444:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 636
 
|long intergenic non-protein coding RNA 636
 +
|_
 
|-
 
|-
 
|''LINC00638''
 
|''LINC00638''
Line 2,043: Line 2,450:
 
|MGC23270
 
|MGC23270
 
|long intergenic non-protein coding RNA 638
 
|long intergenic non-protein coding RNA 638
 +
|_
 
|-
 
|-
 
|''LINC00649''
 
|''LINC00649''
Line 2,048: Line 2,456:
 
|TCONSN/A00028768
 
|TCONSN/A00028768
 
|long intergenic non-protein coding RNA 649
 
|long intergenic non-protein coding RNA 649
 +
|_
 
|-
 
|-
 
|''LINC00652''
 
|''LINC00652''
Line 2,053: Line 2,462:
 
|HSPC072
 
|HSPC072
 
|long intergenic non-protein coding RNA 652
 
|long intergenic non-protein coding RNA 652
 +
|_
 
|-
 
|-
 
|''LINC00661''
 
|''LINC00661''
Line 2,058: Line 2,468:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 661
 
|long intergenic non-protein coding RNA 661
 +
|_
 
|-
 
|-
 
|''LINC00662''
 
|''LINC00662''
Line 2,063: Line 2,474:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 662
 
|long intergenic non-protein coding RNA 662
 +
|_
 
|-
 
|-
 
|''LINC00663''
 
|''LINC00663''
Line 2,068: Line 2,480:
 
|MGC39821
 
|MGC39821
 
|long intergenic non-protein coding RNA 663
 
|long intergenic non-protein coding RNA 663
 +
|_
 
|-
 
|-
 
|''LINC00667''
 
|''LINC00667''
Line 2,073: Line 2,486:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 667
 
|long intergenic non-protein coding RNA 667
 +
|_
 
|-
 
|-
 
|''LINC00668''
 
|''LINC00668''
Line 2,078: Line 2,492:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 668
 
|long intergenic non-protein coding RNA 668
 +
|_
 
|-
 
|-
 
|''LINC00673''
 
|''LINC00673''
Line 2,083: Line 2,498:
 
|HI-LNC75
 
|HI-LNC75
 
|long intergenic non-protein coding RNA 673
 
|long intergenic non-protein coding RNA 673
 +
|type 2 diabetes
 
|-
 
|-
 
|''LINC00675''
 
|''LINC00675''
Line 2,088: Line 2,504:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 675
 
|long intergenic non-protein coding RNA 675
 +
|_
 
|-
 
|-
 
|''LINC00682''
 
|''LINC00682''
Line 2,093: Line 2,510:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 682
 
|long intergenic non-protein coding RNA 682
 +
|_
 
|-
 
|-
 
|''LINC00685''
 
|''LINC00685''
Line 2,098: Line 2,516:
 
|OTTHUMT00000055574
 
|OTTHUMT00000055574
 
|long intergenic non-protein coding RNA 685
 
|long intergenic non-protein coding RNA 685
 +
|_
 
|-
 
|-
 
|''LINC00689''
 
|''LINC00689''
Line 2,103: Line 2,522:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 689
 
|long intergenic non-protein coding RNA 689
 +
|_
 
|-
 
|-
 
|''LINC00692''
 
|''LINC00692''
Line 2,108: Line 2,528:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 692
 
|long intergenic non-protein coding RNA 692
 +
|_
 
|-
 
|-
 
|''LINC00704''
 
|''LINC00704''
Line 2,113: Line 2,534:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 704
 
|long intergenic non-protein coding RNA 704
 +
|breast cancer
 
|-
 
|-
 
|''LINC00705''
 
|''LINC00705''
Line 2,118: Line 2,540:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 705
 
|long intergenic non-protein coding RNA 705
 +
|breast cancer
 
|-
 
|-
 
|''LINC00839''
 
|''LINC00839''
Line 2,123: Line 2,546:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 839
 
|long intergenic non-protein coding RNA 839
 +
|_
 
|-
 
|-
 
|''LINC00852''
 
|''LINC00852''
 
|[[LINC00852]]
 
|[[LINC00852]]
−
|NAG73, GHRL-AS2
+
|"NAG73, GHRL-AS2"
 
|long intergenic non-protein coding RNA 852
 
|long intergenic non-protein coding RNA 852
 +
|_
 
|-
 
|-
 
|''LINC00854''
 
|''LINC00854''
Line 2,133: Line 2,558:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 854
 
|long intergenic non-protein coding RNA 854
 +
|_
 
|-
 
|-
 
|''LINC00857''
 
|''LINC00857''
Line 2,138: Line 2,564:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 857
 
|long intergenic non-protein coding RNA 857
 +
|lung cancer
 
|-
 
|-
 
|''LINC00868''
 
|''LINC00868''
Line 2,143: Line 2,570:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 868
 
|long intergenic non-protein coding RNA 868
 +
|_
 
|-
 
|-
 
|''LINC00869''
 
|''LINC00869''
Line 2,148: Line 2,576:
 
|KIAA0493
 
|KIAA0493
 
|long intergenic non-protein coding RNA 869
 
|long intergenic non-protein coding RNA 869
 +
|_
 
|-
 
|-
 
|''LINC00880''
 
|''LINC00880''
Line 2,153: Line 2,582:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 880
 
|long intergenic non-protein coding RNA 880
 +
|_
 
|-
 
|-
 
|''LINC00882''
 
|''LINC00882''
Line 2,158: Line 2,588:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 882
 
|long intergenic non-protein coding RNA 882
 +
|_
 
|-
 
|-
 
|''LINC00887''
 
|''LINC00887''
Line 2,163: Line 2,594:
 
|linc-ATP13A4-8
 
|linc-ATP13A4-8
 
|long intergenic non-protein coding RNA 887
 
|long intergenic non-protein coding RNA 887
 +
|_
 
|-
 
|-
 
|''LINC00893''
 
|''LINC00893''
Line 2,168: Line 2,600:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 893
 
|long intergenic non-protein coding RNA 893
 +
|_
 
|-
 
|-
 
|''LINC00901''
 
|''LINC00901''
 
|[[LINC00901]]
 
|[[LINC00901]]
−
|TCONSN/A00005428, BC040587
+
|"TCONSN/A00005428, BC040587"
 
|long intergenic non-protein coding RNA 901
 
|long intergenic non-protein coding RNA 901
 +
|_
 
|-
 
|-
 
|''LINC00917''
 
|''LINC00917''
Line 2,178: Line 2,612:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 917
 
|long intergenic non-protein coding RNA 917
 +
|_
 
|-
 
|-
 
|''LINC00936''
 
|''LINC00936''
Line 2,183: Line 2,618:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 936
 
|long intergenic non-protein coding RNA 936
 +
|_
 
|-
 
|-
 
|''LINC00942''
 
|''LINC00942''
Line 2,188: Line 2,624:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 942
 
|long intergenic non-protein coding RNA 942
 +
|autism spectrum disorder
 
|-
 
|-
 
|''LINC00950''
 
|''LINC00950''
Line 2,193: Line 2,630:
 
|FP588
 
|FP588
 
|long intergenic non-protein coding RNA 950
 
|long intergenic non-protein coding RNA 950
 +
|_
 
|-
 
|-
 
|''LINC00951''
 
|''LINC00951''
 
|[[LINC00951]]
 
|[[LINC00951]]
−
|lincRNA-uc003opf.1, FLJ41649
+
|"lincRNA-uc003opf.1, FLJ41649"
 
|long intergenic non-protein coding RNA 951
 
|long intergenic non-protein coding RNA 951
 +
|_
 
|-
 
|-
 
|''LINC00961''
 
|''LINC00961''
Line 2,203: Line 2,642:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 961
 
|long intergenic non-protein coding RNA 961
 +
|_
 
|-
 
|-
 
|''LINC00963''
 
|''LINC00963''
Line 2,208: Line 2,648:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 963
 
|long intergenic non-protein coding RNA 963
 +
|prostate cancer
 
|-
 
|-
 
|''LINC00964''
 
|''LINC00964''
Line 2,213: Line 2,654:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 964
 
|long intergenic non-protein coding RNA 964
 +
|_
 
|-
 
|-
 
|''LINC00970''
 
|''LINC00970''
Line 2,218: Line 2,660:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 970
 
|long intergenic non-protein coding RNA 970
 +
|_
 
|-
 
|-
 
|''LINC00974''
 
|''LINC00974''
Line 2,223: Line 2,666:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 974
 
|long intergenic non-protein coding RNA 974
 +
|hepatocellular carcinoma
 
|-
 
|-
 
|''LINC00977''
 
|''LINC00977''
Line 2,228: Line 2,672:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 977
 
|long intergenic non-protein coding RNA 977
 +
|_
 
|-
 
|-
 
|''LINC00982''
 
|''LINC00982''
Line 2,233: Line 2,678:
 
|FLJ42875
 
|FLJ42875
 
|long intergenic non-protein coding RNA 982
 
|long intergenic non-protein coding RNA 982
 +
|gastric cancer
 
|-
 
|-
 
|''LINC00993''
 
|''LINC00993''
Line 2,238: Line 2,684:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 993
 
|long intergenic non-protein coding RNA 993
 +
|_
 
|-
 
|-
 
|''LINC00994''
 
|''LINC00994''
Line 2,243: Line 2,690:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 994
 
|long intergenic non-protein coding RNA 994
 +
|_
 
|-
 
|-
 
|''LINC00996''
 
|''LINC00996''
Line 2,248: Line 2,696:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 996
 
|long intergenic non-protein coding RNA 996
 +
|_
 
|-
 
|-
 
|''LINC01016''
 
|''LINC01016''
Line 2,253: Line 2,702:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 1016
 
|long intergenic non-protein coding RNA 1016
 +
|Breast Cancer
 
|-
 
|-
 
|''LINC01018''
 
|''LINC01018''
Line 2,258: Line 2,708:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 1018
 
|long intergenic non-protein coding RNA 1018
 +
|_
 
|-
 
|-
 
|''LINC01019''
 
|''LINC01019''
Line 2,263: Line 2,714:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 1019
 
|long intergenic non-protein coding RNA 1019
 +
|_
 
|-
 
|-
 
|''LINC01020''
 
|''LINC01020''
Line 2,268: Line 2,720:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 1020
 
|long intergenic non-protein coding RNA 1020
 +
|_
 
|-
 
|-
 
|''LINC01021''
 
|''LINC01021''
Line 2,273: Line 2,726:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 1021
 
|long intergenic non-protein coding RNA 1021
 +
|_
 
|-
 
|-
 
|''LINC01024''
 
|''LINC01024''
Line 2,278: Line 2,732:
 
|MA-linc1
 
|MA-linc1
 
|long intergenic non-protein coding RNA 1024
 
|long intergenic non-protein coding RNA 1024
 +
|_
 
|-
 
|-
 
|''LINC01029''
 
|''LINC01029''
Line 2,283: Line 2,738:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 1029
 
|long intergenic non-protein coding RNA 1029
 +
|_
 
|-
 
|-
 
|''LINC01080''
 
|''LINC01080''
Line 2,288: Line 2,744:
 
|TCONSN/A00021856
 
|TCONSN/A00021856
 
|long intergenic non-protein coding RNA 1080
 
|long intergenic non-protein coding RNA 1080
 +
|Alzheimer's disease ;amnestic mild cognitive impairment
 
|-
 
|-
 
|''LINC01081''
 
|''LINC01081''
Line 2,293: Line 2,750:
 
|TCONSN/A00024764
 
|TCONSN/A00024764
 
|long intergenic non-protein coding RNA 1081
 
|long intergenic non-protein coding RNA 1081
 +
|alveolar capillary dysplasia ;misalignment of pulmonary veins
 
|-
 
|-
 
|''LINC01082''
 
|''LINC01082''
Line 2,298: Line 2,756:
 
|TCONSN/A00024492
 
|TCONSN/A00024492
 
|long intergenic non-protein coding RNA 1082
 
|long intergenic non-protein coding RNA 1082
 +
|_
 
|-
 
|-
 
|''LINC01089''
 
|''LINC01089''
Line 2,303: Line 2,762:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 1089
 
|long intergenic non-protein coding RNA 1089
 +
|_
 
|-
 
|-
 
|''LINC01090''
 
|''LINC01090''
Line 2,308: Line 2,768:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 1090
 
|long intergenic non-protein coding RNA 1090
 +
|_
 
|-
 
|-
 
|''LINC01091''
 
|''LINC01091''
Line 2,313: Line 2,774:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 1091
 
|long intergenic non-protein coding RNA 1091
 +
|_
 
|-
 
|-
 
|''LINC01096''
 
|''LINC01096''
Line 2,318: Line 2,780:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 1096
 
|long intergenic non-protein coding RNA 1096
 +
|_
 
|-
 
|-
 
|''LINC01105''
 
|''LINC01105''
 
|[[LINC01105]]
 
|[[LINC01105]]
−
|FLJ30594, LOC150622
+
|"FLJ30594, LOC150622"
 
|long intergenic non-protein coding RNA 1105
 
|long intergenic non-protein coding RNA 1105
 +
|3-predicted disease-related genes
 
|-
 
|-
 
|''LINC01108''
 
|''LINC01108''
Line 2,328: Line 2,792:
 
|LncRNA-ES1
 
|LncRNA-ES1
 
|long intergenic non-protein coding RNA 1108
 
|long intergenic non-protein coding RNA 1108
 +
|_
 
|-
 
|-
 
|''LINC01122''
 
|''LINC01122''
Line 2,333: Line 2,798:
 
|FLJ30838
 
|FLJ30838
 
|long intergenic non-protein coding RNA 1122
 
|long intergenic non-protein coding RNA 1122
 +
|_
 
|-
 
|-
 
|''LINC01133''
 
|''LINC01133''
Line 2,338: Line 2,804:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 1133
 
|long intergenic non-protein coding RNA 1133
 +
|lung squamous cell cancer
 
|-
 
|-
 
|''LINC01139''
 
|''LINC01139''
Line 2,343: Line 2,810:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 1139
 
|long intergenic non-protein coding RNA 1139
 +
|_
 
|-
 
|-
 
|''LINC01140''
 
|''LINC01140''
Line 2,348: Line 2,816:
 
|FLJ41676
 
|FLJ41676
 
|long intergenic non-protein coding RNA 1140
 
|long intergenic non-protein coding RNA 1140
 +
|_
 
|-
 
|-
 
|''LINC01150''
 
|''LINC01150''
 
|[[LINC01150]]
 
|[[LINC01150]]
−
|2G7, TCONSN/A00019134
+
|"2G7, TCONSN/A00019134"
 
|long intergenic non-protein coding RNA 1150
 
|long intergenic non-protein coding RNA 1150
 +
|_
 
|-
 
|-
 
|''LINC01152''
 
|''LINC01152''
 
|[[LINC01152]]
 
|[[LINC01152]]
−
|TCONSN/A00025128, CMPD
+
|"TCONSN/A00025128, CMPD"
 
|long intergenic non-protein coding RNA 1152
 
|long intergenic non-protein coding RNA 1152
 +
|_
 
|-
 
|-
 
|''LINC01154''
 
|''LINC01154''
Line 2,363: Line 2,834:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 1154
 
|long intergenic non-protein coding RNA 1154
 +
|_
 
|-
 
|-
 
|''LINC01157''
 
|''LINC01157''
 
|[[LINC01157]]
 
|[[LINC01157]]
−
|TCONSN/A00010378, linc-Enc1
+
|"TCONSN/A00010378, linc-Enc1"
 
|long intergenic non-protein coding RNA 1157
 
|long intergenic non-protein coding RNA 1157
 +
|brain development
 
|-
 
|-
 
|''LINC01158''
 
|''LINC01158''
Line 2,373: Line 2,846:
 
|linc-Brn1a
 
|linc-Brn1a
 
|long intergenic non-protein coding RNA 1158
 
|long intergenic non-protein coding RNA 1158
 +
|_
 
|-
 
|-
 
|''LINC01159''
 
|''LINC01159''
Line 2,378: Line 2,852:
 
|linc-Brn1b
 
|linc-Brn1b
 
|long intergenic non-protein coding RNA 1159
 
|long intergenic non-protein coding RNA 1159
 +
|_
 
|-
 
|-
 
|''LINC01184''
 
|''LINC01184''
Line 2,383: Line 2,858:
 
|FLJ33630
 
|FLJ33630
 
|long intergenic non-protein coding RNA 1184
 
|long intergenic non-protein coding RNA 1184
 +
|_
 
|-
 
|-
 
|''LINC01185''
 
|''LINC01185''
Line 2,388: Line 2,864:
 
|FLJ16341
 
|FLJ16341
 
|long intergenic non-protein coding RNA 1185
 
|long intergenic non-protein coding RNA 1185
 +
|1-Psoriasis
 
|-
 
|-
 
|''LINC01192''
 
|''LINC01192''
Line 2,393: Line 2,870:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 1192
 
|long intergenic non-protein coding RNA 1192
 +
|_
 
|-
 
|-
 
|''LINC01193''
 
|''LINC01193''
Line 2,398: Line 2,876:
 
|LOC348120
 
|LOC348120
 
|long intergenic non-protein coding RNA 1193
 
|long intergenic non-protein coding RNA 1193
 +
|_
 
|-
 
|-
 
|''LINC01194''
 
|''LINC01194''
Line 2,403: Line 2,882:
 
|TAG
 
|TAG
 
|long intergenic non-protein coding RNA 1194
 
|long intergenic non-protein coding RNA 1194
 +
|_
 
|-
 
|-
 
|''LINC01202''
 
|''LINC01202''
Line 2,408: Line 2,888:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 1202
 
|long intergenic non-protein coding RNA 1202
 +
|_
 
|-
 
|-
 
|''LINC01207''
 
|''LINC01207''
Line 2,413: Line 2,894:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 1207
 
|long intergenic non-protein coding RNA 1207
 +
|Lung adenocarcinoma
 
|-
 
|-
 
|''LINC01225''
 
|''LINC01225''
Line 2,418: Line 2,900:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 1225
 
|long intergenic non-protein coding RNA 1225
 +
|hepatocellular carcinoma
 
|-
 
|-
 
|''LINC01228''
 
|''LINC01228''
Line 2,423: Line 2,906:
 
|lincRNA-DYNLRB2-2
 
|lincRNA-DYNLRB2-2
 
|long intergenic non-protein coding RNA 1228
 
|long intergenic non-protein coding RNA 1228
 +
|_
 
|-
 
|-
 
|''LINC01230''
 
|''LINC01230''
 
|[[LINC01230]]
 
|[[LINC01230]]
−
|linc-DMRT2, lnc-DRMT2, TCONSN/A00015639
+
|"linc-DMRT2, lnc-DRMT2, TCONSN/A00015639"
 
|long intergenic non-protein coding RNA 1230
 
|long intergenic non-protein coding RNA 1230
 +
|_
 
|-
 
|-
 
|''LINC01232''
 
|''LINC01232''
 
|[[LINC01232]]
 
|[[LINC01232]]
−
|FLJ41590, TCONSN/A00021520
+
|"FLJ41590, TCONSN/A00021520"
 
|long intergenic non-protein coding RNA 1232
 
|long intergenic non-protein coding RNA 1232
 +
|_
 
|-
 
|-
 
|''LINC01233''
 
|''LINC01233''
Line 2,438: Line 2,924:
 
|XLOCN/A013014
 
|XLOCN/A013014
 
|long intergenic non-protein coding RNA 1233
 
|long intergenic non-protein coding RNA 1233
 +
|_
 
|-
 
|-
 
|''LINC01234''
 
|''LINC01234''
Line 2,443: Line 2,930:
 
|onco-lncRNA-32
 
|onco-lncRNA-32
 
|long intergenic non-protein coding RNA 1234
 
|long intergenic non-protein coding RNA 1234
 +
|oesophageal squamous cell carcinoma
 
|-
 
|-
 
|''LINC01252''
 
|''LINC01252''
Line 2,448: Line 2,936:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 1252
 
|long intergenic non-protein coding RNA 1252
 +
|_
 
|-
 
|-
 
|''LINC01262''
 
|''LINC01262''
 
|[[LINC01262]]
 
|[[LINC01262]]
−
|TCONSN/Al2N/A00021807, RP11-462G22.1
+
|"TCONSN/Al2N/A00021807, RP11-462G22.1"
 
|long intergenic non-protein coding RNA 1262
 
|long intergenic non-protein coding RNA 1262
 +
|Parkinson's disease
 
|-
 
|-
 
|''LINC01264''
 
|''LINC01264''
Line 2,458: Line 2,948:
 
|RP11-124O11.2
 
|RP11-124O11.2
 
|long intergenic non-protein coding RNA 1264
 
|long intergenic non-protein coding RNA 1264
 +
|_
 
|-
 
|-
 
|''LINC01268''
 
|''LINC01268''
Line 2,463: Line 2,954:
 
|LOC285758
 
|LOC285758
 
|long intergenic non-protein coding RNA 1268
 
|long intergenic non-protein coding RNA 1268
 +
|_
 
|-
 
|-
 
|''LINC01296''
 
|''LINC01296''
Line 2,468: Line 2,960:
 
|FLJ39632
 
|FLJ39632
 
|long intergenic non-protein coding RNA 1296
 
|long intergenic non-protein coding RNA 1296
 +
|prognostic biomarker
 
|-
 
|-
 
|''LINC01312''
 
|''LINC01312''
Line 2,473: Line 2,966:
 
|MGC34034
 
|MGC34034
 
|long intergenic non-protein coding RNA 1312
 
|long intergenic non-protein coding RNA 1312
 +
|_
 
|-
 
|-
 
|''LINC01317''
 
|''LINC01317''
Line 2,478: Line 2,972:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 1317
 
|long intergenic non-protein coding RNA 1317
 +
|_
 
|-
 
|-
 
|''LINC01370''
 
|''LINC01370''
Line 2,483: Line 2,978:
 
|HI-LNC25
 
|HI-LNC25
 
|long intergenic non-protein coding RNA 1370
 
|long intergenic non-protein coding RNA 1370
 +
|_
 
|-
 
|-
 
|''LINC01374''
 
|''LINC01374''
Line 2,488: Line 2,984:
 
|TCONSN/A00018278
 
|TCONSN/A00018278
 
|long intergenic non-protein coding RNA 1374
 
|long intergenic non-protein coding RNA 1374
 +
|hepatocellular carcinoma
 
|-
 
|-
 
|''LINC01405''
 
|''LINC01405''
Line 2,493: Line 2,990:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 1405
 
|long intergenic non-protein coding RNA 1405
 +
|_
 
|-
 
|-
 
|''LINC01411''
 
|''LINC01411''
Line 2,498: Line 2,996:
 
|RP11-267A15.1
 
|RP11-267A15.1
 
|long intergenic non-protein coding RNA 1411
 
|long intergenic non-protein coding RNA 1411
 +
|prostate cancer
 
|-
 
|-
 
|''LINC01420''
 
|''LINC01420''
Line 2,503: Line 3,002:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 1420
 
|long intergenic non-protein coding RNA 1420
 +
|_
 
|-
 
|-
 
|''LINC01433''
 
|''LINC01433''
Line 2,508: Line 3,008:
 
|LOC728228
 
|LOC728228
 
|long intergenic non-protein coding RNA 1433
 
|long intergenic non-protein coding RNA 1433
 +
|_
 
|-
 
|-
 
|''LINC01435''
 
|''LINC01435''
 
|[[LINC01435]]
 
|[[LINC01435]]
−
|RP11-215N21.1, TCONSN/A00018040
+
|"RP11-215N21.1, TCONSN/A00018040"
 
|long intergenic non-protein coding RNA 1435
 
|long intergenic non-protein coding RNA 1435
 +
|_
 
|-
 
|-
 
|''LINC01436''
 
|''LINC01436''
Line 2,518: Line 3,020:
 
|AP000688.8
 
|AP000688.8
 
|long intergenic non-protein coding RNA 1436
 
|long intergenic non-protein coding RNA 1436
 +
|_
 
|-
 
|-
 
|''LINC01468''
 
|''LINC01468''
Line 2,523: Line 3,026:
 
|lnc-MBL2-4
 
|lnc-MBL2-4
 
|long intergenic non-protein coding RNA 1468
 
|long intergenic non-protein coding RNA 1468
 +
|_
 
|-
 
|-
 
|''LINC01478''
 
|''LINC01478''
Line 2,528: Line 3,032:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 1478
 
|long intergenic non-protein coding RNA 1478
 +
|_
 
|-
 
|-
 
|''LINC01501''
 
|''LINC01501''
Line 2,533: Line 3,038:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 1501
 
|long intergenic non-protein coding RNA 1501
 +
|_
 
|-
 
|-
 
|''LINC01503''
 
|''LINC01503''
Line 2,538: Line 3,044:
 
|lnc-PPP2R4-5
 
|lnc-PPP2R4-5
 
|long intergenic non-protein coding RNA 1503
 
|long intergenic non-protein coding RNA 1503
 +
|_
 
|-
 
|-
 
|''LINC01507''
 
|''LINC01507''
Line 2,543: Line 3,050:
 
|XLOCN/A000303
 
|XLOCN/A000303
 
|long intergenic non-protein coding RNA 1507
 
|long intergenic non-protein coding RNA 1507
 +
|_
 
|-
 
|-
 
|''LINC01511''
 
|''LINC01511''
Line 2,548: Line 3,056:
 
|RP11-325I22.2
 
|RP11-325I22.2
 
|long intergenic non-protein coding RNA 1511
 
|long intergenic non-protein coding RNA 1511
 +
|lung adenocarcinoma
 
|-
 
|-
 
|''LINC01512''
 
|''LINC01512''
 
|[[LINC01512]]
 
|[[LINC01512]]
−
|LOC100132354, TCONSN/A00011120, HI-LNC77
+
|"LOC100132354, TCONSN/A00011120, HI-LNC77"
 
|long intergenic non-protein coding RNA 1512
 
|long intergenic non-protein coding RNA 1512
 +
|type 2 diabetes
 
|-
 
|-
 
|''LINC01513''
 
|''LINC01513''
 
|[[LINC01513]]
 
|[[LINC01513]]
−
|RP11-1C1.7, TCONSN/A00009352
+
|"RP11-1C1.7, TCONSN/A00009352"
 
|long intergenic non-protein coding RNA 1513
 
|long intergenic non-protein coding RNA 1513
 +
|lung adenocarcinoma
 
|-
 
|-
 
|''LINC01525''
 
|''LINC01525''
Line 2,563: Line 3,074:
 
|lnc-MAN1A2-1
 
|lnc-MAN1A2-1
 
|long intergenic non-protein coding RNA 1525
 
|long intergenic non-protein coding RNA 1525
 +
|_
 
|-
 
|-
 
|''LINC01526''
 
|''LINC01526''
Line 2,568: Line 3,080:
 
|Lnc-FAM46A-1
 
|Lnc-FAM46A-1
 
|long intergenic non-protein coding RNA 1526
 
|long intergenic non-protein coding RNA 1526
 +
|_
 
|-
 
|-
 
|''LINC01527''
 
|''LINC01527''
Line 2,573: Line 3,086:
 
|lnc-SPRR2D-1
 
|lnc-SPRR2D-1
 
|long intergenic non-protein coding RNA 1527
 
|long intergenic non-protein coding RNA 1527
 +
|_
 
|-
 
|-
 
|''LINC01537''
 
|''LINC01537''
Line 2,578: Line 3,092:
 
|RP11-169D4.1-001
 
|RP11-169D4.1-001
 
|long intergenic non-protein coding RNA 1537
 
|long intergenic non-protein coding RNA 1537
 +
|_
 
|-
 
|-
 
|''LINC01547''
 
|''LINC01547''
Line 2,583: Line 3,098:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 1547
 
|long intergenic non-protein coding RNA 1547
 +
|_
 
|-
 
|-
 
|''LINC01553''
 
|''LINC01553''
Line 2,588: Line 3,104:
 
|AC023904.2
 
|AC023904.2
 
|long intergenic non-protein coding RNA 1553
 
|long intergenic non-protein coding RNA 1553
 +
|_
 
|-
 
|-
 
|''LINC01558''
 
|''LINC01558''
 
|[[LINC01558]]
 
|[[LINC01558]]
−
|HGC6.2, dJ431P23.4
+
|"HGC6.2, dJ431P23.4"
 
|long intergenic non-protein coding RNA 1558
 
|long intergenic non-protein coding RNA 1558
 +
|_
 
|-
 
|-
 
|''LINC01559''
 
|''LINC01559''
Line 2,598: Line 3,116:
 
|FLJ33810
 
|FLJ33810
 
|long intergenic non-protein coding RNA 1559
 
|long intergenic non-protein coding RNA 1559
 +
|_
 
|-
 
|-
 
|''LINC01560''
 
|''LINC01560''
Line 2,603: Line 3,122:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 1560
 
|long intergenic non-protein coding RNA 1560
 +
|_
 
|-
 
|-
 
|''LINC01562''
 
|''LINC01562''
Line 2,608: Line 3,128:
 
|RP11-296A18.3
 
|RP11-296A18.3
 
|long intergenic non-protein coding RNA 1562
 
|long intergenic non-protein coding RNA 1562
 +
|intervertebral disc degeneration
 
|-
 
|-
 
|''LINC01564''
 
|''LINC01564''
Line 2,613: Line 3,134:
 
|TCONSN/A00011314
 
|TCONSN/A00011314
 
|long intergenic non-protein coding RNA 1564
 
|long intergenic non-protein coding RNA 1564
 +
|_
 
|-
 
|-
 
|''LINC01565''
 
|''LINC01565''
Line 2,618: Line 3,140:
 
|GR6
 
|GR6
 
|long intergenic non-protein coding RNA 1565
 
|long intergenic non-protein coding RNA 1565
 +
|_
 
|-
 
|-
 
|''LINC01574''
 
|''LINC01574''
 
|[[LINC01574]]
 
|[[LINC01574]]
−
|HI-LNC12, TCONSN/A00009551
+
|"HI-LNC12, TCONSN/A00009551"
 
|long intergenic non-protein coding RNA 1574
 
|long intergenic non-protein coding RNA 1574
 +
|type 2 diabetes
 
|-
 
|-
 
|''LINC01587''
 
|''LINC01587''
Line 2,628: Line 3,152:
 
|aC1
 
|aC1
 
|long intergenic non-protein coding RNA 1587
 
|long intergenic non-protein coding RNA 1587
 +
|_
 
|-
 
|-
 
|''LINC01589''
 
|''LINC01589''
 
|[[LINC01589]]
 
|[[LINC01589]]
−
|CTA-941F9.9, TCONSN/A00029353
+
|"CTA-941F9.9, TCONSN/A00029353"
 
|long intergenic non-protein coding RNA 1589
 
|long intergenic non-protein coding RNA 1589
 +
|_
 
|-
 
|-
 
|''LINC01591''
 
|''LINC01591''
Line 2,638: Line 3,164:
 
|N/A
 
|N/A
 
|long intergenic non-protein coding RNA 1591
 
|long intergenic non-protein coding RNA 1591
 +
|_
 
|-
 
|-
 
|''LINC01602''
 
|''LINC01602''
Line 2,643: Line 3,170:
 
|T1560
 
|T1560
 
|long intergenic non-protein coding RNA 1602
 
|long intergenic non-protein coding RNA 1602
 +
|_
 
|-
 
|-
 
|''LINC01611''
 
|''LINC01611''
 
|[[LINC01611]]
 
|[[LINC01611]]
−
|RP1-90L14.1, TCONSN/Al2N/A00025430
+
|"RP1-90L14.1, TCONSN/Al2N/A00025430"
 
|long intergenic non-protein coding RNA 1611
 
|long intergenic non-protein coding RNA 1611
 +
|_
 
|-
 
|-
 
|''LINC01612''
 
|''LINC01612''
 
|[[LINC01612]]
 
|[[LINC01612]]
−
|RP11-789C1.1, TCONSN/A00008319
+
|"RP11-789C1.1, TCONSN/A00008319"
 
|long intergenic non-protein coding RNA 1612
 
|long intergenic non-protein coding RNA 1612
 +
|gastric cancer
 
|-
 
|-
 
|''LINC01613''
 
|''LINC01613''
Line 2,658: Line 3,188:
 
|n341773
 
|n341773
 
|long intergenic non-protein coding RNA 1613
 
|long intergenic non-protein coding RNA 1613
 +
|idiopathic pulmonary fibrosis
 
|-
 
|-
 
|''LINC01614''
 
|''LINC01614''
 
|[[LINC01614]]
 
|[[LINC01614]]
−
|LCAL4, TCONSN/A00003105
+
|"LCAL4, TCONSN/A00003105"
 
|long intergenic non-protein coding RNA 1614
 
|long intergenic non-protein coding RNA 1614
 +
|_
 
|-
 
|-
 
|''LINC01616''
 
|''LINC01616''
Line 2,668: Line 3,200:
 
|n341006
 
|n341006
 
|long intergenic non-protein coding RNA 1616
 
|long intergenic non-protein coding RNA 1616
 +
|Alzheimer's disease
 
|-
 
|-
 
|''LINC01617''
 
|''LINC01617''
Line 2,673: Line 3,206:
 
|XLOCN/A006844
 
|XLOCN/A006844
 
|long intergenic non-protein coding RNA 1617
 
|long intergenic non-protein coding RNA 1617
 +
|_
 
|-
 
|-
 
|''LINC01618''
 
|''LINC01618''
Line 2,678: Line 3,212:
 
|LOC152578
 
|LOC152578
 
|long intergenic non-protein coding RNA 1618
 
|long intergenic non-protein coding RNA 1618
 +
|colorectal cancer
 
|-
 
|-
 
|''LINC01622''
 
|''LINC01622''
Line 2,683: Line 3,218:
 
|TCONSN/A00011202
 
|TCONSN/A00011202
 
|long intergenic non-protein coding RNA 1622
 
|long intergenic non-protein coding RNA 1622
 +
|_
 
|-
 
|-
 
|''LINC01627''
 
|''LINC01627''
Line 2,688: Line 3,224:
 
|RP11-397D12.4
 
|RP11-397D12.4
 
|long intergenic non-protein coding RNA 1627
 
|long intergenic non-protein coding RNA 1627
 +
|NSCLC
 
|-
 
|-
 
|''LINC01628''
 
|''LINC01628''
Line 2,693: Line 3,230:
 
|AC007403.1
 
|AC007403.1
 
|long intergenic non-protein coding RNA 1628
 
|long intergenic non-protein coding RNA 1628
 +
|_
 
|-
 
|-
 
|''LINC01629''
 
|''LINC01629''
Line 2,698: Line 3,236:
 
|linc-KIAA1737-2
 
|linc-KIAA1737-2
 
|long intergenic non-protein coding RNA 1629
 
|long intergenic non-protein coding RNA 1629
 +
|_
 
|-
 
|-
 
|''LINCMD1''
 
|''LINCMD1''
 
|[[LINCMD1]]
 
|[[LINCMD1]]
 
|N/A
 
|N/A
−
|long intergenic non-protein coding RNA, muscle differentiation 1
+
|"long intergenic non-protein coding RNA, muscle differentiation 1"
 +
|Duchenne muscular dystrophy
 
|-
 
|-
 
|''LINGO1-AS1''
 
|''LINGO1-AS1''
Line 2,708: Line 3,248:
 
|N/A
 
|N/A
 
|LINGO1 antisense RNA 1
 
|LINGO1 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''LMCD1-AS1''
 
|''LMCD1-AS1''
Line 2,713: Line 3,254:
 
|N/A
 
|N/A
 
|LMCD1 antisense RNA 1 (head to head)
 
|LMCD1 antisense RNA 1 (head to head)
 +
|_
 
|-
 
|-
 
|''LOH12CR2''
 
|''LOH12CR2''
 
|[[LOH12CR2]]
 
|[[LOH12CR2]]
 
|LOH2CR12
 
|LOH2CR12
−
|loss of heterozygosity, 12, chromosomal region 2 (non-protein coding)
+
|"loss of heterozygosity, 12, chromosomal region 2 (non-protein coding)"
 +
|tumour suppressor
 
|-
 
|-
 
|''LOXL1-AS1''
 
|''LOXL1-AS1''
Line 2,723: Line 3,266:
 
|N/A
 
|N/A
 
|LOXL1 antisense RNA 1
 
|LOXL1 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''LPP-AS2''
 
|''LPP-AS2''
Line 2,728: Line 3,272:
 
|N/A
 
|N/A
 
|LPP antisense RNA 2
 
|LPP antisense RNA 2
 +
|_
 
|-
 
|-
 
|''LRP1-AS''
 
|''LRP1-AS''
Line 2,733: Line 3,278:
 
|N/A
 
|N/A
 
|LRP1 antisense RNA
 
|LRP1 antisense RNA
 +
|_
 
|-
 
|-
 
|''LRRC75A-AS1''
 
|''LRRC75A-AS1''
Line 2,738: Line 3,284:
 
|MGC40157
 
|MGC40157
 
|LRRC75A antisense RNA 1
 
|LRRC75A antisense RNA 1
 +
|_
 
|-
 
|-
 
|''LUADT1''
 
|''LUADT1''
Line 2,743: Line 3,290:
 
|N/A
 
|N/A
 
|lung adenocarcinoma associated transcript 1
 
|lung adenocarcinoma associated transcript 1
 +
|lung adenocarcinoma
 
|-
 
|-
 
|''LUNAR1''
 
|''LUNAR1''
Line 2,748: Line 3,296:
 
|N/A
 
|N/A
 
|leukemia-associated non-coding IGF1R activator RNA 1
 
|leukemia-associated non-coding IGF1R activator RNA 1
 +
|_
 
|-
 
|-
 
|''MAFA-AS1''
 
|''MAFA-AS1''
 
|[[MAFA-AS1]]
 
|[[MAFA-AS1]]
−
|RP11-909N17.3, TCONSN/A00014882
+
|"RP11-909N17.3, TCONSN/A00014882"
 
|MAFA antisense RNA 1
 
|MAFA antisense RNA 1
 +
|_
 
|-
 
|-
 
|''MAFG-AS1''
 
|''MAFG-AS1''
Line 2,758: Line 3,308:
 
|N/A
 
|N/A
 
|MAFG antisense RNA 1 (head to head)
 
|MAFG antisense RNA 1 (head to head)
 +
|_
 
|-
 
|-
 
|''MAFTRR''
 
|''MAFTRR''
Line 2,763: Line 3,314:
 
|linc-MAF-4
 
|linc-MAF-4
 
|MAF transcriptional regulator RNA
 
|MAF transcriptional regulator RNA
 +
|_
 
|-
 
|-
 
|''MAGEA8-AS1''
 
|''MAGEA8-AS1''
Line 2,768: Line 3,320:
 
|RP5-869M20.2
 
|RP5-869M20.2
 
|MAGEA8 antisense RNA 1 (head to head)
 
|MAGEA8 antisense RNA 1 (head to head)
 +
|_
 
|-
 
|-
 
|''MAPKAPK5-AS1''
 
|''MAPKAPK5-AS1''
Line 2,773: Line 3,326:
 
|FLJ39616
 
|FLJ39616
 
|MAPKAPK5 antisense RNA 1
 
|MAPKAPK5 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''MCM3AP-AS1''
 
|''MCM3AP-AS1''
 
|[[MCM3AP-AS1]]
 
|[[MCM3AP-AS1]]
−
|FLJ10508, NCRNA00031
+
|"FLJ10508, NCRNA00031"
 
|MCM3AP antisense RNA 1
 
|MCM3AP antisense RNA 1
 +
|_
 
|-
 
|-
 
|''MDC1-AS1''
 
|''MDC1-AS1''
Line 2,783: Line 3,338:
 
|MDC1-AS
 
|MDC1-AS
 
|MDC1 antisense RNA 1
 
|MDC1 antisense RNA 1
 +
| bladder cancer
 
|-
 
|-
 
|''MEF2C-AS1''
 
|''MEF2C-AS1''
Line 2,788: Line 3,344:
 
|N/A
 
|N/A
 
|MEF2C antisense RNA 1
 
|MEF2C antisense RNA 1
 +
|_
 
|-
 
|-
 
|''MEG9''
 
|''MEG9''
−
|[[ENST00000553584.1]],[[
+
|[["ENST00000553584.1,[["]]
 
|LINC00584
 
|LINC00584
 
|maternally expressed 9 (non-protein coding)
 
|maternally expressed 9 (non-protein coding)
 +
|_
 
|-
 
|-
 
|''MESTIT1''
 
|''MESTIT1''
 
|[[MESTIT1]]
 
|[[MESTIT1]]
−
|NCRNA00040, MEST-AS1
+
|"NCRNA00040, MEST-AS1"
−
|MEST intronic transcript 1, antisense RNA
+
|"MEST intronic transcript 1, antisense RNA"
 +
|_
 
|-
 
|-
 
|''MGAT3-AS1''
 
|''MGAT3-AS1''
Line 2,803: Line 3,362:
 
|TapSAKI
 
|TapSAKI
 
|MGAT3 antisense RNA 1
 
|MGAT3 antisense RNA 1
 +
|acute kidney injury
 
|-
 
|-
 
|''MHRT''
 
|''MHRT''
Line 2,808: Line 3,368:
 
|Myheart
 
|Myheart
 
|myosin heavy chain-associated RNA transcript
 
|myosin heavy chain-associated RNA transcript
 +
|heart pathological hypertrophy
 
|-
 
|-
 
|''MIF-AS1''
 
|''MIF-AS1''
Line 2,813: Line 3,374:
 
|LOC284889
 
|LOC284889
 
|MIF antisense RNA 1
 
|MIF antisense RNA 1
 +
|malaria susceptibility
 
|-
 
|-
 
|''MIMT1''
 
|''MIMT1''
 
|[[MIMT1]]
 
|[[MIMT1]]
−
|MIM1, NCRNA00067, LINC00067
+
|"MIM1, NCRNA00067, LINC00067"
 
|MER1 repeat containing imprinted transcript 1 (non-protein coding)
 
|MER1 repeat containing imprinted transcript 1 (non-protein coding)
 +
|_
 
|-
 
|-
 
|''MINCR''
 
|''MINCR''
Line 2,823: Line 3,386:
 
|TCONSN/A00015189
 
|TCONSN/A00015189
 
|MYC-induced long noncoding RNA
 
|MYC-induced long noncoding RNA
 +
|Burkitt lymphoma
 
|-
 
|-
 
|''MIR137HG''
 
|''MIR137HG''
Line 2,828: Line 3,392:
 
|N/A
 
|N/A
 
|MIR137 host gene
 
|MIR137 host gene
 +
|schizophrenia
 
|-
 
|-
 
|''MIR17HG''
 
|''MIR17HG''
 
|[[MIR17HG]]
 
|[[MIR17HG]]
−
|FLJ14178, MIRH1, MIHG1, NCRNA00048, miR-17-92, LINC00048
+
|"FLJ14178, MIRH1, MIHG1, NCRNA00048, miR-17-92, LINC00048"
 
|miR-17-92a-1 cluster host gene
 
|miR-17-92a-1 cluster host gene
 +
|"lymphoma, syndromic developmental defect"
 
|-
 
|-
 
|''MIR181A2HG''
 
|''MIR181A2HG''
Line 2,838: Line 3,404:
 
|N/A
 
|N/A
 
|MIR181A2 host gene
 
|MIR181A2 host gene
 +
|_
 
|-
 
|-
 
|''MIR210HG''
 
|''MIR210HG''
Line 2,843: Line 3,410:
 
|N/A
 
|N/A
 
|MIR210 host gene
 
|MIR210 host gene
 +
|inflammatory renal epithelial injury
 
|-
 
|-
 
|''MIR34AHG''
 
|''MIR34AHG''
Line 2,848: Line 3,416:
 
|N/A
 
|N/A
 
|MIR34A host gene
 
|MIR34A host gene
 +
|_
 
|-
 
|-
 
|''MIR4435-2HG''
 
|''MIR4435-2HG''
 
|[[MIR4435-2HG]]
 
|[[MIR4435-2HG]]
−
|LINC00978, AGD2, AK001796
+
|"LINC00978, AGD2, AK001796"
 
|MIR4435-2 host gene
 
|MIR4435-2 host gene
 +
|_
 
|-
 
|-
 
|''MIR600HG''
 
|''MIR600HG''
 
|[[MIR600HG]]
 
|[[MIR600HG]]
−
|GL012, FLJ22161
+
|"GL012, FLJ22161"
 
|MIR600 host gene
 
|MIR600 host gene
 +
|_
 
|-
 
|-
 
|''MIR663AHG''
 
|''MIR663AHG''
Line 2,863: Line 3,434:
 
|RP3-410C9.1
 
|RP3-410C9.1
 
|MIR663A host gene
 
|MIR663A host gene
 +
|_
 
|-
 
|-
 
|''MIR7-3HG''
 
|''MIR7-3HG''
 
|[[MIR7-3HG]]
 
|[[MIR7-3HG]]
−
|PGSF1, PGSF1a, PGSF1b, Huh7, uc002mbe.2
+
|"PGSF1, PGSF1a, PGSF1b, Huh7, uc002mbe.2"
 
|MIR7-3 host gene
 
|MIR7-3 host gene
 +
|_
 
|-
 
|-
 
|''MIRLET7BHG''
 
|''MIRLET7BHG''
Line 2,873: Line 3,446:
 
|linc-Ppara
 
|linc-Ppara
 
|MIRLET7B host gene
 
|MIRLET7B host gene
 +
|asbestos exposure-related lung cancer
 
|-
 
|-
 
|''MIRLET7DHG''
 
|''MIRLET7DHG''
Line 2,878: Line 3,452:
 
|N/A
 
|N/A
 
|MIRLET7D host gene
 
|MIRLET7D host gene
 +
|_
 
|-
 
|-
 
|''MKRN3-AS1''
 
|''MKRN3-AS1''
 
|[[MKRN3-AS1]]
 
|[[MKRN3-AS1]]
−
|FNZ127, NCRNA00009, ZNF127-AS
+
|"FNZ127, NCRNA00009, ZNF127-AS"
 
|MKRN3 antisense RNA 1
 
|MKRN3 antisense RNA 1
 +
|Prader-Willi syndrome ;Angelman syndromes
 
|-
 
|-
 
|''MLK7-AS1''
 
|''MLK7-AS1''
Line 2,888: Line 3,464:
 
|N/A
 
|N/A
 
|MLK7 antisense RNA 1
 
|MLK7 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''MLLT4-AS1''
 
|''MLLT4-AS1''
 
|[[MLLT4-AS1]]
 
|[[MLLT4-AS1]]
−
|HGC6.4, dJ431P23.3
+
|"HGC6.4, dJ431P23.3"
 
|MLLT4 antisense RNA 1 (head to head)
 
|MLLT4 antisense RNA 1 (head to head)
 +
|_
 
|-
 
|-
 
|''MORF4L2-AS1''
 
|''MORF4L2-AS1''
Line 2,898: Line 3,476:
 
|N/A
 
|N/A
 
|MORF4L2 antisense RNA 1
 
|MORF4L2 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''MT-LIPCAR''
 
|''MT-LIPCAR''
 
|[[MT-LIPCAR]]
 
|[[MT-LIPCAR]]
−
|uc022bqs.1, LIPCAR
+
|"uc022bqs.1, LIPCAR"
 
|mitochondrially encoded long non-coding cardiac associated RNA
 
|mitochondrially encoded long non-coding cardiac associated RNA
 +
|heart failure
 
|-
 
|-
 
|''MYCNOS''
 
|''MYCNOS''
 
|[[MYCNOS]]
 
|[[MYCNOS]]
−
|NCYM, N-CYM, MYCN-AS1
+
|"NCYM, N-CYM, MYCN-AS1"
 
|MYCN opposite strand
 
|MYCN opposite strand
 +
|neuroblastoma
 
|-
 
|-
 
|''N4BP2L2-IT2''
 
|''N4BP2L2-IT2''
Line 2,913: Line 3,494:
 
|CG030
 
|CG030
 
|N4BPL2 intronic transcript 2
 
|N4BPL2 intronic transcript 2
 +
|_
 
|-
 
|-
 
|''NALT1''
 
|''NALT1''
Line 2,918: Line 3,500:
 
|TCONSN/Al2N/A00029132
 
|TCONSN/Al2N/A00029132
 
|NOTCH1 associated lncRNA in T-cell acute lymphoblastic leukemia 1
 
|NOTCH1 associated lncRNA in T-cell acute lymphoblastic leukemia 1
 +
|_
 
|-
 
|-
 
|''NBAT1''
 
|''NBAT1''
Line 2,923: Line 3,506:
 
|NBAT-1
 
|NBAT-1
 
|neuroblastoma associated transcript 1
 
|neuroblastoma associated transcript 1
 +
|Fighting Neuroblastomas ;breast cancer
 
|-
 
|-
 
|''NBR2''
 
|''NBR2''
Line 2,928: Line 3,512:
 
|NCRNA00192
 
|NCRNA00192
 
|neighbor of BRCA1 gene 2 (non-protein coding)
 
|neighbor of BRCA1 gene 2 (non-protein coding)
 +
|breast cancer
 
|-
 
|-
 
|''NCBP2-AS2''
 
|''NCBP2-AS2''
Line 2,933: Line 3,518:
 
|N/A
 
|N/A
 
|NCBP2 antisense RNA 2 (head to head)
 
|NCBP2 antisense RNA 2 (head to head)
 +
|_
 
|-
 
|-
 
|''NCOA7-AS1''
 
|''NCOA7-AS1''
Line 2,938: Line 3,524:
 
|N/A
 
|N/A
 
|NCOA7 antisense RNA 1
 
|NCOA7 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''NCRUPAR''
 
|''NCRUPAR''
 
|[[NCRUPAR]]
 
|[[NCRUPAR]]
−
|ncR-uPAR, ncRuPAR, NCRNA00193
+
|"ncR-uPAR, ncRuPAR, NCRNA00193"
−
|non-protein coding RNA, upstream of F2R/PAR1
+
|"non-protein coding RNA, upstream of F2R/PAR1"
 +
|_
 
|-
 
|-
 
|''NFIA-AS1''
 
|''NFIA-AS1''
Line 2,948: Line 3,536:
 
|RP5-833A20.1
 
|RP5-833A20.1
 
|NFIA antisense RNA 1
 
|NFIA antisense RNA 1
 +
|_
 
|-
 
|-
 
|''NIPBL-AS1''
 
|''NIPBL-AS1''
Line 2,953: Line 3,542:
 
|NIPBL-AS
 
|NIPBL-AS
 
|NIPBL antisense RNA 1 (head to head)
 
|NIPBL antisense RNA 1 (head to head)
 +
| autism spectrum disorders
 
|-
 
|-
 
|''NKILA''
 
|''NKILA''
Line 2,958: Line 3,548:
 
|N/A
 
|N/A
 
|NF-kappaB interacting long non-coding RNA
 
|NF-kappaB interacting long non-coding RNA
 +
| breast cancer
 
|-
 
|-
 
|''NKX2-2-AS1''
 
|''NKX2-2-AS1''
Line 2,963: Line 3,554:
 
|NKX2-2AS
 
|NKX2-2AS
 
|NKX2-2 antisense RNA 1
 
|NKX2-2 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''NOP14-AS1''
 
|''NOP14-AS1''
Line 2,968: Line 3,560:
 
|RES4-24
 
|RES4-24
 
|NOP14 antisense RNA 1
 
|NOP14 antisense RNA 1
 +
|Huntington disease
 
|-
 
|-
 
|''NORAD''
 
|''NORAD''
Line 2,973: Line 3,566:
 
|N/A
 
|N/A
 
|non-coding RNA activated by DNA damage
 
|non-coding RNA activated by DNA damage
 +
|_
 
|-
 
|-
 
|''NPHP3-AS1''
 
|''NPHP3-AS1''
Line 2,978: Line 3,572:
 
|N/A
 
|N/A
 
|NPHP3 antisense RNA 1
 
|NPHP3 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''NPPA-AS1''
 
|''NPPA-AS1''
Line 2,983: Line 3,578:
 
|N/A
 
|N/A
 
|NPPA antisense RNA 1
 
|NPPA antisense RNA 1
 +
|_
 
|-
 
|-
 
|''NPSR1-AS1''
 
|''NPSR1-AS1''
 
|[[NPSR1-AS1]]
 
|[[NPSR1-AS1]]
−
|AAA1, IMAGE:4827585
+
|"AAA1, IMAGE:4827585"
 
|NPSR1 antisense RNA 1
 
|NPSR1 antisense RNA 1
 +
|cardiovascular disease
 
|-
 
|-
 
|''NPTN-IT1''
 
|''NPTN-IT1''
Line 2,993: Line 3,590:
 
|lncRNA-LET
 
|lncRNA-LET
 
|NPTN intronic transcript 1
 
|NPTN intronic transcript 1
 +
|colorectal cancer; hepatocelluar carcinoma;squamous-cell lung carcinomas
 
|-
 
|-
 
|''NR2F1-AS1''
 
|''NR2F1-AS1''
Line 2,998: Line 3,596:
 
|FLJ42709
 
|FLJ42709
 
|NR2F1 antisense RNA 1
 
|NR2F1 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''NRAV''
 
|''NRAV''
Line 3,003: Line 3,602:
 
|N/A
 
|N/A
 
|negative regulator of antiviral response (non-protein coding)
 
|negative regulator of antiviral response (non-protein coding)
 +
|influenza A virus (IAV) infection
 
|-
 
|-
 
|''OLMALINC''
 
|''OLMALINC''
 
|[[OLMALINC]]
 
|[[OLMALINC]]
−
|bA34D15.5, FLJ12974, HI-LNC80
+
|"bA34D15.5, FLJ12974, HI-LNC80"
 
|oligodendrocyte maturation-associated long intergenic non-coding RNA
 
|oligodendrocyte maturation-associated long intergenic non-coding RNA
 +
|_
 
|-
 
|-
 
|''PANCR''
 
|''PANCR''
Line 3,013: Line 3,614:
 
|N/A
 
|N/A
 
|PITX2 adjacent non-coding RNA
 
|PITX2 adjacent non-coding RNA
 +
|_
 
|-
 
|-
 
|''PAPPA-AS1''
 
|''PAPPA-AS1''
 
|[[PAPPA-AS1]]
 
|[[PAPPA-AS1]]
−
|PAPPA-AS, DIPAS, TAF4B, TAF2C2, TAFII105, NCRNA00156
+
|"PAPPA-AS, DIPAS, TAF4B, TAF2C2, TAFII105, NCRNA00156"
 
|PAPPA antisense RNA 1
 
|PAPPA antisense RNA 1
 +
|_
 
|-
 
|-
 
|''PAPPA-AS2''
 
|''PAPPA-AS2''
Line 3,023: Line 3,626:
 
|AGU1
 
|AGU1
 
|PAPPA antisense RNA 2
 
|PAPPA antisense RNA 2
 +
|stem cell differentiation
 
|-
 
|-
 
|''PARTICL''
 
|''PARTICL''
Line 3,028: Line 3,632:
 
|PARTICLE
 
|PARTICLE
 
|promoter of MAT2A antisense radiation-induced circulating long non-coding RNA
 
|promoter of MAT2A antisense radiation-induced circulating long non-coding RNA
 +
|_
 
|-
 
|-
 
|''PAXIP1-AS1''
 
|''PAXIP1-AS1''
Line 3,033: Line 3,638:
 
|N/A
 
|N/A
 
|PAXIP1 antisense RNA 1 (head to head)
 
|PAXIP1 antisense RNA 1 (head to head)
 +
|_
 
|-
 
|-
 
|''PCAT14''
 
|''PCAT14''
Line 3,038: Line 3,644:
 
|N/A
 
|N/A
 
|prostate cancer associated transcript 14 (non-protein coding)
 
|prostate cancer associated transcript 14 (non-protein coding)
 +
|prostate cancer
 
|-
 
|-
 
|''PCAT18''
 
|''PCAT18''
Line 3,043: Line 3,650:
 
|LINC01092
 
|LINC01092
 
|prostate cancer associated transcript 18 (non-protein coding)
 
|prostate cancer associated transcript 18 (non-protein coding)
 +
| metastatic prostate cancer
 
|-
 
|-
 
|''PCAT19''
 
|''PCAT19''
Line 3,048: Line 3,656:
 
|LINC01190
 
|LINC01190
 
|prostate cancer associated transcript 19 (non-protein coding)
 
|prostate cancer associated transcript 19 (non-protein coding)
 +
|prostate cancer
 
|-
 
|-
 
|''PCAT29''
 
|''PCAT29''
Line 3,053: Line 3,662:
 
|N/A
 
|N/A
 
|prostate cancer associated transcript 29 (non-protein coding)
 
|prostate cancer associated transcript 29 (non-protein coding)
 +
|prostate cancer
 
|-
 
|-
 
|''PCAT5''
 
|''PCAT5''
Line 3,058: Line 3,668:
 
|TPCAT-10-36067
 
|TPCAT-10-36067
 
|prostate cancer associated transcript 5 (non-protein coding)
 
|prostate cancer associated transcript 5 (non-protein coding)
 +
|Prostate Cancer
 
|-
 
|-
 
|''PCBP2-OT1''
 
|''PCBP2-OT1''
Line 3,063: Line 3,674:
 
|TUC338
 
|TUC338
 
|PCBP2 overlapping transcript 1
 
|PCBP2 overlapping transcript 1
 +
|1-hepatocellular carcinoma
 
|-
 
|-
 
|''PCBP3-OT1''
 
|''PCBP3-OT1''
Line 3,068: Line 3,680:
 
|FLJ44028
 
|FLJ44028
 
|PCBP3 overlapping transcript 1
 
|PCBP3 overlapping transcript 1
 +
|DNA damage
 
|-
 
|-
 
|''PCF11-AS1''
 
|''PCF11-AS1''
Line 3,073: Line 3,686:
 
|ENST00000602322.1
 
|ENST00000602322.1
 
|PCF11 anstisense RNA 1
 
|PCF11 anstisense RNA 1
 +
|_
 
|-
 
|-
 
|''PCNA-AS1''
 
|''PCNA-AS1''
Line 3,078: Line 3,692:
 
|N/A
 
|N/A
 
|PCNA antisense RNA 1
 
|PCNA antisense RNA 1
 +
|tumor
 
|-
 
|-
 
|''PEG13''
 
|''PEG13''
Line 3,083: Line 3,698:
 
|N/A
 
|N/A
 
|paternally expressed 13
 
|paternally expressed 13
 +
|_
 
|-
 
|-
 
|''PEG3-AS1''
 
|''PEG3-AS1''
 
|[[PEG3-AS1]]
 
|[[PEG3-AS1]]
−
|APEG3, NCRNA00155
+
|"APEG3, NCRNA00155"
 
|PEG3 antisense RNA 1
 
|PEG3 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''PICSAR''
 
|''PICSAR''
 
|[[PICSAR]]
 
|[[PICSAR]]
−
|PRED74, NLC1-C
+
|"PRED74, NLC1-C"
 
|P38 inhibited cutaneous squamous cell carcinoma associated lincRNA
 
|P38 inhibited cutaneous squamous cell carcinoma associated lincRNA
 +
|Cutaneous Squamous Cell Carcinoma
 
|-
 
|-
 
|''PINK1-AS''
 
|''PINK1-AS''
 
|[[PINK1-AS]]
 
|[[PINK1-AS]]
−
|FLJ00387, PINK1AS, naPINK1
+
|"FLJ00387, PINK1AS, naPINK1"
 
|PINK1 antisense RNA
 
|PINK1 antisense RNA
 +
|_
 
|-
 
|-
 
|''PISRT1''
 
|''PISRT1''
Line 3,103: Line 3,722:
 
|NCRNA00195
 
|NCRNA00195
 
|polled intersex syndrome regulated transcript 1 (non-protein coding RNA)
 
|polled intersex syndrome regulated transcript 1 (non-protein coding RNA)
 +
|blepharophimosis syndrome
 
|-
 
|-
 
|''PRKCQ-AS1''
 
|''PRKCQ-AS1''
Line 3,108: Line 3,728:
 
|ENST00000414894.1
 
|ENST00000414894.1
 
|PRKCQ antisense RNA 1
 
|PRKCQ antisense RNA 1
 +
|_
 
|-
 
|-
 
|''PRR7-AS1''
 
|''PRR7-AS1''
Line 3,113: Line 3,734:
 
|N/A
 
|N/A
 
|PRR7 antisense RNA 1
 
|PRR7 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''PSMA3-AS1''
 
|''PSMA3-AS1''
Line 3,118: Line 3,740:
 
|FLJ31306
 
|FLJ31306
 
|PSMA3 antisense RNA 1
 
|PSMA3 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''PSMD5-AS1''
 
|''PSMD5-AS1''
Line 3,123: Line 3,746:
 
|N/A
 
|N/A
 
|PSMD5 antisense RNA 1 (head to head)
 
|PSMD5 antisense RNA 1 (head to head)
 +
|_
 
|-
 
|-
 
|''PTENP1-AS''
 
|''PTENP1-AS''
Line 3,128: Line 3,752:
 
|PTENpg1-asRNA
 
|PTENpg1-asRNA
 
|PTENP1 antisense RNA
 
|PTENP1 antisense RNA
 +
|_
 
|-
 
|-
 
|''PTPRJ-AS1''
 
|''PTPRJ-AS1''
Line 3,133: Line 3,758:
 
|N/A
 
|N/A
 
|PTPRJ antisense RNA 1
 
|PTPRJ antisense RNA 1
 +
|_
 
|-
 
|-
 
|''PWAR1''
 
|''PWAR1''
 
|[[PWAR1]]
 
|[[PWAR1]]
−
|PAR1, PAR-1
+
|"PAR1, PAR-1"
 
|Prader Willi/Angelman region RNA 1
 
|Prader Willi/Angelman region RNA 1
 +
|_
 
|-
 
|-
 
|''PWAR4''
 
|''PWAR4''
 
|[[PWAR4]]
 
|[[PWAR4]]
−
|PAR4, PAR-4
+
|"PAR4, PAR-4"
 
|Prader Willi/Angelman region RNA 4
 
|Prader Willi/Angelman region RNA 4
 +
|_
 
|-
 
|-
 
|''PWAR5''
 
|''PWAR5''
 
|[[PWAR5]]
 
|[[PWAR5]]
−
|PAR5, PAR-5
+
|"PAR5, PAR-5"
 
|Prader Willi/Angelman region RNA 5
 
|Prader Willi/Angelman region RNA 5
 +
|_
 
|-
 
|-
 
|''PWARSN''
 
|''PWARSN''
 
|[[PWARSN]]
 
|[[PWARSN]]
−
|PAR-SN, PARSN
+
|"PAR-SN, PARSN"
−
|Prader Willi/Angelman region RNA, SNRPN neighbor
+
|"Prader Willi/Angelman region RNA, SNRPN neighbor"
 +
|Prader-Willi syndrome
 
|-
 
|-
 
|''RAD51-AS1''
 
|''RAD51-AS1''
Line 3,158: Line 3,788:
 
|TODRA
 
|TODRA
 
|RAD51 antisense RNA 1 (head to head)
 
|RAD51 antisense RNA 1 (head to head)
 +
|_
 
|-
 
|-
 
|''RFPL1S''
 
|''RFPL1S''
 
|[[RFPL1S]]
 
|[[RFPL1S]]
−
|RFPL1-AS, NCRNA00006
+
|"RFPL1-AS, NCRNA00006"
 
|RFPL1 antisense RNA 1
 
|RFPL1 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''RGMB-AS1''
 
|''RGMB-AS1''
Line 3,168: Line 3,800:
 
|N/A
 
|N/A
 
|RGMB antisense RNA 1
 
|RGMB antisense RNA 1
 +
|non-small cell lung cancer
 
|-
 
|-
 
|''RHPN1-AS1''
 
|''RHPN1-AS1''
Line 3,173: Line 3,806:
 
|MGC3113
 
|MGC3113
 
|RHPN1 antisense RNA 1 (head to head)
 
|RHPN1 antisense RNA 1 (head to head)
 +
|_
 
|-
 
|-
 
|''RMST''
 
|''RMST''
 
|[[RMST]]
 
|[[RMST]]
−
|NCRMS, NCRNA00054, LINC00054
+
|"NCRMS, NCRNA00054, LINC00054"
 
|rhabdomyosarcoma 2 associated transcript (non-protein coding)
 
|rhabdomyosarcoma 2 associated transcript (non-protein coding)
 +
|Rhabdomyosarcoma subtypes
 
|-
 
|-
 
|''RNF217-AS1''
 
|''RNF217-AS1''
Line 3,183: Line 3,818:
 
|STL
 
|STL
 
|RNF217 antisense RNA 1 (head to head)
 
|RNF217 antisense RNA 1 (head to head)
 +
|_
 
|-
 
|-
 
|''RNF219-AS1''
 
|''RNF219-AS1''
Line 3,188: Line 3,824:
 
|N/A
 
|N/A
 
|RNF219 antisense RNA 1
 
|RNF219 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''RPL34-AS1''
 
|''RPL34-AS1''
 
|[[RPL34-AS1]]
 
|[[RPL34-AS1]]
−
|FLJ37673, RP11-462C24.1
+
|"FLJ37673, RP11-462C24.1"
 
|RPL34 antisense RNA 1 (head to head)
 
|RPL34 antisense RNA 1 (head to head)
 +
|_
 
|-
 
|-
 
|''RPS6KA2-AS1''
 
|''RPS6KA2-AS1''
Line 3,198: Line 3,836:
 
|N/A
 
|N/A
 
|RPS6KA2 antisense RNA 1
 
|RPS6KA2 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''RUSC1-AS1''
 
|''RUSC1-AS1''
Line 3,203: Line 3,842:
 
|FLJ35976
 
|FLJ35976
 
|RUSC1 antisense RNA 1
 
|RUSC1 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''SALRNA1''
 
|''SALRNA1''
 
|[[SALRNA1]]
 
|[[SALRNA1]]
−
|SAL-RNA1, XLOCN/A023166
+
|"SAL-RNA1, XLOCN/A023166"
 
|senescence associated long non-coding RNA 1
 
|senescence associated long non-coding RNA 1
 +
|_
 
|-
 
|-
 
|''SALRNA2''
 
|''SALRNA2''
 
|[[SALRNA2]]
 
|[[SALRNA2]]
−
|SAL-RNA2, XLOCN/A025931
+
|"SAL-RNA2, XLOCN/A025931"
 
|senescence associated long non-coding RNA 2
 
|senescence associated long non-coding RNA 2
 +
|_
 
|-
 
|-
 
|''SALRNA3''
 
|''SALRNA3''
 
|[[SALRNA3]]
 
|[[SALRNA3]]
−
|SAL-RNA3, XLOCN/A025918
+
|"SAL-RNA3, XLOCN/A025918"
 
|senescence associated long non-coding RNA 3
 
|senescence associated long non-coding RNA 3
 +
|_
 
|-
 
|-
 
|''SAMD12-AS1''
 
|''SAMD12-AS1''
Line 3,223: Line 3,866:
 
|N/A
 
|N/A
 
|SAMD12 antisense RNA 1
 
|SAMD12 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''SAMMSON''
 
|''SAMMSON''
Line 3,228: Line 3,872:
 
|N/A
 
|N/A
 
|survival associated mitochondrial melanoma specific oncogenic non-coding RNA
 
|survival associated mitochondrial melanoma specific oncogenic non-coding RNA
 +
|Melanoma
 
|-
 
|-
 
|''SAP30L-AS1''
 
|''SAP30L-AS1''
 
|[[SAP30L-AS1]]
 
|[[SAP30L-AS1]]
−
|FLJ38109, GALNT10-AS1
+
|"FLJ38109, GALNT10-AS1"
 
|SAP30L antisense RNA 1 (head to head)
 
|SAP30L antisense RNA 1 (head to head)
 +
|_
 
|-
 
|-
 
|''SEC24B-AS1''
 
|''SEC24B-AS1''
Line 3,238: Line 3,884:
 
|1/2-SBSRNA4
 
|1/2-SBSRNA4
 
|SEC24B antisense RNA 1
 
|SEC24B antisense RNA 1
 +
|_
 
|-
 
|-
 
|''SGMS1-AS1''
 
|''SGMS1-AS1''
Line 3,243: Line 3,890:
 
|N/A
 
|N/A
 
|SGMS1 antisense RNA 1
 
|SGMS1 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''SIRT1-AS''
 
|''SIRT1-AS''
Line 3,248: Line 3,896:
 
|N/A
 
|N/A
 
|SIRT1 antisense RNA
 
|SIRT1 antisense RNA
 +
|Hepatocellular Carcinoma
 
|-
 
|-
 
|''SMAD1-AS1''
 
|''SMAD1-AS1''
Line 3,253: Line 3,902:
 
|ENST00000513542
 
|ENST00000513542
 
|SMAD1 antisense RNA 1
 
|SMAD1 antisense RNA 1
 +
|Ventricular septal defects
 
|-
 
|-
 
|''SMAD5-AS1''
 
|''SMAD5-AS1''
Line 3,258: Line 3,908:
 
|DAMS
 
|DAMS
 
|SMAD5 antisense RNA 1
 
|SMAD5 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''SMCR2''
 
|''SMCR2''
 
|[[SMCR2]]
 
|[[SMCR2]]
 
|N/A
 
|N/A
−
|Smith-Magenis syndrome chromosome region, candidate 2 (non-protein coding)
+
|"Smith-Magenis syndrome chromosome region, candidate 2 (non-protein coding)"
 +
|_
 
|-
 
|-
 
|''SMCR5''
 
|''SMCR5''
 
|[[SMCR5]]
 
|[[SMCR5]]
 
|NCRNA00034
 
|NCRNA00034
−
|Smith-Magenis syndrome chromosome region, candidate 5 (non-protein coding)
+
|"Smith-Magenis syndrome chromosome region, candidate 5 (non-protein coding)"
 +
|_
 
|-
 
|-
 
|''SMCR6''
 
|''SMCR6''
 
|[[SMCR6]]
 
|[[SMCR6]]
 
|N/A
 
|N/A
−
|Smith-Magenis syndrome chromosome region, candidate 6 (non-protein coding)
+
|"Smith-Magenis syndrome chromosome region, candidate 6 (non-protein coding)"
 +
|Smith-Magenis syndrome
 
|-
 
|-
 
|''SMG7-AS1''
 
|''SMG7-AS1''
Line 3,278: Line 3,932:
 
|DKFZP564C196
 
|DKFZP564C196
 
|SMG7 antisense RNA 1
 
|SMG7 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''SNAI3-AS1''
 
|''SNAI3-AS1''
Line 3,283: Line 3,938:
 
|MGC23284
 
|MGC23284
 
|SNAI3 antisense RNA 1
 
|SNAI3 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''SNHG10''
 
|''SNHG10''
 
|[[SNHG10]]
 
|[[SNHG10]]
−
|FLJ40557, NCRNA00063, LINC00063
+
|"FLJ40557, NCRNA00063, LINC00063"
 
|small nucleolar RNA host gene 10
 
|small nucleolar RNA host gene 10
 +
|_
 
|-
 
|-
 
|''SNHG11''
 
|''SNHG11''
Line 3,293: Line 3,950:
 
|LINC00101
 
|LINC00101
 
|small nucleolar RNA host gene 11
 
|small nucleolar RNA host gene 11
 +
|obesity
 
|-
 
|-
 
|''SNHG12''
 
|''SNHG12''
 
|[[SNHG12]]
 
|[[SNHG12]]
−
|PNAS-123, LINC00100, ASLNC04080
+
|"PNAS-123, LINC00100, ASLNC04080"
 
|small nucleolar RNA host gene 12
 
|small nucleolar RNA host gene 12
 +
|osteosarcoma
 
|-
 
|-
 
|''SNHG14''
 
|''SNHG14''
 
|[[SNHG14]]
 
|[[SNHG14]]
−
|NCRNA00214, UBE3A-AS
+
|"NCRNA00214, UBE3A-AS"
 
|small nucleolar RNA host gene 14
 
|small nucleolar RNA host gene 14
 +
| Prader-Willi
 
|-
 
|-
 
|''SNHG15''
 
|''SNHG15''
 
|[[SNHG15]]
 
|[[SNHG15]]
−
|FLJ38860, MYO1GUT, Linc-Myo1g
+
|"FLJ38860, MYO1GUT, Linc-Myo1g"
 
|small nucleolar RNA host gene 15
 
|small nucleolar RNA host gene 15
 +
|hepatocellular carcinoma
 
|-
 
|-
 
|''SNHG16''
 
|''SNHG16''
Line 3,313: Line 3,974:
 
|ncRAN
 
|ncRAN
 
|small nucleolar RNA host gene 16
 
|small nucleolar RNA host gene 16
 +
|"bladder cancer, colorectal cancer"
 
|-
 
|-
 
|''SNHG20''
 
|''SNHG20''
 
|[[SNHG20]]
 
|[[SNHG20]]
−
|PRO0872, FLJ25582, DKFZp686L05235, SCARNA16HG
+
|"PRO0872, FLJ25582, DKFZp686L05235, SCARNA16HG"
 
|small nucleolar RNA host gene 20
 
|small nucleolar RNA host gene 20
 +
|Hepatocellular Carcinoma
 
|-
 
|-
 
|''SNHG7''
 
|''SNHG7''
 
|[[SNHG7]]
 
|[[SNHG7]]
−
|MGC16037, NCRNA00061
+
|"MGC16037, NCRNA00061"
 
|small nucleolar RNA host gene 7
 
|small nucleolar RNA host gene 7
 +
|_
 
|-
 
|-
 
|''SNHG8''
 
|''SNHG8''
 
|[[SNHG8]]
 
|[[SNHG8]]
−
|NCRNA00060, LINC00060
+
|"NCRNA00060, LINC00060"
 
|small nucleolar RNA host gene 8
 
|small nucleolar RNA host gene 8
 +
|_
 
|-
 
|-
 
|''SOCS2-AS1''
 
|''SOCS2-AS1''
Line 3,333: Line 3,998:
 
|N/A
 
|N/A
 
|SOCS2 antisense RNA 1
 
|SOCS2 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''SOX21-AS1''
 
|''SOX21-AS1''
Line 3,338: Line 4,004:
 
|N/A
 
|N/A
 
|SOX21 antisense RNA 1 (head to head)
 
|SOX21 antisense RNA 1 (head to head)
 +
|_
 
|-
 
|-
 
|''SOX2-OT''
 
|''SOX2-OT''
 
|[[SOX2-OT]]
 
|[[SOX2-OT]]
−
|DKFZp761J1324, NCRNA00043
+
|"DKFZp761J1324, NCRNA00043"
 
|SOX2 overlapping transcript
 
|SOX2 overlapping transcript
 +
|"Esophageal squamous cell cancer, Alzheimer's disease,Neurodevelopmental syndromes associated with the SOX2 locus"
 
|-
 
|-
 
|''SPATA3-AS1''
 
|''SPATA3-AS1''
Line 3,348: Line 4,016:
 
|N/A
 
|N/A
 
|SPATA3 antisense RNA 1 (head to head)
 
|SPATA3 antisense RNA 1 (head to head)
 +
|_
 
|-
 
|-
 
|''ST7-AS1''
 
|''ST7-AS1''
Line 3,353: Line 4,022:
 
|ST7AS1
 
|ST7AS1
 
|ST7 antisense RNA 1
 
|ST7 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''ST7-AS2''
 
|''ST7-AS2''
Line 3,358: Line 4,028:
 
|ST7AS2
 
|ST7AS2
 
|ST7 antisense RNA 2
 
|ST7 antisense RNA 2
 +
|_
 
|-
 
|-
 
|''ST7-OT3''
 
|''ST7-OT3''
Line 3,363: Line 4,034:
 
|NCRNA00026
 
|NCRNA00026
 
|ST7 overlapping transcript 3
 
|ST7 overlapping transcript 3
 +
|_
 
|-
 
|-
 
|''STAM-AS1''
 
|''STAM-AS1''
Line 3,368: Line 4,040:
 
|locus3182
 
|locus3182
 
|STAM antisense RNA 1 (head to head)
 
|STAM antisense RNA 1 (head to head)
 +
|_
 
|-
 
|-
 
|''STX18-AS1''
 
|''STX18-AS1''
Line 3,373: Line 4,046:
 
|LOC100507266
 
|LOC100507266
 
|STX18 antisense RNA 1 (head to head)
 
|STX18 antisense RNA 1 (head to head)
 +
|_
 
|-
 
|-
 
|''TCL6''
 
|''TCL6''
 
|[[TCL6]]
 
|[[TCL6]]
−
|TCL6e1, TNG2, TNG1
+
|"TCL6e1, TNG2, TNG1"
 
|T-cell leukemia/lymphoma 6 (non-protein coding)
 
|T-cell leukemia/lymphoma 6 (non-protein coding)
 +
|"leukemia, lymphoma"
 
|-
 
|-
 
|''TDRG1''
 
|''TDRG1''
 
|[[NONHSAT112472]]
 
|[[NONHSAT112472]]
−
|LINC00532, lincRNA-NRN/A024015
+
|"LINC00532, lincRNA-NRN/A024015"
 
|testis development related 1 (non-protein coding)
 
|testis development related 1 (non-protein coding)
 +
|testicular cancer
 
|-
 
|-
 
|''TEX41''
 
|''TEX41''
 
|[[TEX41]]
 
|[[TEX41]]
−
|DKFZp686O1327, LINC00953
+
|"DKFZp686O1327, LINC00953"
 
|testis expressed 41 (non-protein coding)
 
|testis expressed 41 (non-protein coding)
 +
|_
 
|-
 
|-
 
|''TGFB2-OT1''
 
|''TGFB2-OT1''
Line 3,393: Line 4,070:
 
|FLJ11812
 
|FLJ11812
 
|TGFB2 overlapping transcript 1
 
|TGFB2 overlapping transcript 1
 +
|_
 
|-
 
|-
 
|''TH2LCRR''
 
|''TH2LCRR''
Line 3,398: Line 4,076:
 
|TH2-LCR
 
|TH2-LCR
 
|T helper type 2 locus control region associated RNA
 
|T helper type 2 locus control region associated RNA
 +
|_
 
|-
 
|-
 
|''THRIL''
 
|''THRIL''
 
|[[Lnc-DHX37-1:1]]
 
|[[Lnc-DHX37-1:1]]
−
|Linc1992, TCONSN/A00020260, BRI3BP-AS1
+
|"Linc1992, TCONSN/A00020260, BRI3BP-AS1"
 
|TNF and HNRNPL related immunoregulatory long non-coding RNA
 
|TNF and HNRNPL related immunoregulatory long non-coding RNA
 +
|Kawasaki disease
 
|-
 
|-
 
|''TINCR''
 
|''TINCR''
 
|[[ENST00000448587.1]]
 
|[[ENST00000448587.1]]
−
|FLJ90734, NCRNA00036, LINC00036, onco-lncRNA-16
+
|"FLJ90734, NCRNA00036, LINC00036, onco-lncRNA-16"
 
|tissue differentiation-inducing non-protein coding RNA
 
|tissue differentiation-inducing non-protein coding RNA
 +
|"squamous cell carcinoma, gastric cancer"
 
|-
 
|-
 
|''TLX1NB''
 
|''TLX1NB''
 
|[[TLX1NB]]
 
|[[TLX1NB]]
−
|TD1, TDI, APT-B7
+
|"TD1, TDI, APT-B7"
 
|TLX1 neighbor
 
|TLX1 neighbor
 +
|_
 
|-
 
|-
 
|''TMEM92-AS1''
 
|''TMEM92-AS1''
 
|[[TMEM92-AS1]]
 
|[[TMEM92-AS1]]
−
|RP11-893F2.9, lncRNA-508851, TCONSN/A00025237
+
|"RP11-893F2.9, lncRNA-508851, TCONSN/A00025237"
 
|TMEM92 antisense RNA 1
 
|TMEM92 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''TMEM9B-AS1''
 
|''TMEM9B-AS1''
Line 3,423: Line 4,106:
 
|N/A
 
|N/A
 
|TMEM9B antisense RNA 1
 
|TMEM9B antisense RNA 1
 +
|_
 
|-
 
|-
 
|''TOLLIP-AS1''
 
|''TOLLIP-AS1''
Line 3,428: Line 4,112:
 
|N/A
 
|N/A
 
|TOLLIP antisense RNA 1 (head to head)
 
|TOLLIP antisense RNA 1 (head to head)
 +
|_
 
|-
 
|-
 
|''TP53COR1''
 
|''TP53COR1''
 
|[[TP53COR1]]
 
|[[TP53COR1]]
−
|linc-p21, lincRNA-p21, Trp53cor1
+
|"linc-p21, lincRNA-p21, Trp53cor1"
 
|tumor protein p53 pathway corepressor 1 (non-protein coding)
 
|tumor protein p53 pathway corepressor 1 (non-protein coding)
 +
|_
 
|-
 
|-
 
|''TP53TG1''
 
|''TP53TG1''
 
|[[TP53TG1]]
 
|[[TP53TG1]]
−
|HN/ARG012D21.9, LINC00096
+
|"HN/ARG012D21.9, LINC00096"
 
|TP53 target 1 (non-protein coding)
 
|TP53 target 1 (non-protein coding)
 +
|_
 
|-
 
|-
 
|''TP73-AS1''
 
|''TP73-AS1''
Line 3,443: Line 4,130:
 
|PDAM
 
|PDAM
 
|TP73 antisense RNA 1
 
|TP73 antisense RNA 1
 +
|esophageal squamous cell carcinoma.
 
|-
 
|-
 
|''TRERNA1''
 
|''TRERNA1''
 
|[[TRERNA1]]
 
|[[TRERNA1]]
−
|ncRNA-a7, treRNA
+
|"ncRNA-a7, treRNA"
 
|translation regulatory long non-coding RNA 1
 
|translation regulatory long non-coding RNA 1
 +
|_
 
|-
 
|-
 
|''TRPM2-AS''
 
|''TRPM2-AS''
Line 3,453: Line 4,142:
 
|TRPM2-AS1
 
|TRPM2-AS1
 
|TRPM2 antisense RNA
 
|TRPM2 antisense RNA
 +
|cancer
 
|-
 
|-
 
|''TSIX''
 
|''TSIX''
 
|[[TSIX]]
 
|[[TSIX]]
−
|NCRNA00013, XIST-AS1, LINC00013
+
|"NCRNA00013, XIST-AS1, LINC00013"
−
|TSIX transcript, XIST antisense RNA
+
|"TSIX transcript, XIST antisense RNA"
 +
|_
 
|-
 
|-
 
|''TSPEAR-AS2''
 
|''TSPEAR-AS2''
Line 3,463: Line 4,154:
 
|N/A
 
|N/A
 
|TSPEAR antisense RNA 2
 
|TSPEAR antisense RNA 2
 +
|_
 
|-
 
|-
 
|''TTC28-AS1''
 
|''TTC28-AS1''
Line 3,468: Line 4,160:
 
|KIAA1648
 
|KIAA1648
 
|TTC28 antisense RNA 1
 
|TTC28 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''TTTY15''
 
|''TTTY15''
 
|[[TTTY15]]
 
|[[TTTY15]]
−
|DKFZP434I143, NCRNA00138
+
|"DKFZP434I143, NCRNA00138"
−
|testis-specific transcript, Y-linked 15 (non-protein coding)
+
|"testis-specific transcript, Y-linked 15 (non-protein coding)"
 +
|prostate cancer sample
 
|-
 
|-
 
|''TTTY17A''
 
|''TTTY17A''
 
|[[TTTY17A]]
 
|[[TTTY17A]]
 
|NCRNA00140
 
|NCRNA00140
−
|testis-specific transcript, Y-linked 17A (non-protein coding)
+
|"testis-specific transcript, Y-linked 17A (non-protein coding)"
 +
|_
 
|-
 
|-
 
|''TTTY3''
 
|''TTTY3''
 
|[[TTTY3]]
 
|[[TTTY3]]
−
|TTY3, TTTY3A, LINC00121
+
|"TTY3, TTTY3A, LINC00121"
−
|testis-specific transcript, Y-linked 3 (non-protein coding)
+
|"testis-specific transcript, Y-linked 3 (non-protein coding)"
 +
|_
 
|-
 
|-
 
|''TTTY4''
 
|''TTTY4''
 
|[[TTTY4]]
 
|[[TTTY4]]
−
|TTY4, TTTY4A, LINC00123
+
|"TTY4, TTTY4A, LINC00123"
−
|testis-specific transcript, Y-linked 4 (non-protein coding)
+
|"testis-specific transcript, Y-linked 4 (non-protein coding)"
 +
|_
 
|-
 
|-
 
|''TTTY5''
 
|''TTTY5''
 
|[[TTTY5]]
 
|[[TTTY5]]
−
|TTY5, LINC00126
+
|"TTY5, LINC00126"
−
|testis-specific transcript, Y-linked 5 (non-protein coding)
+
|"testis-specific transcript, Y-linked 5 (non-protein coding)"
 +
|_
 
|-
 
|-
 
|''TTTY6''
 
|''TTTY6''
 
|[[TTTY6]]
 
|[[TTTY6]]
−
|TTY6, TTTY6A, LINC00127
+
|"TTY6, TTTY6A, LINC00127"
−
|testis-specific transcript, Y-linked 6 (non-protein coding)
+
|"testis-specific transcript, Y-linked 6 (non-protein coding)"
 +
|_
 
|-
 
|-
 
|''TTTY9B''
 
|''TTTY9B''
 
|[[TTTY9B]]
 
|[[TTTY9B]]
 
|NCRNA00132
 
|NCRNA00132
−
|testis-specific transcript, Y-linked 9B (non-protein coding)
+
|"testis-specific transcript, Y-linked 9B (non-protein coding)"
 +
|_
 
|-
 
|-
 
|''TUNAR''
 
|''TUNAR''
 
|[[TUNAR]]
 
|[[TUNAR]]
−
|TUNA, HI-LNC78
+
|"TUNA, HI-LNC78"
 
|TCL1 upstream neural differentiation-associated RNA
 
|TCL1 upstream neural differentiation-associated RNA
 +
|type 2 diabetes
 
|-
 
|-
 
|''TUSC8''
 
|''TUSC8''
Line 3,513: Line 4,214:
 
|XLOCN/A010588
 
|XLOCN/A010588
 
|tumor suppressor candidate 8 (non-protein coding)
 
|tumor suppressor candidate 8 (non-protein coding)
 +
|cervical cancer
 
|-
 
|-
 
|''UMODL1-AS1''
 
|''UMODL1-AS1''
Line 3,518: Line 4,220:
 
|FLJ33471
 
|FLJ33471
 
|UMODL1 antisense RNA 1
 
|UMODL1 antisense RNA 1
 +
|breast cancer
 
|-
 
|-
 
|''VLDLR-AS1''
 
|''VLDLR-AS1''
Line 3,523: Line 4,226:
 
|N/A
 
|N/A
 
|VLDLR antisense RNA 1
 
|VLDLR antisense RNA 1
 +
|_
 
|-
 
|-
 
|''WAC-AS1''
 
|''WAC-AS1''
Line 3,528: Line 4,232:
 
|N/A
 
|N/A
 
|WAC antisense RNA 1 (head to head)
 
|WAC antisense RNA 1 (head to head)
 +
|_
 
|-
 
|-
 
|''WASIR2''
 
|''WASIR2''
Line 3,533: Line 4,238:
 
|N/A
 
|N/A
 
|WASH and IL9R antisense RNA 2
 
|WASH and IL9R antisense RNA 2
 +
|_
 
|-
 
|-
 
|''WDFY3-AS2''
 
|''WDFY3-AS2''
Line 3,538: Line 4,244:
 
|FBI4
 
|FBI4
 
|WDFY3 antisense RNA 2
 
|WDFY3 antisense RNA 2
 +
|_
 
|-
 
|-
 
|''WSPAR''
 
|''WSPAR''
 
|[[WSPAR]]
 
|[[WSPAR]]
−
|TCONSN/A00009511-XLOCN/A004555, lncTCF7
+
|"TCONSN/A00009511-XLOCN/A004555, lncTCF7"
 
|WNT signaling pathway activating non-coding RNA
 
|WNT signaling pathway activating non-coding RNA
 +
|_
 
|-
 
|-
 
|''XACT''
 
|''XACT''
Line 3,548: Line 4,256:
 
|N/A
 
|N/A
 
|X active specific transcript (non-protein coding)
 
|X active specific transcript (non-protein coding)
 +
|chromosome inactivation
 
|-
 
|-
 
|''YAM1''
 
|''YAM1''
Line 3,553: Line 4,262:
 
|Yam-1
 
|Yam-1
 
|YY1-associated myogenesis RNA 1
 
|YY1-associated myogenesis RNA 1
 +
|skeletal myogenesis
 
|-
 
|-
 
|''ZBED3-AS1''
 
|''ZBED3-AS1''
Line 3,558: Line 4,268:
 
|N/A
 
|N/A
 
|ZBED3 antisense RNA 1
 
|ZBED3 antisense RNA 1
 +
|chondrogenic differentiation
 
|-
 
|-
 
|''ZEB1-AS1''
 
|''ZEB1-AS1''
Line 3,563: Line 4,274:
 
|N/A
 
|N/A
 
|ZEB1 antisense RNA 1
 
|ZEB1 antisense RNA 1
 +
|hepatocellular carcinoma,  esophageal squamous cell carcinoma
 
|-
 
|-
 
|''ZFAT-AS1''
 
|''ZFAT-AS1''
 
|[[ZFAT-AS1]]
 
|[[ZFAT-AS1]]
−
|SAS-ZFAT, NCRNA00070
+
|"SAS-ZFAT, NCRNA00070"
 
|ZFAT antisense RNA 1
 
|ZFAT antisense RNA 1
 +
|autoimmune thyroid disease
 
|-
 
|-
 
|''ZIM2-AS1''
 
|''ZIM2-AS1''
Line 3,573: Line 4,286:
 
|ZIM2as
 
|ZIM2as
 
|ZIM2 antisense RNA 1
 
|ZIM2 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''ZNF205-AS1''
 
|''ZNF205-AS1''
Line 3,578: Line 4,292:
 
|MGC3771
 
|MGC3771
 
|ZNF205 antisense RNA 1
 
|ZNF205 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''ZNF252P-AS1''
 
|''ZNF252P-AS1''
Line 3,583: Line 4,298:
 
|N/A
 
|N/A
 
|ZNF252P antisense RNA 1
 
|ZNF252P antisense RNA 1
 +
|_
 
|-
 
|-
 
|''ZNF436-AS1''
 
|''ZNF436-AS1''
Line 3,588: Line 4,304:
 
|FLJ90508
 
|FLJ90508
 
|ZNF436 antisense RNA 1
 
|ZNF436 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''ZNF582-AS1''
 
|''ZNF582-AS1''
Line 3,593: Line 4,310:
 
|N/A
 
|N/A
 
|ZNF582 antisense RNA 1 (head to head)
 
|ZNF582 antisense RNA 1 (head to head)
 +
|_
 
|-
 
|-
 
|''ZNF667-AS1''
 
|''ZNF667-AS1''
Line 3,598: Line 4,316:
 
|MORT
 
|MORT
 
|ZNF667 antisense RNA 1 (head to head)
 
|ZNF667 antisense RNA 1 (head to head)
 +
|cancer
 
|-
 
|-
 
|''ZRANB2-AS2''
 
|''ZRANB2-AS2''
Line 3,603: Line 4,322:
 
|N/A
 
|N/A
 
|ZRANB2 antisense RNA 2 (head to head)
 
|ZRANB2 antisense RNA 2 (head to head)
 +
|_
 +
|-
 
|}
 
|}

Revision as of 08:07, 30 June 2016

Jump to section in alphabetical order : A B C D E F G H I J K L M N O P R S T U V W X Y Z

Name Transcript ID Alias Description Disease
21A NONHSAT128494 ncRNA 21A N/A _
7SK NONHSAT113149 "7-3 RNA, K-RNA, 7SK-RNA, 7SK snRNA, RN7SK, ENSG00000202198" "RNA, 7SK small nuclear" AIDS,cardiac hypertrophy,gastric cancer
7SL lnc-LRR1-1:1 "7S RNA, SRP RNA, 4.5S SRP RNA, 4.5S RNA, RN7SL1 RNA, ENSG00000258486" "RNA, 7SL, cytoplasmic 1" AIDS,dermatomyositis
ABALON ABALON INXS apoptotic BCL2L1-antisense long non-coding RNA tumor
AIRN ENST00000609176.1 "AIR, IGF2RAS" Antisense of IGF2R non-protein coding RNA alcoholic liver disease,chronic nonalcoholic liver disease, hepatocelluar carcinoma
APOA1-AS ENST00000444200.1 APOA1 antisense RNA N/A _
APTR NONHSAT121673 Alu-mediated CDKN1A/p21 N/A liver cirrhosis
BANCR BANCR LINC00586 BRAF-activated non-protein coding RNA osteosarcoma, hepatocellular carcinoma, gastric cancer
BDNF-AS ENST00000499008.3 BDNF antisense RNA "BT2A, BT2B,BT2C,BT2D,NCRNA00049,BDNF-AS1, NCRNA00049" Huntington's disease, psychiatric disease, schizophrenia, obesity
BLACAT1 BLACAT1 "linc-UBC1,LINC00912, onco-lncRNA-30" bladder cancer associated transcript 1 (non-protein coding) bladder cancer
CAHM ENST00000604200.1 LINC00468 colon adenocarcinoma hypermethylated (non-protein coding) colorectal neoplasia.
PTCSC1 NONHSAT129210 AK023948 papillary thyroid carcinoma susceptibility candidate 1 (non-protein coding) thyroid carcinoma
BCYRN1 lnc-EPCAM-1:2 "BC200,BC200a, NCRNA00004, LINC00004" "BCYRN1, brain cytoplasmic RNA 1" "Alzheimer's disease,breast cancer,cervical cancer, lung cancer,oesophagus cancer, ovarian cancer, parotid cancer,tongue cancer"
BPESC1 ENST00000418282.1 NCRNA00187 "blepharophimosis, epicanthus inversus and ptosis, candidate 1 (non-protein coding)" blepharophimosis syndrome
CYP4A22-AS1 ENST00000444042.2 "Noncoding RNA activating3: ncRNA-a3, ENST00000444042.2, ENSG00000225506" CYP4A22 antisense RNA 1 _
CASC8 CASC8 "LINC00860,CARLo-1" cancer susceptibility candidate 8 (non-protein coding) "Colorectal Cancer,Lung Cancer"
CCAT1 NONHSAT129017 "CARLo-5, onco-lncRNA-40" colon cancer associated transcript 1 (non-protein coding) "colorectal cancer,gastric cancer"
CCAT2 CCAT2 "NCCP1, LINC00873" colon cancer associated transcript 2 (non-protein coding) non-small cell lung cancer
CISTR NONHSAT028496 "CISTR-ACT, CISTRACT, re52431" chondrogenesis-associated transcript _
CRNDE Lnc-IRX3-4:2 "LOC643911, LINC00180, CRNDEP" colorectal neoplasia differentially expressed (non-protein coding) colorectal cancer
CYYR1-AS1 ENST00000357401.3 cysteine and tyrosine rich 1 antisense RNA 1 N/A _
DALIR DALIR DALI DNMT1-associated long intergenic non-coding RNA _
DANCR NONHSAT096369 differentiation antagonizing non-protein coding RNA "ANCR, AGU2, lncRNA-ANCR" bone diseases
DBET NONHSAT099821 "DBE-T, DUX4L30" D4Z4 binding element transcript (non-protein coding) "Pancreatic ductal adenocarcinoma, Facioscapulohumeral muscular dystrophy"
DHFR upstream transcripts NONHSAT102417 "DHFR minor transcript 5'-UTR, ENSG00000228716" N/A _
DHRS4-AS1 NONHSAT035954 DHRS4 antisense RNA 1 "PRO1488,AS1DHRS4" _
DLEU1 NONHSAT033797 deleted in lymphocytic leukemia 1 (non-protein coding) "LEU1, XTP6, NCRNA00021, LINC00021, BCMS1" chronic lymphocytic leukemia
DLEU2 NONHSAT033821 deleted in lymphocytic leukemia 2 (non-protein coding) "LEU2, TRIM13OS, NCRNA00022, LINC00022, MIR15AHG" "chronic lymphocytic leukemia, lymphocytic leukemia, myeloma"
DISC2 NONHSAT010191 "DISC1-AS1, DISC1OS, NCRNA00015" disrupted in schizophrenia 2 (non-protein coding) "affective disorders, Autism spectrum disorder, bipolar disorder, depression, schizophrenia"
EGOT NONHSAT087635 "EGO, ""eosinophil granule ontogeny"", NCRNA00190, ""non-protein coding RNA 190"", ENSG00000235947" Eosinophil granule ontogeny (EGO) RNA "breast cancer,"
EMX2OS lnc-PDZD8-3:1 "EMX2-AS1, NCRNA00045, ""non-protein coding RNA 45"",ENSG00000229847" Emx2 opposite strand transcript. _
ERICD Lnc-CHRAC1-2:1 "TCONS_00014875, ERIC" E2F1-regulated inhibitor of cell death (non-protein coding) _
ESRG ENST00000583516.1 HESRG embryonic stem cell related (non-protein coding) "embryonal carcinoma, intracranial aneurism"
Evf2 lnc-DLX5-3:1 "Evf-2, Dlx6as1, Dlx6os1, ENSG00000231764" _ _
FENDRR FENDRR FOXF1 adjacent non-coding developmental regulatory RNA "lincFOXF1, onco-lncRNA-21" Heart Failure
FIRRE ENST00000427391.1 firre intergenic repeating RNA element LINC01200 _
FOXCUT "Lnc-FOXC1-1:1,NONHSAT106529" TCONS_00011636 FOXC1 upstream transcript (non-protein coding) "esophageal squamous cell carcinoma, basal-like breast cancer"
FTX ENST00000602812.1 "LINC00182,FLJ33139" "FTX transcript, XIST regulator (non-protein coding)" "hepatocellular carcinoma, colorectal cancer"
GHET1 GHET1 lncRNA-GHET1 gastric carcinoma proliferation enhancing transcript 1 gastric cancer
GHRLOS NONHSAT087920 "NCRNA00068,GHRL-AS1" ghrelin opposite strand/antisense RNA "obesity, diabetes and cancer"
GPR1-AS NONHSAT076558 GPR1AS GPR1 antisense RNA _
HAGLR "ENST00000416928.2,NONHSAT075638" Mdgt HOXD antisense growth-associated long non-coding RNA neuroblastoma
HEIH HEIH "LINC-HEIH, lncRNA-HEIH, LINC00848, HCCAT2" hepatocellular carcinoma up-regulated EZH2-associated long non-coding RNA hepatocelluar carcinoma
JADRR JADRR lncRNA-JADE JADE1 adjacent regulatory RNA breast cancer
KANTR ENST00000604849.1 KDM5C adjacent non-coding transcript Spasm _
LINC-PINT NONHSAT123382 "FLJ43663, PINT, LincRNA-Pint" "long intergenic non-protein coding RNA, p53 induced transcript" pancreatic cancer
LINC00163 LINC00163 "NLC1-A, NLC1A" long intergenic non-protein coding RNA 163 _
LINC00312 NONHSAT087716 "NAG7, NAG-7, ERR10, LMCD1DN, ERR-10" long intergenic non-protein coding RNA 312 nasopharyngeal carcinoma
LINC00850 LINC00850 KUCG1 long intergenic non-protein coding RNA 850 _
LINC01191 ENST00000412690.1 "VIN, lnc-ACTR3" long intergenic non-protein coding RNA 1191 _
LSINCT5 LSINCT5 N/A long stress-induced non-coding transcript 5 "gastric cancer,breast and ovarian cancer"
LUCAT1 ENST00000511918.1 SCAL1 lung cancer associated transcript 1 (non-protein coding) non-small cell lung cancer
MIR22HG ENST00000574306.1 "MGC14376, DKFZp686O06159, LOC554202" MIR22 host gene _
MIR31HG NONHSAT130385 LOC554202 MIR31 host gene "gastric cancer, pancreatic ductal adenocarcinoma"
MIR99AHG ENST00000602580.1 MONC mir-99a-let-7c cluster host gene myeloid leukemia
MIR100HG ENST00000531381.1 "AGD1, lncRNA-N2" mir-100-let-7a-2 cluster host gene myeloid leukemia
MIR155HG NONHSAT081499 "BIC, NCRNA00172" MIR155 host gene chronic lymphocytic leukemia
MIR222HG ENST00000602507.1 Lnc-Ang362 MIR222 host gene Ang II-associated cardiovascular disease
MIR503HG ENST00000414769.1 "MGC16121, H19X" MIR503 host gene choriocarcinoma
MYCNUT ENST00000433810.1 lncUSMycN MYCN upstream transcript (non-protein coding) neuroblastoma
NAMA ENST00000604258.1 N/A "non-protein coding RNA, associated with MAP kinase pathway and growth arrest" papillary thyroid carcinoma
NRIR ENST00000414795.1 lncRNA-CMPK2 negative regulator of interferon response (non-protein coding) _
OIP5-AS1 ENST00000500949.2 "cyrano,LOC729082, linc-NUSAP1-1, OIP5-AS1" OIP5 antisense RNA 1 _
OVAAL ENST00000442621.1 "LINC01131,OVAL" ovarian adenocarcinoma amplified long non-coding RNA ovarian cancer
PACERR ENST00000608917.1 "PACER, PTGS2-AS1" PTGS2 antisense NFKB1 complex-mediated expression regulator RNA "1-PACER, as a new potential target for COX-2-modulation in inflammation and cancer."
PART1 ENST00000506884.1 "DKFZP586D0823, NCRNA00206" prostate androgen-regulated transcript 1 (non-protein coding) prostate carcinogenesis
PAUPAR NONHSAT018635 N/A PAX6 upstream antisense RNA _
PCA3 ENST00000412654.1 "DD3, NCRNA00019, PCAT3" prostate cancer associated 3 (non-protein coding) Prostate Cancer
PCAT1 ENST00000561978.1 "PCAT-1, PCA1" prostate cancer associated transcript 1 (non-protein coding) Prostate Cancer
PCAT4 ENST00000504263.1 "GDEP, PCAN1, PCA4" prostate cancer associated transcript 4 (non-protein coding) Prostate Cancer
PCAT7 ENST00000452148.2 PCAN-R2 prostate cancer associated transcript 7 (non-protein coding) Prostate Cancer
PRNCR1 NONHSAT129019 N/A prostate cancer associated non-coding RNA 1 Prostate Cancer
PTCSC2 ENST00000430058.1 N/A papillary thyroid carcinoma susceptibility candidate 2 (non-protein coding) papillary thyroid carcinoma
PTCSC3 ENST00000556013.2 N/A papillary thyroid carcinoma susceptibility candidate 3 (non-protein coding) psoriasis
PVT1 ENST00000513868.2 "NCRNA00079, LINC00079, onco-lncRNA-100" Pvt1 oncogene (non-protein coding) "breast cancer, Burkitt's lymphomas, diabetic nephropathy, Hodgkin's lymphoma, lymphoma, murine plasmacytomas, ovarian cancer, pancreas cancer, prostate cancer,renal cancer"
PWRN1 NONHSAT040920 NCRNA00198 Prader-Willi region non-protein coding RNA 1 Prader-Willi syndrome
PWRN2 NONHSAT040875 NCRNA00199 Prader-Willi region non-protein coding RNA 2 Prader-Willi syndrome
RASSF1-AS1 RASSF1-AS1 RASSF1 antisense RNA 1 ANRASSF1 breast cancer
SCAANT1 SCAANT1 SCA7/ATXN7 antisense RNA 1 ATXN7-AS1 Spinocerebellar ataxia type 7
SCHLAP1 NONHSAT075852 SWI/SNF complex antagonist associated with prostate cancer 1 (non-protein coding) "SChLAP1,PCAT11" prostate cancer
SENCR ENST00000526269.2 smooth muscle and endothelial cell enriched migration/differentiation-associated long non-coding RNA N/A _
TARID ENST00000607033.1 N/A TCF21 antisense RNA inducing promoter demethylation _
WFDC21P Lnc-HEATR6-1:4 "WAP four-disulfide core domain 21, pseudogene" "LOC645638, lnc-DC, LNCDC" _
GAS5 NONHSAT007663 "SNHG2, ENSG00000234741" _ "autoimmune disease, B-cell neoplasms, breast cancer, kidney cancer, lymphoma, prostate cancer, melanoma, systemic lupus erythaematosus"
MIAT lnc-CRYBA4-2:1 "FLJ25967, gomafu, LINC00066, lncRNA-MIAT, ""long intergenic non-protein coding RNA 66"", NCRNA00066, ""non-protein coding RNA 66"", Rncr2" myocardial infarction associated transcript (non-protein coding) myocardial infarction
H19 NONHSAT017465 "Q96MK8,ENSG00000130600" "H19, imprinted maternally expressed transcript (non-protein coding)" "bladder cancer, breast cancer, cervical cancer, choricarcinoma, colon cancer, Congenital hyperinsulinism, Esophageal squamous cell cancer, gastric cancer, germ cell tumor, gestational choriocarcinoma, glioblastoma, glioma, growth restriction, hematopoiesis, infertility, kidney cancer, liver cancer, lung cancer, Marek's disease, Medulloblastoma, melanoma, Meningioma, Mullerian aplasia, myeloproliferative polycythaemia vera, neural tube defects, neuroblastoma, obesity, ovarian cancer, pheochromocytoma, pituitary adenoma, Prader-Willi syndrome, pre-eclampsia, prostate cancer, Silver-Russell syndrome, Wiedemann-Beckwith syndrome, Wilms' tumor"
HAR1A lnc-BIRC7-2:1 "HAR1F, ENSG00000238820" highly accelerated region 1A "Alzheimer's disease,Huntington's disease, schizophrenia"
HAR1B ENST00000447910.2 "HAR1R, ENSG00000231133" highly accelerated region 1B "Huntington's disease, schizophrenia"
HOTAIR NONHSAT028508 "Gm16258, Hox antisense intergenic RNA, ENSG00000228630" Hox antisense intergenic RNA B-cell neoplasms,breast cancer,cervical cancer,colon cancer,colorectal cancer,endometrial cancer,gastric cancer,hepatocelluar carcinoma,laryngeal squamous cell carcinoma,liver cancer,lung adenocarcinoma,nasopharyngeal carcinoma,non-small cell lung cancer,oesophageal squamous cell carcinoma,oral squamous cell carcinoma,pancreas cancer,rheumatoid arthritis,small cell lung cancer
HOTAIRM1 lnc-EVX1-12:1 "HIT06113, HIT92376, linc1548, ENSG00000233429" "HOXA transcript antisense RNA, myeloid-specific 1" _
HOTTIP NONHSAT119717 "HOXA13as, HIT18844, NCRNA00213, ENSG00000243766" HOXA transcript at the distal tip hepatocelluar carcinoma
HOXA11-AS NONHSAT119704 "HOXA cluster antisense RNA 5 (non-protein coding), HOXA-AS5, ""HOXA11 antisense RNA 1 (non-protein coding)"", HOXA11-AS1, HOXA11S, NCRNA00076, ""non-protein coding RNA 76"", ENSG00000240990" HOXA11 antisense RNA "glioma, ovarian cancer"
HOXA-AS2 NONHSAT119676 "HOXA3as, ENSG00000253552" HOXA cluster antisense RNA 2 gastric cancer
HOXA-AS3 lnc-EVX1-9:1 HOXA6as HOXA cluster antisense RNA 3 _
HULC NONHSAT107640 ENSG00000251164 hepatocellular carcinoma up-regulated long non-coding RNA "hepatocelluar carcinoma, liver cancer"
IPW NONHSAT041063 NCRNA00002 imprinted in Prader-Willi syndrome Prader-Willi syndrome
JPX lnc-ZCCHC13-1:1 "DCBALD06, ENOX, ""expressed neighbor of XIST"", ""just proximal to XIST"", LINC00183" "JPX transcript, XIST activator (non-protein coding)" X chromosome inactivatio
KCNQ1OT1 NONHSAT017524 "KCNQ1 antisense RNA 2 (non-protein coding), ""KCNQ1 overlapping transcript 1 (non-protein coding)"", KCNQ1-AS2, KvDMR1, KvLQT1-AS, LIT1, NCRNA00012, ""non-protein coding RNA 12""" KCNQ1 opposite strand/antisense transcript 1 (non-protein coding) Beckwith-Wiedemann syndrome,colorectal cancer,hepatocelluar carcinoma,kidney cancer
KRASP1 NONHSAT113225 ENSG00000220635 KRAS Pseudogene 1 _
FALEC ENST00000416894.1 "LINC00568, ""long intergenic non-protein coding RNA 568"", ENSG00000228126.1" focally amplified long non-coding RNA in epithelial cancer ovarian cancer
lincRNA-ROR NONHSAT059436 "ROR, lincRNA-ST8SIA3, ENSG00000258609" "long intergenic non-protein coding RNA, regulator of reprogramming" _
LOC100887755 lnc-SNAI1-1:1 "Noncoding RNA activating7: ncRNA-a7, ENST00000431460.1,ENSG00000231265,TRERNA1" translation regulatory long non-coding RNA 1 _
TUSC7 NONHSAT091315 "LINC00902, LOC285194, ENSG00000243197" tumor suppressor candidate 7 (non-protein coding) colorectal cancer
RBM5-AS1 NONHSAT089783 "LUCA-15-specific transcript, LUST, ENSG00000003756" RBM5 antisense RNA 1 _
MALAT1 ENST00000534336.1 "HCN, ""hepcarcin"", LINC00047, ""long intergenic non-protein coding RNA 47"", MALAT-1, mascRNA, ""metastasis associated in lung adenocarcinoma transcript 1"", NCRNA00047, NEAT2, ""non-protein coding RNA 47"", ""nuclear enriched abundant transcript 2"", ""nuclear paraspeckle assembly transcript 2 (non-protein coding)"", PRO1073, ENSG00000251562" metastasis associated lung adenocarcinoma transcript 1 (non-protein coding) B-cell neoplasms,bladder cancer,breast cancer, cervial cancer, colon cancer, decreased myogenesis,Diabetes, endometrial cancer, gallbladder cancer, hepatocelluar carcinoma, kidney cancer, laryngeal squamous cell carcinoma, liver cancer, lung cancer, nasopharyngeal carcinoma, neuroblastoma, non-small cell lung cancer, osteosarcoma, pancreas cancer, prostate cancer, small cell lung cancer, uterus cancer
mascRNA lnc-SCYL1-1:5 Malat1 mascRNA (MALAT1-associated small cytoplasmic RNA) _
MEG3 NONHSAT039745 "Gtl2, ENSG00000214548" maternally expressed 3 (non-protein coding) bladder cancer, breast cancer, chronic myeloid leukemia, colon cancer, gastric cancer, glioma, hepatocelluar carcinoma, heroin abuse, Huntington's disease, kidney cancer, lung cancer, Meningioma, myelodysplastic syndrome, nonfunctioning pituitary adenomas, Pituitary adenoma, prostate cancer, type 1 diabetes
ncR-PAR NONHSAT102247 "NCRUPAR, ENSG00000225407" "non-protein coding RNA, upstream of F2R/PAR1" _
NDM29 lnc-C11orf16-1:1 29A "neuroblastoma differentiation marker 29 (Castelnuovo (2010), Pagano (2007))." neuroblastoma
GNAS-AS1 lnc-CTSZ-5:1 "GNAS antisense, GNAS1AS, NCRNA00075, NESP-AS, NESPAS, ""non-protein coding RNA 75"", SANG, ENSG00000235590" neuroendocrine secretory protein (Nesp) antisense. pseudohypoparathyroidism type Ib
NRON NONHSAT134764 ENSG00000253079 "non-protein coding RNA, repressor of NFAT" AIDS
NTT NONHSAT115106 noncoding transcript in T cells. _
OTX2-AS1 lnc-C14orf101-5:1 "OTX2OS1, ENSG00000248550" OTX2 antisense RNA 1 (head to head) _
PANDAR lnc-CDKN1A-1:1 "P21 associated ncRNA DNA damage activated, PANDA antisense RNA, ENSG00000213500, PANDAR" promoter of CDKN1A antisense DNA damage activated RNA cancer
PCGEM1 NONHSAT076153 ENSG00000227418; PCAT9; LINC00071; NCRNA00071 lncRNA Prostate-specific transcript 1 prostate cancer
LINC00853 ENST00000429328.2 "PDZK1IP1 antisense RNA 1 (non-protein coding), ""PDZK1IP1 antisense RNA 1 (tail to tail)"", PDZK1IP1-AS1 ,ENSG00000224805" long intergenic non-protein coding RNA 853 _
PRINS NONHSAT011777 ENSG00000238115 Psoriasis susceptibility-related RNA Gene Induced by Stress psoriasis
PTENP1 NONHSAT130775 "PTENpg1, PTEN2, ENSG00000237984" PTEN Pseudogene 1 prostate cancer
MEG8 ENST00000553584.1 "Bsr, ""Imprinted RNA near Meg3/Gtl2"", Irm, LINC00024, ""long intergenic non-protein coding RNA 24"", NCRNA00024, ""non-protein coding RNA 24"", Rian, ""RNA Imprinted and Accumulated in Nucleus"", ENSG00000258399" Rian: RNA Imprinted and Accumulated in Nucleus;Irm: Imprinted RNA near Meg3/Gtl2;MEG8: Maternally expressed gene 8 Prader-Willi/Angelman syndrome
LINC00599 lnc-TNKS-1:1 "retinal non-coding RNA 3, Rncr3, ENSG00000253230" "Retinal noncoding RNA 3, long intergenic non-protein coding RNA 599" _
FAS-AS NONHSAT015489 "SAF, ENSG00000026103" FAS antisense RNA 1 B-cell lymphoma
ATXN8OS NONHSAT034251 "NCRNA00003, ""non-protein coding RNA 3"", ATXN8OS, KLHL1AS, SCA8, ENSG00000230223" Spinocerebellar ataxia 8 (SCA8) RNA;KLHL1AS: kelch-like 1 (Drosophila) antisense;ATXN8OS: ataxin 8 opposite strand human spinocerebellar ataxia type 8,Spinocerebellar ataxia type 8
SNHG1 NONHSAT021826 "UHG, ENSG00000255717" SNHG1:Small nucleolar RNA host gene 1;UHG: U22 host gene. gastric cancer
SNHG3 lnc-OR10H5-1:1 "U17HG, linc1343, ENSG00000242125" Small nucleolar RNA host gene 3 Alzheimer's disease
SNHG4 NONHSAT104072 "U19H, ENSG00000200959" Small nucleolar RNA host gene 4 myelodysplastic syndrome
SNHG5 NONHSAT054526 "U50HG, ENSG00000203875" Small nucleolar RNA host gene 5 lymphoma
SNHG6 lnc-TCF24-2:3 "U87HG, ENSG00000245910" Small nucleolar RNA host gene 6 _
SPRY4-IT1 lnc-NDFIP1-3:1 "AK024556, ENSG00000274721" SPRY4 intronic transcript 1 (non-protein coding) melanoma
SRA lnc-SRA1-1:1 "SRA1, ENSG00000213523" Steroid receptor RNA Activator _
TEA-ncRNAs NONHSAT035776 ENSG00000251002 T early alpha _
IFNG-AS1 ENST00000538665.1 "LincR-Ifng-3'AS, NEST, ""Theiler's murine encephalomyelitis virus persistence candidate gene 1"", Tmevpg1, ENSG00000255733" IFNG antisense RNA 1 multiple sclerosis
TncRNA NONHSAT022116 TSU TncRNA: trophoblast noncoding RNA; TSU: trophoblast STAT utron (untranslated region of an mRNA). _
TUG1 NONHSAT084827 ENSG00000253352 taurine up-regulated gene 1 B-cell neoplasms, bladder cancer, Huntington's disease, non-small cell lung cancer
UCA1 lnc-OR10H5-1:1 "UCA1a, CUDR, UCAT1, LINC00178, NCRNA00178, GCAP2, GUCA1B, GUCA2, RP48, ENSG00000214049" urothelial cancer associated 1 (non-protein coding) bladder cancer, oral squamous cell carcinoma, pancreaticobiliary maljunction, squamous carcinoma, tongue squamous cell carcinomas
KCNIP4-IT1 NONHSAT095745 "non coding transcript UM9(5), UM9-5" KCNIP4 intronic transcript 1 (non-protein coding) _
WT1-AS lnc-EIF3M-1:1 "WIT1, ENSG00000183242" WT1 (Wilms' tumor 1) antisense transcript "gastric cancer, hepatocellular carcinoma"
XIST NONHSAT137541 ENSG00000229807 X inactive-specific transcript bladder cancer, breast cancer, Klinefelter's syndrome, testicular cancer,
ZEB2-AS1 NONHSAT074775 "Zeb2NAT, ENSG00000238057" Zeb2 natural antisense transcript bladder cancer
ZFAS1 NONHSAT080206 "Znfx1 antisense, 1500012F01Rik, NCRNA00275, ENSG00000177410" ZNFX1 antisense RNA 1 breast cancer
Zfhx2as ENST00000554403.1 "Zfh-5AS, ENSG00000157306" "zinc finger homeobox 2, antisense" _
TMEM161B-AS1 "lnc-RASA1-3:23,lnc-RASA1-3:25" "AK082072,linc-POLR3G-8, ENSG00000247828" TMEM161B antisense RNA 1 _
Alpha 250/ Alpha 280 "NONHSAT104559,lnc-NDST1-1:2" N/A N/A _
CDKN2B-AS1 "NONHSAT130421,lnc-C9orf53-2:1" "ANRIL, p15AS, ENSG00000240498" CDKN2B antisense RNA 1 abdominal aortic aneurysm,acute lymphoblastic leukemia,basal cell carcinoma,breast cancer,cardiovascular disease,coronary artery disease,coronary heart disease,Diabetes,endometriosis,Esophageal squamous cell cancer,gastric cancer,glioma,hereditary cutaneous malignant melanoma,intracranial aneurism,ischemic stroke,melanoma,myocardial infarction,nasopharyngeal carcinoma,neural system tumors syndrome,Neurofibromatosis type 1,periodontitis,prostate cancer,
BACE1-AS "NONHSAT024403,lnc-RNF214-1:2" "BACE1AS,NCRNA00177; FJ573250" BACE1 antisense RNA Alzheimer's disease,
Beta-globin transcripts "NONHSAT017676,NONHSAT017675,NONHSAT017674" N/A N/A _
LINC00581 "lnc-PRL-6:2,lnc-PRL-6:1" "BX118339,Hs.112750, linc-MBOAT1-4: TCONS_00012107, linc-MBOAT1-4: TCONS_00012678" long intergenic non-protein coding RNA 581 West Syndrome
CAR Intergenic 10 "NONHSAT016928,lnc-FANK1-3:1" "Intergenic10, CR611911, AK055628" Chromatin Associated RNA 10 _
DIO3OS "NONHSAT040032,NONHSAT040039" "DIO3-AS1, NCRNA00041, ""non-protein coding RNA 41"", ENSG00000258498" DIO3 opposite strand/antisense RNA (head to head) _
PCAT6 "ENST00000425295.1,ENST00000553157.1,ENST00000417262.1" "Noncoding RNA activating2: ncRNA-a2, KDM5B antisense RNA 1 (KDM5B-AS1),, ENSG00000228288" N/A prostate cancer
LINC00570 "ENST00000437795.1,ENST00000432665.1,ENST00000453100.1,ENST00000417473.2" "KDM5BAS1, ncRNA-a2, onco-lncRNA-96, PCAN-R1, ""prostate cancer-associated noncoding RNA 1"",ENSG00000224177," prostate cancer associated transcript 6 (non-protein coding) _
NEAT1 "ENST00000501122.2,NONHSAT022111" "MEN epsilon/beta, VINC, TncRNA, linc1317, ENSG00000245532" Nuclear enriched abundant transcript 1. infertility
ST7OT "NONHSAT122926,NONHSAT122918,NONHSAT122914,NONHSAT122932" "ST7OT1, ST7OT2, ST7OT3, ST7OT4, ST7AS1, ST7AS2, ST7AS3, ST7AS4, ENSG00000214188" N/A _
snaR "lnc-BSPH1-1:1,lnc-BSPH1-2:1" small NF90-associated RNAs small NF90-associated RNAs _
Y RNAs lnc-PDIA4-1:1 N/A N/A _
PR antisense transcripts NONHSAT023851 N/A N/A _
FAM3D-AS1 FAM3D-AS1 lnc-KCTD6-3 FAM3D antisense RNA 1 head and neck squamous cell carcinoma
SHANK2-AS3 SHANK2-AS3 N/A SHANK2 antisense RNA 3 _
AATBC AATBC N/A apoptosis associated transcript in bladder cancer bladder cancer
ABHD11-AS1 ABHD11-AS1 NCRNA00035 ABHD11 antisense RNA 1 (tail to tail) gastric cancer
ABHD15-AS1 ABHD15-AS1 "linc-TP53I13, lnc-TP53I13" ABHD15 antisense RNA 1 cardiometabolic diseases
ACTA2-AS1 ACTA2-AS1 "uc001kfo.1, ZXF1" ACTA2 antisense RNA 1 lung adenocarcinoma
ADAMTS9-AS2 ADAMTS9-AS2 N/A ADAMTS9 antisense RNA 2 glioma
ADORA2A-AS1 ADORA2A-AS1 FLJ34651 ADORA2A antisense RNA 1 _
AFAP1-AS1 AFAP1-AS1 MGC10981 AFAP1 antisense RNA 1 Barrett's esophagus and esophageal adenocarcinoma
AGAP2-AS1 AGAP2-AS1 "LOC100130776, PUNISHER" AGAP2 antisense RNA 1 _
Alpha 250/Alpha 280 "NONHSAT104559,lnc-NDST1-1:2" N/A N/A _
ANP32A-IT1 ANP32A-IT1 "FLJ11722, HsT18971" ANP32A intronic transcript 1 _
ARRDC1-AS1 ARRDC1-AS1 N/A ARRDC1 antisense RNA 1 breast cancer
ASAP1-IT1 ASAP1-IT1 "HSPC054, NCRNA00050, ASAP1IT, ASAP1-IT" ASAP1 intronic transcript 1 _
ASMTL-AS1 ASMTL-AS1 FLJ13330 ASMTL antisense RNA 1 _
ATP1A1-AS1 ATP1A1-AS1 MGC16179 ATP1A1 antisense RNA 1 _
B3GALT5-AS1 B3GALT5-AS1 N/A B3GALT5 antisense RNA 1 _
B4GALT1-AS1 B4GALT1-AS1 N/A B4GALT1 antisense RNA 1 _
BAALC-AS2 BAALC-AS2 MGC39526 BAALC antisense RNA 2 _
BCAR4 BCAR4 N/A breast cancer anti-estrogen resistance 4 (non-protein coding) breast cancer
BFSP2-AS1 BFSP2-AS1 MGC2848 BFSP2 antisense RNA 1 _
BGLT3 BGLT3 "LINC01083, BGL3, lncRNA-BGL3" beta globin locus transcript 3 (non-protein coding) Bcr-Abl-positive leukemia
BIN3-IT1 BIN3-IT1 FLJ14107 BIN3 intronic transcript 1 _
BIRC6-AS1 BIRC6-AS1 N/A BIRC6 antisense RNA 1 _
BIRC6-AS2 BIRC6-AS2 megamind BIRC6 antisense RNA 2 _
BISPR BISPR N/A BST2 interferon stimulated positive regulator (non-protein coding) _
BOK-AS1 BOK-AS1 "NCRNA00151, NAToB" BOK antisense RNA 1 testicular cancer
BRWD1-AS2 BRWD1-AS2 N/A BRWD1 antisense RNA 2 _
C1QTNF9B-AS1 C1QTNF9B-AS1 PCOTH C1QTNF9B antisense RNA 1 prostate cancer
C21orf91-OT1 C21orf91-OT1 D21S2089E C21orf91 overlapping transcript 1 _
C5orf66-AS1 C5orf66-AS1 "CTC-276P9.1, Epist" C5orf66 antisense RNA 1 esophageal squamous cell carcinoma
C5orf66-AS2 C5orf66-AS2 N/A C5orf66 antisense RNA 2 _
C8orf34-AS1 C8orf34-AS1 N/A C8orf34 antisense RNA 1 _
CACNA1G-AS1 CACNA1G-AS1 N/A CACNA1G antisense RNA 1 keloid
CAPN10-AS1 CAPN10-AS1 locus959 CAPN10 antisense RNA 1 (head to head) _
CARD8-AS1 CARD8-AS1 LOC100505812 CARD8 antisense RNA 1 _
CARMN CARMN CARMEN cardiac mesoderm enhancer-associated non-coding RNA _
CASC11 CASC11 "TCONSN/A00014535, LINC00990, CARLo-7" cancer susceptibility candidate 11 (non-protein coding) colorectal cancer
CASC15 CASC15 N/A cancer susceptibility candidate 15 (non-protein coding) metastatic melanoma
CASC19 CASC19 CARLo-6 cancer susceptibility candidate 19 (non-protein coding) prostate cancer
CASC2 CASC2 N/A cancer susceptibility candidate 2 (non-protein coding) colorectal cancer
CASC21 CASC21 CARLo-2 cancer susceptibility candidate 21 (non-protein coding) _
CASC22 CASC22 "TCONSN/A00024290, LincRNA-ENST00000515084" cancer susceptibility candidate 22 (non-protein coding) breast cancer
CASC9 CASC9 "LINC00981, ESCCAL-1" cancer susceptibility candidate 9 (non-protein coding) 3-predicted esophageal squamous cell carcinoma
CBR3-AS1 CBR3-AS1 PlncRNA-1 CBR3 antisense RNA 1 esophageal squamous carcinoma cell
CCDC18-AS1 CCDC18-AS1 ENST00000440778.1 CCDC18 antisense RNA 1 Adolescent Idiopathic Scoliosis
CCDC26 CCDC26 "MGC27434, RAM" CCDC26 long non-coding RNA glioma
CCEPR CCEPR CCHE1 cervical carcinoma expressed PCNA regulatory lncRNA cervical cancer
CDKN1A-AS1 CDKN1A-AS1 p21NAT CDKN1A antisense RNA 1 _
CDR1-AS CDR1-AS "CDR1NAT, ciRS-7, CDR1as" CDR1 antisense RNA _
CDRT7 CDRT7 "NCRNA00025, LINC00025" CMT1A duplicated region transcript 7 (non-protein coding) _
CDRT8 CDRT8 N/A CMT1A duplicated region transcript 8 _
CECR3 CECR3 N/A "cat eye syndrome chromosome region, candidate 3 (non-protein coding)" cat eye syndrome
CECR5-AS1 CECR5-AS1 NCRNA00017 CECR5 antisense RNA 1 cat eye syndrome
CECR7 CECR7 SAHL1 "cat eye syndrome chromosome region, candidate 7 (non-protein coding)" cat eye syndrome
CECR9 CECR9 N/A "cat eye syndrome chromosome region, candidate 9 (non-protein coding)" cat eye syndrome
CEP83-AS1 CEP83-AS1 N/A CEP83 antisense RNA 1 (head to head) _
CIRBP-AS1 CIRBP-AS1 MGC39338 CIRBP antisense RNA 1 _
CLRN1-AS1 CLRN1-AS1 UCRP CLRN1 antisense RNA 1 Usher syndrome type 3
COPG2IT1 COPG2IT1 "CIT1, NCRNA00170, COPG2AS" COPG2 imprinted transcript 1 (non-protein coding) _
CPS1-IT1 CPS1-IT1 "PRO0132, CPS1-IT" CPS1 intronic transcript 1 _
CSNK1G2-AS1 CSNK1G2-AS1 MGC39696 CSNK1G2 antisense RNA 1 _
CSTF3-AS1 CSTF3-AS1 N/A CSTF3 antisense RNA 1 (head to head) _
CTBP1-AS CTBP1-AS PCAT10 CTBP1 antisense RNA prostate cancer
CTBP1-AS2 CTBP1-AS2 MGC21675 CTBP1 antisense RNA 2 (head to head) _
CYP1B1-AS1 CYP1B1-AS1 MGC34824 CYP1B1 antisense RNA 1 _
CYP51A1-AS1 CYP51A1-AS1 "ENST00000453068, LRRD1-AS1" CYP51A1 antisense RNA 1 renal cell carcinoma
DACOR1 DACOR1 TCONSN/A00023265 DNMT1-associated colon cancer repressed lncRNA 1 colon cancer
DANT1 DANT1 N/A "DXZ4 associated non-coding transcript 1, proximal" _
DANT2 DANT2 N/A "DXZ4 associated non-coding transcript 2, distal" _
DAOA-AS1 DAOA-AS1 G30 DAOA antisense RNA 1 "bipolar illness,schizophrenia"
DAPK1-IT1 DAPK1-IT1 N/A DAPK1 intronic transcript 1 pancreatic cancer
DBH-AS1 DBH-AS1 BPR DBH antisense RNA 1 hepatocellular carcinoma
DGCR10 DGCR10 DGS-B DiGeorge syndrome critical region gene 10 (non-protein coding) DiGeorge syndrome
DGCR11 DGCR11 DGS-D DiGeorge syndrome critical region gene 11 (non-protein coding) 1-DiGeorge and velo-cardio-facial syndrome
DGCR12 DGCR12 DGS-E DiGeorge syndrome critical region gene 12 (non-protein coding) DiGeorge and velo-cardio-facial syndrome
DGCR5 DGCR5 "NCRNA00037, LINC00037" DiGeorge syndrome critical region gene 5 (non-protein coding) DiGeorge syndrome
DGCR9 DGCR9 "DGS-A, POM121L5P" DiGeorge syndrome critical region gene 9 (non-protein coding) DiGeorge syndrome
DIAPH2-AS1 DIAPH2-AS1 N/A DIAPH2 antisense RNA 1 _
DISC1FP1 DISC1FP1 N/A DISC1 fusion partner 1 (non-protein coding) _
DLG2-AS1 DLG2-AS1 "PSZA11q14, SZ-1" DLG2 antisense RNA 1 schizophrenia
DLGAP1-AS3 DLGAP1-AS3 N/A DLGAP1 antisense RNA 3 _
DLX6-AS1 DLX6-AS1 "FLJ34048, Evf-2" DLX6 antisense RNA 1 _
DNM3OS DNM3OS "MIR199A2HG, DNM3-AS1" DNM3 opposite strand/antisense RNA Sézary syndrome
DRAIC DRAIC N/A "downregulated RNA in cancer, inhibitor of cell invasion and migration" "prostate cancer, bladder cancer, low-grade gliomas, lung adenocarcinoma, stomach adenocarcinoma, renal clear cell carcinoma, hepatocellular carcinoma, skin melanoma"
DSCR10 DSCR10 N/A Down syndrome critical region 10 (non-protein coding) _
DSCR9 DSCR9 NCRNA00038 Down syndrome critical region 9 (non-protein coding) _
DUBR DUBR N/A DPPA2 upstream binding RNA _
EGFR-AS1 EGFR-AS1 N/A EGFR antisense RNA 1 _
ELFN1-AS1 ELFN1-AS1 N/A ELFN1 antisense RNA 1 _
ENTPD3-AS1 ENTPD3-AS1 FLJ36665 ENTPD3 antisense RNA 1 _
EPB41L4A-AS1 EPB41L4A-AS1 TIGA1 EPB41L4A antisense RNA 1 cancer
EPB41L4A-AS2 EPB41L4A-AS2 FLJ11235 EPB41L4A antisense RNA 2 (head to head) _
ERC2-IT1 ERC2-IT1 Po42 ERC2 intronic transcript 1 _
ERICH1-AS1 ERICH1-AS1 N/A ERICH1 antisense RNA 1 _
EWSAT1 EWSAT1 FLJ33768 Ewing sarcoma associated transcript 1 Ewing sarcoma
EXOC3-AS1 EXOC3-AS1 N/A EXOC3 antisense RNA 1 _
EXTL3-AS1 EXTL3-AS1 N/A EXTL3 antisense RNA 1 _
F11-AS1 F11-AS1 N/A F11 antisense RNA 1 _
FAM138A FAM138A F379 family with sequence similarity 138 member A _
FAM138B FAM138B F379 family with sequence similarity 138 member B _
FAM138C FAM138C F379 family with sequence similarity 138 member C _
FAM138D FAM138D F379 family with sequence similarity 138 member D _
FAM138E FAM138E F379 family with sequence similarity 138 member E _
FAM138F FAM138F F379 family with sequence similarity 138 member F _
FAM13A-AS1 FAM13A-AS1 NCRNA00039 FAM13A antisense RNA 1 _
FAM201A FAM201A N/A family with sequence similarity 201 member A _
FAM215A FAM215A "APR-2, LINC00530" family with sequence similarity 215 member A (non-protein coding) _
FAM222A-AS1 FAM222A-AS1 N/A FAM222A antisense RNA 1 _
FAM226A FAM226A MGC34827 family with sequence similarity 226 member A (non-protein coding) _
FAM226B FAM226B N/A family with sequence similarity 226 member B (non-protein coding) _
FAM27E3 FAM27E3 MGC42630 family with sequence similarity 27 member E3 _
FAM41AY1 FAM41AY1 N/A "family with sequence similarity 41 member A, Y-linked 1" _
FAM41C FAM41C N/A family with sequence similarity 41 member C _
FAM66C FAM66C N/A family with sequence similarity 66 member C _
FAM74A3 FAM74A3 OTTHUMG00000067149 family with sequence similarity 74 member A3 _
FAM83H-AS1 FAM83H-AS1 onco-lncRNA-3 FAM83H antisense RNA 1 (head to head) _
FAM87A FAM87A N/A family with sequence similarity 87 member A _
FAS-AS1 FAS-AS1 SAF FAS antisense RNA 1 _
FGF10-AS1 FGF10-AS1 RP11-473L15.2 FGF10 antisense RNA 1 _
FLG-AS1 FLG-AS1 N/A FLG antisense RNA 1 _
FLVCR1-AS1 FLVCR1-AS1 LQK1 FLVCR1 antisense RNA 1 (head to head) _
FMR1-AS1 FMR1-AS1 "ASFMR1, FMR4" FMR1 antisense RNA 1 _
FOXC2-AS1 FOXC2-AS1 ODRUL FOXC2 antisense RNA 1 osteosarcoma
FOXG1-AS1 FOXG1-AS1 FOXG1-AS FOXG1 antisense RNA 1 (head to head) autism spectrum disorders
FRGCA FRGCA LncRNA-AP001631.9 "FOXM1-regulated, gastric cancer associated" gastric cancer
GABPB1-AS1 GABPB1-AS1 N/A GABPB1 antisense RNA 1 _
GACAT1 ENST00000441383.1 "LINC00876, AC096655.1-002" gastric cancer associated transcript 1 (non-protein coding) gastric cancer
GACAT2 ENST00000579368.1 HMlincRNA717 gastric cancer associated transcript 2 (non-protein coding) gastric cancer
GACAT3 ENST00000426539.1 lncRNA-AC130710 gastric cancer associated transcript 3 (non-protein coding) gastric cancer
GAPLINC GAPLINC TCONSN/A00026238 "gastric adenocarcinoma associated, positive CD44 regulator, long intergenic non-coding RNA" gastric cancer
GAS1RR GAS1RR LncRNA-Hh GAS1 adjacent regulatory RNA _
GAS6-AS1 GAS6-AS1 N/A GAS6 antisense RNA 1 _
GAS8-AS1 GAS8-AS1 N/A GAS8 antisense RNA 1 _
GATA3-AS1 GATA3-AS1 N/A GATA3 antisense RNA 1 _
GATA6-AS1 GATA6-AS1 locus5689 GATA6 antisense RNA 1 (head to head) _
GDNF-AS1 GDNF-AS1 GDNFOS GDNF antisense RNA 1 (head to head) _
GLIDR GLIDR "MGC21881, TCONSN/A00015562" glioblastoma down-regulated RNA glioblastoma
GLIS3-AS1 GLIS3-AS1 MGC16153 GLIS3 antisense RNA 1 _
GNG12-AS1 GNG12-AS1 N/A GNG12 antisense RNA 1 _
GTSCR1 GTSCR1 N/A "Gilles de la Tourette syndrome chromosome region, candidate 1 (non-protein coding)" _
H1FX-AS1 H1FX-AS1 FLJ34151 H1FX antisense RNA 1 _
HAND2-AS1 HAND2-AS1 "DEIN, NBLA00301, FLJ11539" HAND2 antisense RNA 1 (head to head) neuroblastoma
HAS2-AS1 HAS2-AS1 "HASNT, NCRNA00077" HAS2 antisense RNA 1 _
HCCAT5 HCCAT5 "HTA, FJ222407" hepatocellular carcinoma associated transcript 5 (non-protein coding) hepatocellular carcinoma
HCG27 HCG27 "bPG299F13.9, bCX101P6.9, bQB115I13.2, FLJ40123" HLA complex group 27 (non-protein coding) _
HCG4 HCG4 "HCGIV-10, HCGIV.9" HLA complex group 4 (non-protein coding) _
HCG4B HCG4B "HCGIV-6, HCGIV.5, HCGIV-06, bCX67J3.3, Em:AB023056.16, bPG309N1.1, bQB90C11.3" HLA complex group 4B (non-protein coding) _
HCG9 HCG9 "PERB11, HCGIX, HCGIX4, HCGIX-4" HLA complex group 9 (non-protein coding) _
HCP5 HCP5 "D6S2650E, P5-1" HLA complex P5 (non-protein coding) _
HELLPAR HELLPAR LINC-HELLP HELLP associated long non-coding RNA extravillous trophoblast
HEXA-AS1 HEXA-AS1 FLJ13315 HEXA antisense RNA 1 _
HIF1A-AS1 HIF1A-AS1 5'aHIF-1A HIF1A antisense RNA 1 kidney cancer
HIF1A-AS2 HIF1A-AS2 "3'aHIF-1A, aHIF" HIF1A antisense RNA 2 kidney cancer
HNF1A-AS1 HNF1A-AS1 FLJ38690 HNF1A antisense RNA 1 "adenocarcinoma, oesophageal adenocarcinoma"
HNF4A-AS1 HNF4A-AS1 uc002xlx HNF4A antisense RNA 1 _
HORMAD2-AS1 HORMAD2-AS1 "MTMR3-AS1, NONHSAG033653" HORMAD2 antisense RNA 1 _
HPVC1 HPVC1 "PE5L, HPV18E5L" human papillomavirus (type 18) E5 central sequence-like 1 _
HTT-AS HTT-AS HTTAS HTT antisense RNA (head to head) Huntington's disease
HYMAI HYMAI NCRNA00020 hydatidiform mole associated and imprinted (non-protein coding) _
IDI2-AS1 IDI2-AS1 "HT009, Em:AC022536.4" IDI2 antisense RNA 1 _
IGF2-AS IGF2-AS "PEG8, IGF2-AS1" IGF2 antisense RNA "hepatocelluar carcinoma,prostate cancer, type 1 diabetes, Wilms' tumor"
ILF3-AS1 ILF3-AS1 N/A ILF3 antisense RNA 1 (head to head) _
INE1 INE1 NCRNA00010 inactivation escape 1 (non-protein coding) _
INE2 INE2 NCRNA00011 inactivation escape 2 (non-protein coding) _
IRAIN IRAIN IGF1R-AS IGF1R antisense imprinted non-protein coding RNA _
JMJD1C-AS1 JMJD1C-AS1 N/A JMJD1C antisense RNA 1 _
KCNK15-AS1 KCNK15-AS1 RP11-445H22.4 KCNK15 antisense RNA 1 (head to head) _
KCNMB2-AS1 KCNMB2-AS1 RP11-385J1.2 KCNMB2 antisense RNA 1 _
KCNQ1DN KCNQ1DN "BWRT, HSA404617" KCNQ1 downstream neighbor (non-protein coding) Wilms' tumor
KIAA1614-AS1 KIAA1614-AS1 RP11-46A10.4 KIAA1614 antisense RNA 1 _
KIF25-AS1 KIF25-AS1 HGC6.1.1 KIF25 antisense RNA 1 _
LAMP5-AS1 LAMP5-AS1 N/A LAMP5 antisense RNA 1 leukemogenesis
LBX2-AS1 LBX2-AS1 N/A LBX2 antisense RNA 1 renal cell carcinoma
LCAL1 LCAL1 onco-lncRNA-27 lung cancer associated lncRNA 1 lung cancer
LHX5-AS1 LHX5-AS1 locus4010 LHX5 antisense RNA 1 (head to head) _
LIFR-AS1 LIFR-AS1 N/A LIFR antisense RNA 1 1-preterm birth
LINC00029 LINC00029 bA305P22.4 long intergenic non-protein coding RNA 29 _
LINC00052 LINC00052 FLJ31461 long intergenic non-protein coding RNA 52 _
LINC00094 LINC00094 "FLJ35348, bA374P20.3" long intergenic non-protein coding RNA 94 _
LINC00114 LINC00114 N/A long intergenic non-protein coding RNA 114 _
LINC00115 LINC00115 FLJ22639 long intergenic non-protein coding RNA 115 cancer
LINC00152 LINC00152 MGC4677 long intergenic non-protein coding RNA 152 clear cell renal cell carcinoma
LINC00160 LINC00160 N/A long intergenic non-protein coding RNA 160 Breast Cancer
LINC00161 LINC00161 N/A long intergenic non-protein coding RNA 161 predicted
LINC00165 LINC00165 NLC1-B long intergenic non-protein coding RNA 165 narcolepsy
LINC00189 LINC00189 N/A long intergenic non-protein coding RNA 189 Breast Cancer
LINC00205 LINC00205 N/A long intergenic non-protein coding RNA 205 _
LINC00235 LINC00235 N/A long intergenic non-protein coding RNA 235 _
LINC00237 LINC00237 N/A long intergenic non-protein coding RNA 237 "macrosomia, obesity, macrocephaly, and ocular abnormalities"
LINC00244 LINC00244 N/A long intergenic non-protein coding RNA 244 _
LINC00261 LINC00261 "bA216C10.1, HCCDR1, TCONSN/A00027846, ALIEN, DEANR1, onco-lncRNA-17" long intergenic non-protein coding RNA 261 gastric cancer
LINC00265 LINC00265 NCRNA00265-1 long intergenic non-protein coding RNA 265 _
LINC00272 LINC00272 RP1-223H12.3 long intergenic non-protein coding RNA 272 prostate cancer region
LINC00293 LINC00293 BEYLA long intergenic non-protein coding RNA 293 _
LINC00294 LINC00294 N/A long intergenic non-protein coding RNA 294 _
LINC00299 LINC00299 FLJ45673 long intergenic non-protein coding RNA 299 Intellectual and developmental disability
LINC00301 LINC00301 MGC39681 long intergenic non-protein coding RNA 301 _
LINC00302 LINC00302 XP33 long intergenic non-protein coding RNA 302 _
LINC00305 LINC00305 "MGC39571, HsT1235" long intergenic non-protein coding RNA 305 _
LINC00307 LINC00307 D21S2091E long intergenic non-protein coding RNA 307 _
LINC00308 LINC00308 PRED16 long intergenic non-protein coding RNA 308 _
LINC00310 LINC00310 N/A long intergenic non-protein coding RNA 310 _
LINC00311 LINC00311 MGC22001 long intergenic non-protein coding RNA 311 _
LINC00313 LINC00313 N/A long intergenic non-protein coding RNA 313 lung cancer
LINC00314 LINC00314 N/A long intergenic non-protein coding RNA 314 _
LINC00315 LINC00315 N/A long intergenic non-protein coding RNA 315 _
LINC00320 LINC00320 "PRED14, FLJ37539" long intergenic non-protein coding RNA 320 _
LINC00322 LINC00322 FLJ16545 long intergenic non-protein coding RNA 322 _
LINC00323 LINC00323 "PRED42, FLJ37173" long intergenic non-protein coding RNA 323 _
LINC00324 LINC00324 "FLJ34790, MGC104931" long intergenic non-protein coding RNA 324 _
LINC00334 LINC00334 N/A long intergenic non-protein coding RNA 334 _
LINC00337 LINC00337 MGC40168 long intergenic non-protein coding RNA 337 _
LINC00339 LINC00339 HSPC157 long intergenic non-protein coding RNA 339 _
LINC00342 LINC00342 N/A long intergenic non-protein coding RNA 342 Non-small cell lung cancer
LINC00346 LINC00346 N/A long intergenic non-protein coding RNA 346 _
LINC00347 LINC00347 N/A long intergenic non-protein coding RNA 347 _
LINC00426 LINC00426 N/A long intergenic non-protein coding RNA 426 _
LINC00441 LINC00441 ncRNA-RB1 long intergenic non-protein coding RNA 441 _
LINC00461 LINC00461 "EyeLinc1, Visc-1a, Visc-1b, Visc-2, LOC645323" long intergenic non-protein coding RNA 461 _
LINC00466 LINC00466 N/A long intergenic non-protein coding RNA 466 _
LINC00467 LINC00467 MGC14801 long intergenic non-protein coding RNA 467 _
LINC00470 LINC00470 N/A long intergenic non-protein coding RNA 470 _
LINC00471 LINC00471 MGC43122 long intergenic non-protein coding RNA 471 _
LINC00472 LINC00472 "dJ288M22.3, FLJ13189" long intergenic non-protein coding RNA 472 breast cancer
LINC00473 LINC00473 bA142J11.1 long intergenic non-protein coding RNA 473 lung cancer
LINC00477 LINC00477 "FLJ32894, FAM191B" long intergenic non-protein coding RNA 477 _
LINC00491 LINC00491 BC008363 long intergenic non-protein coding RNA 491 pancreatic ductal adenocarcinoma
LINC00493 LINC00493 LOC388789 long intergenic non-protein coding RNA 493 _
LINC00494 LINC00494 N/A long intergenic non-protein coding RNA 494 _
LINC00507 LINC00507 N/A long intergenic non-protein coding RNA 507 _
LINC00511 LINC00511 onco-lncRNA-12 long intergenic non-protein coding RNA 511 _
LINC00518 LINC00518 MGC40222 long intergenic non-protein coding RNA 518 _
LINC00526 LINC00526 "MGC17515, HsT959" long intergenic non-protein coding RNA 526 _
LINC00528 LINC00528 FLJ40542 long intergenic non-protein coding RNA 528 _
LINC00529 LINC00529 N/A long intergenic non-protein coding RNA 529 keratolytic winter erythema
LINC00536 LINC00536 N/A long intergenic non-protein coding RNA 536 _
LINC00538 LINC00538 "Yiya, PROX1UT" long intergenic non-protein coding RNA 538 cancers
LINC00575 LINC00575 N/A long intergenic non-protein coding RNA 575 _
LINC00588 LINC00588 DKFZP434F122 long intergenic non-protein coding RNA 588 _
LINC00593 LINC00593 MGC42951 long intergenic non-protein coding RNA 593 _
LINC00598 LINC00598 TTL long intergenic non-protein coding RNA 598 _
LINC00608 LINC00608 N/A long intergenic non-protein coding RNA 608 _
LINC00612 LINC00612 "MGC40170, FLJ41814" long intergenic non-protein coding RNA 612 _
LINC00620 LINC00620 N/A long intergenic non-protein coding RNA 620 _
LINC00623 LINC00623 N/A long intergenic non-protein coding RNA 623 _
LINC00628 LINC00628 N/A long intergenic non-protein coding RNA 628 _
LINC00632 LINC00632 N/A long intergenic non-protein coding RNA 632 _
LINC00634 LINC00634 N/A long intergenic non-protein coding RNA 634 _
LINC00635 LINC00635 N/A long intergenic non-protein coding RNA 635 _
LINC00636 LINC00636 N/A long intergenic non-protein coding RNA 636 _
LINC00638 LINC00638 MGC23270 long intergenic non-protein coding RNA 638 _
LINC00649 LINC00649 TCONSN/A00028768 long intergenic non-protein coding RNA 649 _
LINC00652 LINC00652 HSPC072 long intergenic non-protein coding RNA 652 _
LINC00661 LINC00661 N/A long intergenic non-protein coding RNA 661 _
LINC00662 LINC00662 N/A long intergenic non-protein coding RNA 662 _
LINC00663 LINC00663 MGC39821 long intergenic non-protein coding RNA 663 _
LINC00667 LINC00667 N/A long intergenic non-protein coding RNA 667 _
LINC00668 LINC00668 N/A long intergenic non-protein coding RNA 668 _
LINC00673 LINC00673 HI-LNC75 long intergenic non-protein coding RNA 673 type 2 diabetes
LINC00675 LINC00675 N/A long intergenic non-protein coding RNA 675 _
LINC00682 LINC00682 N/A long intergenic non-protein coding RNA 682 _
LINC00685 LINC00685 OTTHUMT00000055574 long intergenic non-protein coding RNA 685 _
LINC00689 LINC00689 N/A long intergenic non-protein coding RNA 689 _
LINC00692 LINC00692 N/A long intergenic non-protein coding RNA 692 _
LINC00704 LINC00704 N/A long intergenic non-protein coding RNA 704 breast cancer
LINC00705 LINC00705 N/A long intergenic non-protein coding RNA 705 breast cancer
LINC00839 LINC00839 N/A long intergenic non-protein coding RNA 839 _
LINC00852 LINC00852 "NAG73, GHRL-AS2" long intergenic non-protein coding RNA 852 _
LINC00854 LINC00854 N/A long intergenic non-protein coding RNA 854 _
LINC00857 LINC00857 N/A long intergenic non-protein coding RNA 857 lung cancer
LINC00868 LINC00868 N/A long intergenic non-protein coding RNA 868 _
LINC00869 LINC00869 KIAA0493 long intergenic non-protein coding RNA 869 _
LINC00880 LINC00880 N/A long intergenic non-protein coding RNA 880 _
LINC00882 LINC00882 N/A long intergenic non-protein coding RNA 882 _
LINC00887 LINC00887 linc-ATP13A4-8 long intergenic non-protein coding RNA 887 _
LINC00893 LINC00893 N/A long intergenic non-protein coding RNA 893 _
LINC00901 LINC00901 "TCONSN/A00005428, BC040587" long intergenic non-protein coding RNA 901 _
LINC00917 LINC00917 N/A long intergenic non-protein coding RNA 917 _
LINC00936 LINC00936 N/A long intergenic non-protein coding RNA 936 _
LINC00942 LINC00942 N/A long intergenic non-protein coding RNA 942 autism spectrum disorder
LINC00950 LINC00950 FP588 long intergenic non-protein coding RNA 950 _
LINC00951 LINC00951 "lincRNA-uc003opf.1, FLJ41649" long intergenic non-protein coding RNA 951 _
LINC00961 LINC00961 N/A long intergenic non-protein coding RNA 961 _
LINC00963 LINC00963 N/A long intergenic non-protein coding RNA 963 prostate cancer
LINC00964 LINC00964 N/A long intergenic non-protein coding RNA 964 _
LINC00970 LINC00970 N/A long intergenic non-protein coding RNA 970 _
LINC00974 LINC00974 N/A long intergenic non-protein coding RNA 974 hepatocellular carcinoma
LINC00977 LINC00977 N/A long intergenic non-protein coding RNA 977 _
LINC00982 LINC00982 FLJ42875 long intergenic non-protein coding RNA 982 gastric cancer
LINC00993 LINC00993 N/A long intergenic non-protein coding RNA 993 _
LINC00994 LINC00994 N/A long intergenic non-protein coding RNA 994 _
LINC00996 LINC00996 N/A long intergenic non-protein coding RNA 996 _
LINC01016 LINC01016 N/A long intergenic non-protein coding RNA 1016 Breast Cancer
LINC01018 LINC01018 N/A long intergenic non-protein coding RNA 1018 _
LINC01019 LINC01019 N/A long intergenic non-protein coding RNA 1019 _
LINC01020 LINC01020 N/A long intergenic non-protein coding RNA 1020 _
LINC01021 LINC01021 N/A long intergenic non-protein coding RNA 1021 _
LINC01024 LINC01024 MA-linc1 long intergenic non-protein coding RNA 1024 _
LINC01029 LINC01029 N/A long intergenic non-protein coding RNA 1029 _
LINC01080 LINC01080 TCONSN/A00021856 long intergenic non-protein coding RNA 1080 Alzheimer's disease ;amnestic mild cognitive impairment
LINC01081 LINC01081 TCONSN/A00024764 long intergenic non-protein coding RNA 1081 alveolar capillary dysplasia ;misalignment of pulmonary veins
LINC01082 LINC01082 TCONSN/A00024492 long intergenic non-protein coding RNA 1082 _
LINC01089 LINC01089 N/A long intergenic non-protein coding RNA 1089 _
LINC01090 LINC01090 N/A long intergenic non-protein coding RNA 1090 _
LINC01091 LINC01091 N/A long intergenic non-protein coding RNA 1091 _
LINC01096 LINC01096 N/A long intergenic non-protein coding RNA 1096 _
LINC01105 LINC01105 "FLJ30594, LOC150622" long intergenic non-protein coding RNA 1105 3-predicted disease-related genes
LINC01108 LINC01108 LncRNA-ES1 long intergenic non-protein coding RNA 1108 _
LINC01122 LINC01122 FLJ30838 long intergenic non-protein coding RNA 1122 _
LINC01133 LINC01133 N/A long intergenic non-protein coding RNA 1133 lung squamous cell cancer
LINC01139 LINC01139 N/A long intergenic non-protein coding RNA 1139 _
LINC01140 LINC01140 FLJ41676 long intergenic non-protein coding RNA 1140 _
LINC01150 LINC01150 "2G7, TCONSN/A00019134" long intergenic non-protein coding RNA 1150 _
LINC01152 LINC01152 "TCONSN/A00025128, CMPD" long intergenic non-protein coding RNA 1152 _
LINC01154 LINC01154 N/A long intergenic non-protein coding RNA 1154 _
LINC01157 LINC01157 "TCONSN/A00010378, linc-Enc1" long intergenic non-protein coding RNA 1157 brain development
LINC01158 LINC01158 linc-Brn1a long intergenic non-protein coding RNA 1158 _
LINC01159 LINC01159 linc-Brn1b long intergenic non-protein coding RNA 1159 _
LINC01184 LINC01184 FLJ33630 long intergenic non-protein coding RNA 1184 _
LINC01185 LINC01185 FLJ16341 long intergenic non-protein coding RNA 1185 1-Psoriasis
LINC01192 LINC01192 N/A long intergenic non-protein coding RNA 1192 _
LINC01193 LINC01193 LOC348120 long intergenic non-protein coding RNA 1193 _
LINC01194 LINC01194 TAG long intergenic non-protein coding RNA 1194 _
LINC01202 LINC01202 N/A long intergenic non-protein coding RNA 1202 _
LINC01207 LINC01207 N/A long intergenic non-protein coding RNA 1207 Lung adenocarcinoma
LINC01225 LINC01225 N/A long intergenic non-protein coding RNA 1225 hepatocellular carcinoma
LINC01228 LINC01228 lincRNA-DYNLRB2-2 long intergenic non-protein coding RNA 1228 _
LINC01230 LINC01230 "linc-DMRT2, lnc-DRMT2, TCONSN/A00015639" long intergenic non-protein coding RNA 1230 _
LINC01232 LINC01232 "FLJ41590, TCONSN/A00021520" long intergenic non-protein coding RNA 1232 _
LINC01233 LINC01233 XLOCN/A013014 long intergenic non-protein coding RNA 1233 _
LINC01234 LINC01234 onco-lncRNA-32 long intergenic non-protein coding RNA 1234 oesophageal squamous cell carcinoma
LINC01252 LINC01252 N/A long intergenic non-protein coding RNA 1252 _
LINC01262 LINC01262 "TCONSN/Al2N/A00021807, RP11-462G22.1" long intergenic non-protein coding RNA 1262 Parkinson's disease
LINC01264 LINC01264 RP11-124O11.2 long intergenic non-protein coding RNA 1264 _
LINC01268 LINC01268 LOC285758 long intergenic non-protein coding RNA 1268 _
LINC01296 LINC01296 FLJ39632 long intergenic non-protein coding RNA 1296 prognostic biomarker
LINC01312 LINC01312 MGC34034 long intergenic non-protein coding RNA 1312 _
LINC01317 LINC01317 N/A long intergenic non-protein coding RNA 1317 _
LINC01370 LINC01370 HI-LNC25 long intergenic non-protein coding RNA 1370 _
LINC01374 LINC01374 TCONSN/A00018278 long intergenic non-protein coding RNA 1374 hepatocellular carcinoma
LINC01405 LINC01405 N/A long intergenic non-protein coding RNA 1405 _
LINC01411 LINC01411 RP11-267A15.1 long intergenic non-protein coding RNA 1411 prostate cancer
LINC01420 LINC01420 N/A long intergenic non-protein coding RNA 1420 _
LINC01433 LINC01433 LOC728228 long intergenic non-protein coding RNA 1433 _
LINC01435 LINC01435 "RP11-215N21.1, TCONSN/A00018040" long intergenic non-protein coding RNA 1435 _
LINC01436 LINC01436 AP000688.8 long intergenic non-protein coding RNA 1436 _
LINC01468 LINC01468 lnc-MBL2-4 long intergenic non-protein coding RNA 1468 _
LINC01478 LINC01478 N/A long intergenic non-protein coding RNA 1478 _
LINC01501 LINC01501 N/A long intergenic non-protein coding RNA 1501 _
LINC01503 LINC01503 lnc-PPP2R4-5 long intergenic non-protein coding RNA 1503 _
LINC01507 LINC01507 XLOCN/A000303 long intergenic non-protein coding RNA 1507 _
LINC01511 LINC01511 RP11-325I22.2 long intergenic non-protein coding RNA 1511 lung adenocarcinoma
LINC01512 LINC01512 "LOC100132354, TCONSN/A00011120, HI-LNC77" long intergenic non-protein coding RNA 1512 type 2 diabetes
LINC01513 LINC01513 "RP11-1C1.7, TCONSN/A00009352" long intergenic non-protein coding RNA 1513 lung adenocarcinoma
LINC01525 LINC01525 lnc-MAN1A2-1 long intergenic non-protein coding RNA 1525 _
LINC01526 LINC01526 Lnc-FAM46A-1 long intergenic non-protein coding RNA 1526 _
LINC01527 LINC01527 lnc-SPRR2D-1 long intergenic non-protein coding RNA 1527 _
LINC01537 LINC01537 RP11-169D4.1-001 long intergenic non-protein coding RNA 1537 _
LINC01547 LINC01547 N/A long intergenic non-protein coding RNA 1547 _
LINC01553 LINC01553 AC023904.2 long intergenic non-protein coding RNA 1553 _
LINC01558 LINC01558 "HGC6.2, dJ431P23.4" long intergenic non-protein coding RNA 1558 _
LINC01559 LINC01559 FLJ33810 long intergenic non-protein coding RNA 1559 _
LINC01560 LINC01560 N/A long intergenic non-protein coding RNA 1560 _
LINC01562 LINC01562 RP11-296A18.3 long intergenic non-protein coding RNA 1562 intervertebral disc degeneration
LINC01564 LINC01564 TCONSN/A00011314 long intergenic non-protein coding RNA 1564 _
LINC01565 LINC01565 GR6 long intergenic non-protein coding RNA 1565 _
LINC01574 LINC01574 "HI-LNC12, TCONSN/A00009551" long intergenic non-protein coding RNA 1574 type 2 diabetes
LINC01587 LINC01587 aC1 long intergenic non-protein coding RNA 1587 _
LINC01589 LINC01589 "CTA-941F9.9, TCONSN/A00029353" long intergenic non-protein coding RNA 1589 _
LINC01591 LINC01591 N/A long intergenic non-protein coding RNA 1591 _
LINC01602 LINC01602 T1560 long intergenic non-protein coding RNA 1602 _
LINC01611 LINC01611 "RP1-90L14.1, TCONSN/Al2N/A00025430" long intergenic non-protein coding RNA 1611 _
LINC01612 LINC01612 "RP11-789C1.1, TCONSN/A00008319" long intergenic non-protein coding RNA 1612 gastric cancer
LINC01613 LINC01613 n341773 long intergenic non-protein coding RNA 1613 idiopathic pulmonary fibrosis
LINC01614 LINC01614 "LCAL4, TCONSN/A00003105" long intergenic non-protein coding RNA 1614 _
LINC01616 LINC01616 n341006 long intergenic non-protein coding RNA 1616 Alzheimer's disease
LINC01617 LINC01617 XLOCN/A006844 long intergenic non-protein coding RNA 1617 _
LINC01618 LINC01618 LOC152578 long intergenic non-protein coding RNA 1618 colorectal cancer
LINC01622 LINC01622 TCONSN/A00011202 long intergenic non-protein coding RNA 1622 _
LINC01627 LINC01627 RP11-397D12.4 long intergenic non-protein coding RNA 1627 NSCLC
LINC01628 LINC01628 AC007403.1 long intergenic non-protein coding RNA 1628 _
LINC01629 LINC01629 linc-KIAA1737-2 long intergenic non-protein coding RNA 1629 _
LINCMD1 LINCMD1 N/A "long intergenic non-protein coding RNA, muscle differentiation 1" Duchenne muscular dystrophy
LINGO1-AS1 LINGO1-AS1 N/A LINGO1 antisense RNA 1 _
LMCD1-AS1 LMCD1-AS1 N/A LMCD1 antisense RNA 1 (head to head) _
LOH12CR2 LOH12CR2 LOH2CR12 "loss of heterozygosity, 12, chromosomal region 2 (non-protein coding)" tumour suppressor
LOXL1-AS1 LOXL1-AS1 N/A LOXL1 antisense RNA 1 _
LPP-AS2 LPP-AS2 N/A LPP antisense RNA 2 _
LRP1-AS LRP1-AS N/A LRP1 antisense RNA _
LRRC75A-AS1 LRRC75A-AS1 MGC40157 LRRC75A antisense RNA 1 _
LUADT1 LUADT1 N/A lung adenocarcinoma associated transcript 1 lung adenocarcinoma
LUNAR1 LUNAR1 N/A leukemia-associated non-coding IGF1R activator RNA 1 _
MAFA-AS1 MAFA-AS1 "RP11-909N17.3, TCONSN/A00014882" MAFA antisense RNA 1 _
MAFG-AS1 MAFG-AS1 N/A MAFG antisense RNA 1 (head to head) _
MAFTRR MAFTRR linc-MAF-4 MAF transcriptional regulator RNA _
MAGEA8-AS1 MAGEA8-AS1 RP5-869M20.2 MAGEA8 antisense RNA 1 (head to head) _
MAPKAPK5-AS1 MAPKAPK5-AS1 FLJ39616 MAPKAPK5 antisense RNA 1 _
MCM3AP-AS1 MCM3AP-AS1 "FLJ10508, NCRNA00031" MCM3AP antisense RNA 1 _
MDC1-AS1 MDC1-AS1 MDC1-AS MDC1 antisense RNA 1 bladder cancer
MEF2C-AS1 MEF2C-AS1 N/A MEF2C antisense RNA 1 _
MEG9 [["ENST00000553584.1," LINC00584 maternally expressed 9 (non-protein coding) _
MESTIT1 MESTIT1 "NCRNA00040, MEST-AS1" "MEST intronic transcript 1, antisense RNA" _
MGAT3-AS1 MGAT3-AS1 TapSAKI MGAT3 antisense RNA 1 acute kidney injury
MHRT MHRT Myheart myosin heavy chain-associated RNA transcript heart pathological hypertrophy
MIF-AS1 MIF-AS1 LOC284889 MIF antisense RNA 1 malaria susceptibility
MIMT1 MIMT1 "MIM1, NCRNA00067, LINC00067" MER1 repeat containing imprinted transcript 1 (non-protein coding) _
MINCR ENST00000517411.1 TCONSN/A00015189 MYC-induced long noncoding RNA Burkitt lymphoma
MIR137HG MIR137HG N/A MIR137 host gene schizophrenia
MIR17HG MIR17HG "FLJ14178, MIRH1, MIHG1, NCRNA00048, miR-17-92, LINC00048" miR-17-92a-1 cluster host gene "lymphoma, syndromic developmental defect"
MIR181A2HG MIR181A2HG N/A MIR181A2 host gene _
MIR210HG MIR210HG N/A MIR210 host gene inflammatory renal epithelial injury
MIR34AHG MIR34AHG N/A MIR34A host gene _
MIR4435-2HG MIR4435-2HG "LINC00978, AGD2, AK001796" MIR4435-2 host gene _
MIR600HG MIR600HG "GL012, FLJ22161" MIR600 host gene _
MIR663AHG MIR663AHG RP3-410C9.1 MIR663A host gene _
MIR7-3HG MIR7-3HG "PGSF1, PGSF1a, PGSF1b, Huh7, uc002mbe.2" MIR7-3 host gene _
MIRLET7BHG MIRLET7BHG linc-Ppara MIRLET7B host gene asbestos exposure-related lung cancer
MIRLET7DHG MIRLET7DHG N/A MIRLET7D host gene _
MKRN3-AS1 MKRN3-AS1 "FNZ127, NCRNA00009, ZNF127-AS" MKRN3 antisense RNA 1 Prader-Willi syndrome ;Angelman syndromes
MLK7-AS1 MLK7-AS1 N/A MLK7 antisense RNA 1 _
MLLT4-AS1 MLLT4-AS1 "HGC6.4, dJ431P23.3" MLLT4 antisense RNA 1 (head to head) _
MORF4L2-AS1 MORF4L2-AS1 N/A MORF4L2 antisense RNA 1 _
MT-LIPCAR MT-LIPCAR "uc022bqs.1, LIPCAR" mitochondrially encoded long non-coding cardiac associated RNA heart failure
MYCNOS MYCNOS "NCYM, N-CYM, MYCN-AS1" MYCN opposite strand neuroblastoma
N4BP2L2-IT2 N4BP2L2-IT2 CG030 N4BPL2 intronic transcript 2 _
NALT1 NALT1 TCONSN/Al2N/A00029132 NOTCH1 associated lncRNA in T-cell acute lymphoblastic leukemia 1 _
NBAT1 NBAT1 NBAT-1 neuroblastoma associated transcript 1 Fighting Neuroblastomas ;breast cancer
NBR2 NBR2 NCRNA00192 neighbor of BRCA1 gene 2 (non-protein coding) breast cancer
NCBP2-AS2 NCBP2-AS2 N/A NCBP2 antisense RNA 2 (head to head) _
NCOA7-AS1 NCOA7-AS1 N/A NCOA7 antisense RNA 1 _
NCRUPAR NCRUPAR "ncR-uPAR, ncRuPAR, NCRNA00193" "non-protein coding RNA, upstream of F2R/PAR1" _
NFIA-AS1 NFIA-AS1 RP5-833A20.1 NFIA antisense RNA 1 _
NIPBL-AS1 NIPBL-AS1 NIPBL-AS NIPBL antisense RNA 1 (head to head) autism spectrum disorders
NKILA NKILA N/A NF-kappaB interacting long non-coding RNA breast cancer
NKX2-2-AS1 NKX2-2-AS1 NKX2-2AS NKX2-2 antisense RNA 1 _
NOP14-AS1 NOP14-AS1 RES4-24 NOP14 antisense RNA 1 Huntington disease
NORAD NORAD N/A non-coding RNA activated by DNA damage _
NPHP3-AS1 NPHP3-AS1 N/A NPHP3 antisense RNA 1 _
NPPA-AS1 NPPA-AS1 N/A NPPA antisense RNA 1 _
NPSR1-AS1 NPSR1-AS1 "AAA1, IMAGE:4827585" NPSR1 antisense RNA 1 cardiovascular disease
NPTN-IT1 NPTN-IT1 lncRNA-LET NPTN intronic transcript 1 colorectal cancer; hepatocelluar carcinoma;squamous-cell lung carcinomas
NR2F1-AS1 NR2F1-AS1 FLJ42709 NR2F1 antisense RNA 1 _
NRAV NRAV N/A negative regulator of antiviral response (non-protein coding) influenza A virus (IAV) infection
OLMALINC OLMALINC "bA34D15.5, FLJ12974, HI-LNC80" oligodendrocyte maturation-associated long intergenic non-coding RNA _
PANCR PANCR N/A PITX2 adjacent non-coding RNA _
PAPPA-AS1 PAPPA-AS1 "PAPPA-AS, DIPAS, TAF4B, TAF2C2, TAFII105, NCRNA00156" PAPPA antisense RNA 1 _
PAPPA-AS2 PAPPA-AS2 AGU1 PAPPA antisense RNA 2 stem cell differentiation
PARTICL PARTICL PARTICLE promoter of MAT2A antisense radiation-induced circulating long non-coding RNA _
PAXIP1-AS1 PAXIP1-AS1 N/A PAXIP1 antisense RNA 1 (head to head) _
PCAT14 PCAT14 N/A prostate cancer associated transcript 14 (non-protein coding) prostate cancer
PCAT18 PCAT18 LINC01092 prostate cancer associated transcript 18 (non-protein coding) metastatic prostate cancer
PCAT19 PCAT19 LINC01190 prostate cancer associated transcript 19 (non-protein coding) prostate cancer
PCAT29 PCAT29 N/A prostate cancer associated transcript 29 (non-protein coding) prostate cancer
PCAT5 PCAT5 TPCAT-10-36067 prostate cancer associated transcript 5 (non-protein coding) Prostate Cancer
PCBP2-OT1 PCBP2-OT1 TUC338 PCBP2 overlapping transcript 1 1-hepatocellular carcinoma
PCBP3-OT1 PCBP3-OT1 FLJ44028 PCBP3 overlapping transcript 1 DNA damage
PCF11-AS1 PCF11-AS1 ENST00000602322.1 PCF11 anstisense RNA 1 _
PCNA-AS1 PCNA-AS1 N/A PCNA antisense RNA 1 tumor
PEG13 PEG13 N/A paternally expressed 13 _
PEG3-AS1 PEG3-AS1 "APEG3, NCRNA00155" PEG3 antisense RNA 1 _
PICSAR PICSAR "PRED74, NLC1-C" P38 inhibited cutaneous squamous cell carcinoma associated lincRNA Cutaneous Squamous Cell Carcinoma
PINK1-AS PINK1-AS "FLJ00387, PINK1AS, naPINK1" PINK1 antisense RNA _
PISRT1 PISRT1 NCRNA00195 polled intersex syndrome regulated transcript 1 (non-protein coding RNA) blepharophimosis syndrome
PRKCQ-AS1 PRKCQ-AS1 ENST00000414894.1 PRKCQ antisense RNA 1 _
PRR7-AS1 PRR7-AS1 N/A PRR7 antisense RNA 1 _
PSMA3-AS1 PSMA3-AS1 FLJ31306 PSMA3 antisense RNA 1 _
PSMD5-AS1 PSMD5-AS1 N/A PSMD5 antisense RNA 1 (head to head) _
PTENP1-AS PTENP1-AS PTENpg1-asRNA PTENP1 antisense RNA _
PTPRJ-AS1 PTPRJ-AS1 N/A PTPRJ antisense RNA 1 _
PWAR1 PWAR1 "PAR1, PAR-1" Prader Willi/Angelman region RNA 1 _
PWAR4 PWAR4 "PAR4, PAR-4" Prader Willi/Angelman region RNA 4 _
PWAR5 PWAR5 "PAR5, PAR-5" Prader Willi/Angelman region RNA 5 _
PWARSN PWARSN "PAR-SN, PARSN" "Prader Willi/Angelman region RNA, SNRPN neighbor" Prader-Willi syndrome
RAD51-AS1 RAD51-AS1 TODRA RAD51 antisense RNA 1 (head to head) _
RFPL1S RFPL1S "RFPL1-AS, NCRNA00006" RFPL1 antisense RNA 1 _
RGMB-AS1 RGMB-AS1 N/A RGMB antisense RNA 1 non-small cell lung cancer
RHPN1-AS1 RHPN1-AS1 MGC3113 RHPN1 antisense RNA 1 (head to head) _
RMST RMST "NCRMS, NCRNA00054, LINC00054" rhabdomyosarcoma 2 associated transcript (non-protein coding) Rhabdomyosarcoma subtypes
RNF217-AS1 RNF217-AS1 STL RNF217 antisense RNA 1 (head to head) _
RNF219-AS1 RNF219-AS1 N/A RNF219 antisense RNA 1 _
RPL34-AS1 RPL34-AS1 "FLJ37673, RP11-462C24.1" RPL34 antisense RNA 1 (head to head) _
RPS6KA2-AS1 RPS6KA2-AS1 N/A RPS6KA2 antisense RNA 1 _
RUSC1-AS1 RUSC1-AS1 FLJ35976 RUSC1 antisense RNA 1 _
SALRNA1 SALRNA1 "SAL-RNA1, XLOCN/A023166" senescence associated long non-coding RNA 1 _
SALRNA2 SALRNA2 "SAL-RNA2, XLOCN/A025931" senescence associated long non-coding RNA 2 _
SALRNA3 SALRNA3 "SAL-RNA3, XLOCN/A025918" senescence associated long non-coding RNA 3 _
SAMD12-AS1 SAMD12-AS1 N/A SAMD12 antisense RNA 1 _
SAMMSON SAMMSON N/A survival associated mitochondrial melanoma specific oncogenic non-coding RNA Melanoma
SAP30L-AS1 SAP30L-AS1 "FLJ38109, GALNT10-AS1" SAP30L antisense RNA 1 (head to head) _
SEC24B-AS1 SEC24B-AS1 1/2-SBSRNA4 SEC24B antisense RNA 1 _
SGMS1-AS1 SGMS1-AS1 N/A SGMS1 antisense RNA 1 _
SIRT1-AS SIRT1-AS N/A SIRT1 antisense RNA Hepatocellular Carcinoma
SMAD1-AS1 SMAD1-AS1 ENST00000513542 SMAD1 antisense RNA 1 Ventricular septal defects
SMAD5-AS1 SMAD5-AS1 DAMS SMAD5 antisense RNA 1 _
SMCR2 SMCR2 N/A "Smith-Magenis syndrome chromosome region, candidate 2 (non-protein coding)" _
SMCR5 SMCR5 NCRNA00034 "Smith-Magenis syndrome chromosome region, candidate 5 (non-protein coding)" _
SMCR6 SMCR6 N/A "Smith-Magenis syndrome chromosome region, candidate 6 (non-protein coding)" Smith-Magenis syndrome
SMG7-AS1 SMG7-AS1 DKFZP564C196 SMG7 antisense RNA 1 _
SNAI3-AS1 SNAI3-AS1 MGC23284 SNAI3 antisense RNA 1 _
SNHG10 SNHG10 "FLJ40557, NCRNA00063, LINC00063" small nucleolar RNA host gene 10 _
SNHG11 SNHG11 LINC00101 small nucleolar RNA host gene 11 obesity
SNHG12 SNHG12 "PNAS-123, LINC00100, ASLNC04080" small nucleolar RNA host gene 12 osteosarcoma
SNHG14 SNHG14 "NCRNA00214, UBE3A-AS" small nucleolar RNA host gene 14 Prader-Willi
SNHG15 SNHG15 "FLJ38860, MYO1GUT, Linc-Myo1g" small nucleolar RNA host gene 15 hepatocellular carcinoma
SNHG16 NONHSAT056039 ncRAN small nucleolar RNA host gene 16 "bladder cancer, colorectal cancer"
SNHG20 SNHG20 "PRO0872, FLJ25582, DKFZp686L05235, SCARNA16HG" small nucleolar RNA host gene 20 Hepatocellular Carcinoma
SNHG7 SNHG7 "MGC16037, NCRNA00061" small nucleolar RNA host gene 7 _
SNHG8 SNHG8 "NCRNA00060, LINC00060" small nucleolar RNA host gene 8 _
SOCS2-AS1 SOCS2-AS1 N/A SOCS2 antisense RNA 1 _
SOX21-AS1 SOX21-AS1 N/A SOX21 antisense RNA 1 (head to head) _
SOX2-OT SOX2-OT "DKFZp761J1324, NCRNA00043" SOX2 overlapping transcript "Esophageal squamous cell cancer, Alzheimer's disease,Neurodevelopmental syndromes associated with the SOX2 locus"
SPATA3-AS1 SPATA3-AS1 N/A SPATA3 antisense RNA 1 (head to head) _
ST7-AS1 ST7-AS1 ST7AS1 ST7 antisense RNA 1 _
ST7-AS2 ST7-AS2 ST7AS2 ST7 antisense RNA 2 _
ST7-OT3 ST7-OT3 NCRNA00026 ST7 overlapping transcript 3 _
STAM-AS1 STAM-AS1 locus3182 STAM antisense RNA 1 (head to head) _
STX18-AS1 STX18-AS1 LOC100507266 STX18 antisense RNA 1 (head to head) _
TCL6 TCL6 "TCL6e1, TNG2, TNG1" T-cell leukemia/lymphoma 6 (non-protein coding) "leukemia, lymphoma"
TDRG1 NONHSAT112472 "LINC00532, lincRNA-NRN/A024015" testis development related 1 (non-protein coding) testicular cancer
TEX41 TEX41 "DKFZp686O1327, LINC00953" testis expressed 41 (non-protein coding) _
TGFB2-OT1 TGFB2-OT1 FLJ11812 TGFB2 overlapping transcript 1 _
TH2LCRR TH2LCRR TH2-LCR T helper type 2 locus control region associated RNA _
THRIL Lnc-DHX37-1:1 "Linc1992, TCONSN/A00020260, BRI3BP-AS1" TNF and HNRNPL related immunoregulatory long non-coding RNA Kawasaki disease
TINCR ENST00000448587.1 "FLJ90734, NCRNA00036, LINC00036, onco-lncRNA-16" tissue differentiation-inducing non-protein coding RNA "squamous cell carcinoma, gastric cancer"
TLX1NB TLX1NB "TD1, TDI, APT-B7" TLX1 neighbor _
TMEM92-AS1 TMEM92-AS1 "RP11-893F2.9, lncRNA-508851, TCONSN/A00025237" TMEM92 antisense RNA 1 _
TMEM9B-AS1 TMEM9B-AS1 N/A TMEM9B antisense RNA 1 _
TOLLIP-AS1 TOLLIP-AS1 N/A TOLLIP antisense RNA 1 (head to head) _
TP53COR1 TP53COR1 "linc-p21, lincRNA-p21, Trp53cor1" tumor protein p53 pathway corepressor 1 (non-protein coding) _
TP53TG1 TP53TG1 "HN/ARG012D21.9, LINC00096" TP53 target 1 (non-protein coding) _
TP73-AS1 TP73-AS1 PDAM TP73 antisense RNA 1 esophageal squamous cell carcinoma.
TRERNA1 TRERNA1 "ncRNA-a7, treRNA" translation regulatory long non-coding RNA 1 _
TRPM2-AS TRPM2-AS TRPM2-AS1 TRPM2 antisense RNA cancer
TSIX TSIX "NCRNA00013, XIST-AS1, LINC00013" "TSIX transcript, XIST antisense RNA" _
TSPEAR-AS2 TSPEAR-AS2 N/A TSPEAR antisense RNA 2 _
TTC28-AS1 TTC28-AS1 KIAA1648 TTC28 antisense RNA 1 _
TTTY15 TTTY15 "DKFZP434I143, NCRNA00138" "testis-specific transcript, Y-linked 15 (non-protein coding)" prostate cancer sample
TTTY17A TTTY17A NCRNA00140 "testis-specific transcript, Y-linked 17A (non-protein coding)" _
TTTY3 TTTY3 "TTY3, TTTY3A, LINC00121" "testis-specific transcript, Y-linked 3 (non-protein coding)" _
TTTY4 TTTY4 "TTY4, TTTY4A, LINC00123" "testis-specific transcript, Y-linked 4 (non-protein coding)" _
TTTY5 TTTY5 "TTY5, LINC00126" "testis-specific transcript, Y-linked 5 (non-protein coding)" _
TTTY6 TTTY6 "TTY6, TTTY6A, LINC00127" "testis-specific transcript, Y-linked 6 (non-protein coding)" _
TTTY9B TTTY9B NCRNA00132 "testis-specific transcript, Y-linked 9B (non-protein coding)" _
TUNAR TUNAR "TUNA, HI-LNC78" TCL1 upstream neural differentiation-associated RNA type 2 diabetes
TUSC8 TUSC8 XLOCN/A010588 tumor suppressor candidate 8 (non-protein coding) cervical cancer
UMODL1-AS1 UMODL1-AS1 FLJ33471 UMODL1 antisense RNA 1 breast cancer
VLDLR-AS1 VLDLR-AS1 N/A VLDLR antisense RNA 1 _
WAC-AS1 WAC-AS1 N/A WAC antisense RNA 1 (head to head) _
WASIR2 WASIR2 N/A WASH and IL9R antisense RNA 2 _
WDFY3-AS2 WDFY3-AS2 FBI4 WDFY3 antisense RNA 2 _
WSPAR WSPAR "TCONSN/A00009511-XLOCN/A004555, lncTCF7" WNT signaling pathway activating non-coding RNA _
XACT XACT N/A X active specific transcript (non-protein coding) chromosome inactivation
YAM1 YAM1 Yam-1 YY1-associated myogenesis RNA 1 skeletal myogenesis
ZBED3-AS1 ZBED3-AS1 N/A ZBED3 antisense RNA 1 chondrogenic differentiation
ZEB1-AS1 ZEB1-AS1 N/A ZEB1 antisense RNA 1 hepatocellular carcinoma, esophageal squamous cell carcinoma
ZFAT-AS1 ZFAT-AS1 "SAS-ZFAT, NCRNA00070" ZFAT antisense RNA 1 autoimmune thyroid disease
ZIM2-AS1 ZIM2-AS1 ZIM2as ZIM2 antisense RNA 1 _
ZNF205-AS1 ZNF205-AS1 MGC3771 ZNF205 antisense RNA 1 _
ZNF252P-AS1 ZNF252P-AS1 N/A ZNF252P antisense RNA 1 _
ZNF436-AS1 ZNF436-AS1 FLJ90508 ZNF436 antisense RNA 1 _
ZNF582-AS1 ZNF582-AS1 N/A ZNF582 antisense RNA 1 (head to head) _
ZNF667-AS1 ZNF667-AS1 MORT ZNF667 antisense RNA 1 (head to head) cancer
ZRANB2-AS2 ZRANB2-AS2 N/A ZRANB2 antisense RNA 2 (head to head) _
Retrieved from "https://ngdc.cncb.ac.cn/lncrnawiki1/index.php?title=LncRNAWiki:Featured&oldid=1272144"